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ABSTRACT 
New Jl>yridylboronic Acids and their Cross-Coupling Reactions 
Paul Richard Parry, University of Durham, 2003 
The novel substituted pyridylboronic acids 2-bromo-5-pyridylboronic acid 92, 3-bromo-
5-pyridylboronic acid 97, 2-chloro-5-pyridylboronic acid 
pyridylboronic acid 108, 2-methoxy-5-pyridylboronic acid 
103, 2-fluoro-5-
123, 2-ethoxy-5-
pyridylboronic acid 125, 2-methoxy-3-pyridylboronic acid 131, 3-bromo-6-methoxy-4-
pyridylboronic acid 134, 3-chloro-6-methoxy-4-pyridylboronic acid 137 and 3-bromo-
6-ethoxy-4-pyridylboronic acid 138 have been synthesised and shown to undergo 
palladium-catalysed Suzuki cross-coupling reactions with a vast variety of heteroaryl 
bromides to yield novel heteroarylpyridine derivatives. 
5-Formylfuran-2-boronic acid 170 has been synthesised and isolated and has been 
shown to undergo palladium-catalysed Suzuki cross-coupling reactions with a variety of 
heteroaryl bromides to yield novel heteroaryl substituted furyl derivatives. These 
derivatives have been shown to undergo efficient functionalisation by Wittig chemistry. 
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Introduction to Heterocyclic 
Boronic Acids 
Introduction to Heterocyclic Boronic Acids 
1.0 ll.ntroducHon to Heterocyclic lBororuic Acids 
Arylboronic acids have been known since 1880 when Michaelis and Becker1 first 
synthesised phenylboronic acid (1 ). From that early discovery the synthesis and study 
of phenyl- and substituted-phenylboronic acids has been extensive. This thesis 
concerns heterocyclic boronic acids, in particular, substituted-pyridylboronic acids (2). 
The main objectives of this work were: (i) to obtain shelf-stable pyridylboronic acids 
containing substituents that are suitable for subsequent transformations, and (ii) to 
explore the scope of their reactions with a variety of halogenated ring systems, i.e. 
heterocyclic or phenyl, under Suzuki cross-coupling conditions, and thereby obtain new 
aryl- and heteroaryl-substituted pyridine derivatives. 
1 
R2 
~,(. 
R 1- 1 'I B(OH) ~ ~ 2 
N 
R\ R2=Halogen, Alkoxy 
2 
1.1 Why Make Heterocyclic Boronic Acids? 
The attraction to heterocyclic boronic acids stems from the fact that many natural 
products,2 modem pharmaceuticals3 and materials4 contain at least one heterocycle. So, 
new reagents that are applicable to the synthesis of such products are valuable tools in 
the arsenal ofthe synthetic chemist. 
However, many organoboron compounds are mr sensitive, and in some cases 
pyrophoric, for example Me3B.5 Also, organoboron compounds containing boron-
hydrogen, oxygen, nitrogen and halogen bonds tend to be easily hydrolysed. Boronic 
acids, Ar-B(OH)2 (Ar=aryl, heteroaryl) on the other hand are an exception to this trend. 
They are relatively stable to air and moisture, temperature stable, exhibit low toxicity 
and are environmentally friendly. 
Most boronic acids readily undergo dehydration at room temperature to form the cyclic 
trimeric anhydride structure (3) (Scheme 1.1 ). 
1 
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Ar-B(OHh 
tj\r 
o .... 8 'o 
I I 
Ar_....B ..... O .... B'Ar 
3 
Ar = Phenyi,Furyl, Thienyl, Pyridyl 
Scheme 1.1: Formation of the Cyclic Trimeric Anhydride by Dehydration. 
It is often difficult to obtain the free acid from the anhydride. Since, in almost all cases, 
either the acid or the anhydride will undergo the required reaction, they can be regarded 
as equivalent reagents. 
The main application of boronic acids is in the synthesis of biaryls (Ar-Ar) and their 
homologues, such as teraryls and polyaryls by a transition metal-catalysed cross-
coupling reaction, known as the Suzuki cross-coupling reaction. This chapter will look 
at the general synthesis of boronic acids and will review the Suzuki reaction. This 
chapter will also review the history, synthesis and application of heterocyclic boronic 
acids, such as furyl- (4), thienyl- (5), and quinolylboronic acid (6), concluding with a 
review of the parent pyridylboronic acids (7). 
4 
OB(OHh 
s 
5 6 
1.2 Synthesis of Heterocyclic Boronic Acids 
0 B(OHh 
N 
7 
Classically, the synthesis of heterocyclic boronic acids involves the reaction of an in 
situ generated heteroaryl organometallic reagent with a suitable electrophile, usually 
trimethylborate, TMB (8), triethylborate, TEB (9), triisopropylborate, TPB (1 0) or tri-n-
butylborate, TBB (11) (Scheme 1.2). 
2 
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Ar-M + E Work-up Ar-B(OHh 
Ar =Furan, Thiophene, Pyridine 
M = MgX (X=I, Br, Cl}, Li 
""o ~0 ~0 ~0 J I 
o--8--oj o-- 8--o~ o--8--o E = o" 8 'o/ 
I l__ A \ 
8 9 10 11 
Scheme 1.2: Formation of Boronic Acids. 
The favoured alkylborate is generally TPB, as it avoids the formation of contaminates 
resulting in multiple alkylation of the borates.6 Borates are the electrophile of choice 
because the boron has a vacant 2p orbital, which can accept electrons. 
In the case of pyridine, the organometallic reagents are required to generate a 
nucleophilic carbon, which will then attack the electrophile, as pyridine undergoes 
electrophilic substitution with great difficulty.7 There are two reasons for this. Firstly, 
when pyridines are exposed to electrophiles, they tend to form a pyridinium cation, 
making electrophilic substitution at a carbon atom even more difficult. Secondly, the 
electrophilic substitution at the carbon atoms of the pyridine ring is a selective reaction. 
Substitution normally occurs at the 3-position, which leads to the formation of the least 
destabilized intermediates in the presence of nitrogen. Scheme 1.3 is an illustration of 
the electrophilic substitution intermediates of pyridine. 8 
3 
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~ G) G)_ ~()_H ... .., ;) H "" 2-Position H N E N E ~ E 
G) H H H f:f-E ... • o-E.,. aE 3-Position G)r>: .,. N G) 
N N 
6) H E 0 G) 0 G) 4-Position ) I ... • ... • _..-; N ~ N 
Scheme 1.3: Electrophilic Substitution of Pyridine at the 2-, 3-, and 4-positions. 
With respect to five-membered heterocycles, such as furan and thiophene, which readily 
undergo electrophilic substitution, the generation of organometallic reagents 
compliments the electrophilic substitution reaction. 9 
1.2.1 Generation of Organometallic Reagents 
Formation of either a Grignard reagent or an organolithium reagent generates the 
required nucleophilic carbon, due to the polarity of the covalent bond between the 
carbon and the magnesium or lithium. Figure 1.1 shows the polarization of the carbon-
magnesium and carbon-lithium bonds. 
Electronegativities 
2.5 1.3 2.5 1.0 
~ ~ ~ ~ 
C~Mg C~Li 
8- 8+ 8- 8+ 
Figure 1.1: Generation of Nucleophilic Carbon. 
4 
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1.2.1.1 Grignard Reagents 
The significance of the Grignard reaction 10 is clearly expressed in the following 
quotations: " ... he who knows and understands the Grignard reaction has a fair grasp of 
organic chemistry ... " 11 and " ... every chemist has carried out the Grignard reaction at 
least once in their lifetime ... " 12 • A Grignard reagent takes the form RMgX, 13 where R 
can be an alkyl, aryl or heteroaryl, and X can be I, Br or Cl. The reactions, which are 
carried out in ether solutions, involve the 'insertion' of Mg into the C-halogen bond 
(Scheme 1.4). 
Scheme 1.4: Generation of a Grignard Reagent. 
8- 0+ 
R-MgX 
After the insertion step, the oxidation state of the magnesium changes from Mg(O) to 
Mg (II). This means that the reaction is an oxidative insertion or addition. Grignard 
reagents are not isolated and are reacted in situ. 14 The Mg acts as a Lewis acid, due to 
its empty 3p orbital, and accepts a lone pair of electrons from the solvent (Figure 1.2). 
~~~ 1-o o-\ \/ 
Mg 
R/ 'x 
Figure 1.2: Coordination of Solvent to Magnesium. 
The success of Grignard reagent generation often depends on the state of the metal 
surface. Magnesium is often covered with a thin coating of magnesium oxide, so the 
magnesium needs activating for which there are two main procedures: 1) Activated 
magnesium by entrainment, 2) Iodine-activated magnesium. 10 
Activation by entrainment involves the use of catalytic amounts of a lower, but more 
reactive alkyl halide to continuously activate the magnesium surface. The reactive 
5 
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halide cleans and activates the surface of the magnesium, thus allowing the inert halide 
subsequently to react. 
An example of an entrainer is 1,2-dibromoethane (12). 15 A proposed mechanism for its 
action is via 2-bromoethylmagnesium bromide which rapidly eliminates MgBr2 to give 
ethene (Scheme 1.5). The MgBr2 produced subsequently reacts with the inert halide to 
give the desired Grignard reagent. 
Br~Br + Mg H H >=< + H H 
12 
Scheme 1.5: Application of 1,2-Dibromoethane in the Generation of Grignard Reagents. 
Iodine is used as a catalyst in the activation of magnesium. Iodine is known to be one of 
the earliest catalysts in this context. 16 The accepted mechanism involves the formation 
of magnesium (I) iodide. 10' 17 This is the catalytic species as it is regenerated during the 
reaction. The mechanism for its formation is illustrated in Scheme 1.6. 
Mg + 2 Mgl 
R-X + Mgl + XMgl 
XMgl + Mg MgX + Mgl 
+ MgX RMgX 
Scheme 1.6: Mechanism of Grignard Reagent Formation via Iodine Catalysis. 
This methodology has been applied to the synthesis of 3-pyridylboronic acid (13) 
(Scheme 1. 7). 18 
6 
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(J--s(OH)2 
N 
13 
Scheme 1.7: Formation of 3-Pyridylboronic Acid. Reagents and Conditions: (i) 1. Mg/12/1,2-
dibromoethane. 2. TBB. 3. Aq. Work-up (Yield, 28%). 
The yield of 13 was low, even when the Grignard reagent was generated using both of 
the activation techniques previously described. The fmmation of Grignard reagents 
from halopyridines is known to be difficult and low yielding. 
Alternative routes for the synthesis of Grignard reagents involve the use of halogen-
magnesiwn exchange reactions. These routes are valuable due to the difficulty in 
forming pyridine Grignard reagents. A review of the literature revealed that successful 
syntheses of pyridine Grignard reagents had been achieved using iodopyridines 
(Scheme 1.8). 19 
0 I + Et-MgBr 
N 
0 MgBr + Etl 
N 
Scheme 1.8: Generation of Grignard Reagents via Halogen-Magnesium Exchange. 
Unfortunately, iodopyridines are expensive and are not readily available. Paradies20 and 
Meunie~ 1 have reported results using chloro- and bromopyridines. Paradies has 
described the bromine- and chlorine-magnesium exchange with phenylmagnesium 
halides,20 and Meunier obtained bromine-magnesium exchange when 
isopropylmagnesium chloride, iPrMgCl, was used in THF at -25°C.21 Trecourt et aP2 
have optimized conditions to form the Grignard reagent at room temperature. They 
took 2-and 3-bromopyridine and reacted them with iPrMgCl and trapped the Grignard 
reagent with various electrophiles. An example of this reaction is illustrated in Scheme 
1.9. 
7 
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~ i) ~ __ ;J Br ---------=--.. 
N 
0 CH(OH)Ph 
N 
Scheme 1.9: Entrapment of Grignard Species Generated by the Action of ;PrMgCI on 2-and 3-
Bromopyridine. Reagents and Conditions: (i) 1. ;PrMgCI, THF, rt. 2). Benzaldehyde. 3). H20. 
This method has recently been used in the attempted synthesis of 13,23 although the 
route gave unsatisfactory results due to the poor solubility and low conversions. 
1.2.1.2 Lithium Reagents 
Some of the most important developments in heterocyclic chemistry in the last 20 years 
have been in the area of organometallic chemistry.9 Lithio-heterocycles are most useful 
as they can react with a whole range of electrophiles. The two main methods for the 
preparation of this class of compound are metal-hydrogen and metal-halogen exchange. 
Metal-hydrogen exchange is achieved usmg commercially available organolithium 
reagents, typically n-butyllithium, n-BuLi, and lithium diisopropylamide, LDA. 
The ease of the deprotonation reaction generally depends on two factors: 
1) The acidity of the hydrogen to be removed 
2) The stability of the carbanion produced?4 
The reaction is aided by the presence of functional groups that possess either inductive 
(e.g. Br, Cl) or chelating effects (e.g. OMe, CH20H), which are present ortho to the site 
of metal-hydrogen exchange. This is known as directed ortho metallation (Do M). An 
example of this is the regioselective lithiation of 4-methoxypyridine by LDA.25 The 
functional group 'guides' the LDA so that it attacks the ortho proton, due to the 
formation of a complex with the Lewis-acidic atom (Scheme 1.1 0). 13 
8 
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Complexation between --( J 
o>yg'" ~cl Uwi•<>oidi~~ .Ji) \ 
~ 
L.J 
N 
:Lu 
l .. J 
N 
+ 
~ 
H-N ;-
Scheme 1.10: Generation of Lithium Reagent via Complexation. 
Metal-halogen exchange (Scheme 1.11) IS one of the most powerful methods for 
preparing organometallic compounds. 26 
~Br 
ll .. J N 
nBuli a li + BuBr ....-: 
N 
LcfB~~IL~ 
N 
Scheme 1.11: Halogen-Lithium Exchange. 
The reagent of choice for this reaction IS normally nBuLi, as the by-product, n-
butylbromide, does not usually interfere with subsequent steps. The metal-halogen 
exchange reaction is strongly exothermic,27 which means the addition of nBuLi has to 
be performed slowly at low temperatures, typically -1 oooc to -40°C. These 
temperatures are not easy to realise industrially, but they are required in order to reduce 
the possibility of side reactions,22 such as deprotonation, addition of substrate, LiBr 
elimination yielding pyridynes, bromine migration or ring opening reactions. 
The advantages that lithiation has over Grignard reagents, with respect to this work, is 
that lithiated pyridines are known to display a high reactivity toward many 
electrophiles;28 they are more convenient to synthesise and behave as typical 
organometallic reagents. 29 
9 
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1.3 Transition Metal-Mediated Cross-Coupling Reactions 
The synthesis of biaryls (Ar-Ar) by transition metal-mediated cross-coupling reactions 
is important because, along with their homologues, i.e. teraryls, oligoaryls and 
polyaryls, they are constituents which are present in a number of compounds ranging 
from natural products, polymers, advanced materials, liquid crystals, ligands and 
pharmaceuticals.30 Interest in the transition metal-mediated cross-coupling reaction 
began almost 60 years ago when Kharasch set the stage for catalytic C-C bond 
formation reactions. Ever since then, the study and development of metal-catalysed 
cross-coupling reactions of various organometallics (Mg, Li, Cu, Zn, Zr, AI, Sn and B) 
has grown rapidly. 
Kharasch's reaction did not achieve importance as a method for biaryl synthesis until 
the 1970s.31 Kharasch reacted an aryl Grignard reagent with an arylhalide in the 
presence of an appropriate catalyst to yield the biaryl (Ar-Ar). 3° Corriu32 and Kumada33 
also showed the synthetic promise of catalytic ArMgX plus ArX combinations to afford 
biaryls. 34 Negishi35 cross-coupled an arylzinc reagent (ArZnX) with an aryl halide to 
generate the corresponding biaryl. The late 1970s saw the introduction of the Stille 
reaction in the formation of biaryls. This involved the reaction of an organostannane 
reagent (ArSnR3, R=Me, Bu) with an arylhalide or triflate (tri:fluoromethanesulfonate). 
Then, the early 1980s saw the advent of the Suzuki reaction, which involves the 
reaction of an arylboronic acid (ArB(OH)2) with ArX to give the desired biaryl. The 
Kharasch,36 Negishi,37 Stille38 and Suzuki39 cross-coupling reactions are the most 
common catalytic methods for the synthesis of biaryls. These reactions are used for the 
production of symmetrical and unsymmetrical biaryls using either nickel or palladium 
catalysts. Scheme 1.12 shows examples of each of these reactions. 
10 
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()__ Br-o-Br 
Pd(dppb)CI2 
Kharasch o-G-sr S MgBr N- S N 
o- -{) Pd(PPh3)4 o-o N ZnBr Br :-.., /; Negishi 
N N N 
Q-snMe3 Br-cN 
Pd(PPh3)4 
Q-CN 
Stille 
B(OHh Br o-t'H 0 NOCMe3 Pd(PPh3)4 N o )=o Suzuki 2.5M HCI 0 NYN N, 
H 
OCMe3 
Scheme 1.12: Examples of Transition Metal-Mediated Cross-Coupling Reactions. 
All these methods exhibit chemo- and regioselectivity, and the Stille reaction has the 
advantage that it can tolerate more functionalities on either coupling partner than the 
Kharasch and Negishi reactions. However, the Stille reaction is avoided whenever 
possible because of the toxicity of the organotin reagents and the by-products generated. 
This has resulted in the Suzuki reaction being the first choice cross-coupling reaction. 
1. 3.1 Suzuki Cross-Coupling Reaction 
Suzuki et af0 first published the cross-coupling of an arylboronic acid in 1981. 
Gronowitz et af1 later modified Suzuki's work, allowing the synthesis of biaryls, 
heterobiaryls, teraryls and condensed ring systems. 
The advantages of the Suzuki cross-coupling reaction are: 34 
• Boronic acids are often air stable, non-toxic and have long shelf-lives 
• Experiences little homocoupling, i.e. self-coupling 
• Can tolerate aqueous conditions 
11 
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o Reaction is applicable with a number of leaving groups, whose reactivity follows 
this trend: I>OTf>Br>>Cl 
o Environmentally friendly 
® Can tolerate different functional groups on either coupling partner 
A wide range of palladium catalysts or precursors can be used for the reaction, 
tetrakis(triphenylphosphine)palladium(O), Pd(PPh3) 4, being the most commonly used. 
The accepted catalytic mechanism involves oxidative addition-transmetallation-
reductive elimination sequences as depicted in Scheme 1.13.42 
Reductive Elimination 
NaOR 
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Ar1Pd(II)OR 
Scheme 1.13: Catalytic Mechanism for the Suzuki Cross-Coupling Reaction. 
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The process involves oxidative addition of the halide to the palladium(O) complex to 
fom1 an organopalladium halide (Figure 1.3). 
Ar-X ( ) Ar-Pd(II)-X 
Pd(O) 
Figure 1.3: Oxidative Addition Step. 
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This step is seen as the rate-determining step. Although chloro-compounds are often 
cheaper and more readily available than the corresponding iodo- or bromo-compounds, 
the reaction is more difficult when Cl is the leaving group because higher energies are 
needed for the oxidative addition of the chloro-compound to the palladium(O) 
complex.43 This step is followed by the transmetallation step, which involves the 
formation of the more reactive organopalladium alkoxide (Figure 1.4). 
tr 
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Figure 1.4: Transmetallation Step. 
This complex is more reactive (i.e. more electrophilic) than the organopalladium halide 
complex because the Pd-0 bond is more polar than the Pd-X bond. This in turn 
facilitates the next transmetallation step. Finally, the biaryl is generated by the 
reductive elimination step, thus regenerating the palladium(O) complex (Figure 1.5). 
,' ' 
------1~ Pd: , 
' ' 
',}..(2 
Figure 1.5: Product Formation, i.e. Reductive Elimination Step. 
The reductive elimination step occurs because the organopalladium species with two 
aryl units attached is usually unstable. 
This whole process needs at least two equivalents of a suitable base. Firstly, the base is 
required for the removal of the halide after the oxidative addition of the arylhalide to the 
Pd(O) complex in order to generate the more reactive organopalladium alkoxide 
13 
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complex. Secondly, the boronic acids are highly electrophilic and the groups attached 
to the boron are usually weakly nucleophilic. The coordination of the negatively 
charged base to the boron increases its nucleophilicity, which facilitates the transfer of 
the aryl group attached to the boron to the palladium complex. 
The Suzuki reaction has been successfully employed in the synthesis of various 
different heterobiaryls, e.g. substituted pyrazines (14),44 terthiophenes (15),45 and 
pharmaceuticals such as substituted uracils (Scheme 1.14),39 which are potential 
antiviral agents. The boronic acid couples to a substituted halopyrimidine followed by 
the removal of the 0-protecting to yield the uracil analogue. 
14 
Ar-B(OHh + 
Ar= {J__ 
0 
Scheme 1.14: Synthesis of Substituted Uracils. 
~s~ l!.__l u \3 
15 
12.5M HCI 
Ar-tN>=o 
NH 
Therefore, the Suzuki cross-coupling reaction with various boronic acids can involve a 
number of different functionalised heterocyclic ring systems. This aspect is relevant to 
the work in this thesis. 
14 
Introduction to Heterocyclic Boronic Acids 
1.4 Heterocyclic Boronic Acids 
1. 4.1 Furylboronic Acid 
The chemistry of furan has been a topic of great interest due to the presence of furan in 
many natural products and its known versatility, e.g. a component of pharmaceuticals 
and materials. For example, roseophilin (16), an alkaloid isolated from Streptomyces 
griseoviridis, which is a potential anticancer agent;46 and 2,6-di-(2-furyl)pyridine45 (17), 
a monomer which could be used in the construction of conducting polymers. 
17 
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Johnson et af7 first synthesised 2-furylboronic acid (18) in 1938 by reacting 2-
furylmagnesium iodide with an excess TMB at low temperature (Scheme 1.15). 
n ~0/-cooH i.) • (J_ _iz-"--) ___.. ()__ 0 I O Mgl iii.) ~B(OHh 78% 
18 
Scheme 1.15: Synthesis of 2-Furylboronic Acid. Reagents and Conditions: (i) Aq. NaOH, KI, (ii) 
Mg turnings, Et20, (iii) l.TMB, low temperature. 2. Aq. Work-up. 
At the time, this route could not be used in the synthesis of 3-furylboronic acid because 
3-furylmagnesium iodide was not known,48 but can now be formed in modem times. 
The use of Grignard reagents with borate esters is a conventional procedure for the 
preparation ofboronic acids. 49 Both the 2- and the 3-isomers have been synthesised by 
the reaction of their corresponding lithium derivative with TBB48 and TPB. 50 The 2-
lithioisomer was synthesised by direct lithiation of the furan ring,51 and the 
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3-lithioisomer by halogen-metal exchange between 3-bromofuran and ethyllithium 
(Scheme 1.16).48 '52 
0 i) 0-u 0 
Br Li 
d il) d 0 0 
Scheme 1.16: Formation of the lithio-species of Furan. Reagents and Conditions: (i) Et20, -40°C, 
1M Ethyllithium, (ii) EtzO, -70°C, lM Ethyllithium. 
Nowadays, furylboronic acid (18) is commercially available and it has been widely used 
in the Suzuki cross-coupling reaction to form various compounds. For example, in the 
development of rapid phannacomodulation methods to N-bridgehead heterocycles, 
which contain a fused imidazole ring (19) (Scheme 1.17). 53 
i) 
X= I, Br 19 
R = H, Me, p-F-C6H4 
Scheme 1.17: Formation of Functionalised Imidazole Ring. Reagents and Conditions: (i) 18, Pd(O), 
base, DME-H20, Reflux. 
Furylboronic acid (18) has also been applied in the synthesis of9,10-difurylanthracenes 
(21) from 9,1 0-dibromoanthracene (20) (Scheme 1.18), for applications in fluorescence, 
electrochemiluminescence and nonlinear optical materials. 54 
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Scheme 1.18: Synthesis of 9,10-Difurylanthracene. Reagents and Conditions: (i) 18, Pd(PPh3) 4, 
Na2C03, THF-Toluene, 85°C. 
However, the Suzuki reaction is not the only application of furylboronic acid.55 This 
acid has been used in the synthesis of functionalised aminoalkylphenols,56 which have 
attracted interest from both the pharmaceutical and agrochemical sectors. This is a 
novel one-pot multi-component reaction between boronic acids, amines and 
salicylaldehyde, which makes use of the fact that boronic acids are weakly electrophilic 
molecules. Scheme 1.19 shows the mechanism of this reaction. 
Ph 
Ph 0 OH lN/ OH 0-- lN/ H~ c(6 0 B(OHh ~ /./ 
l I H,O -B(OH)J 
OH OH OH OH QoH 
c(6 'NAQ -H20 0 I__...OH ( B, 
Ph) I/./ (l eo /./ 0N1)) 
23 22 Ph~ 0 
Scheme 1.19: Synthesis of Functionalised Aminofurylphenol. 
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The amine and carbonyl react initially to give the aminal intermediate (22), which will 
then react with the boronic acid. A key feature of the reaction is that (23) does not 
form. 
1.4.2 Thienylboronic Acids 
2-Thienylboronic acid (24) was first synthesised by Krause and Renwanz57 in 1932 by 
the reaction of 2-thienylmagnesium bromide with boron trifluoride (Scheme 1.20). 
~MgBr + BF3 O--s B(OHh 
24 
Scheme 1.20: First Synthesis of 2-Thienylboronic Acid. 
Later, Johnson et at7 reported the synthesis of 24 vta the reaction of 2-
thienylmagnesium iodide with TMB (Scheme 1.21 ). 
O-s I i) n ~s/--Mgl ii) O--s B(OHh 95% 
24 
Scheme 1.21: Synthesis of 2-Thienylboronic Acid. Reagents and Conditions: (i) Mg turnings, Et20, 
(ii) 1. TMB, low temperature. 2. Aq. Work-up. 
Organomercurials have also been employed in the synthesis of these boronic acids and 
in high yields (80-90%) (Scheme 1.22). 58 
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Ar-HgX + BH3 Ar-B(OHh 
Ar = ()__ 
s 
0--0 
Scheme 1.22: Synthesis of Boronic Acids via the use of Organomercurial Reagents. 
The organomercurial reagent is reacted with an excess of borane. The resulting 
borohydride is then hydrolysed to give the corresponding boronic acid. This 
methodology has also been applied to the synthesis of furylboronic acid. Modern 
methods for the formation of these acids involve the generation of the corresponding 
lithio-derivative followed by the addition of an alkylborate (Scheme 1.23). 
0 s i) O-s B(OHh 
24 
Br 
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Scheme 1.23: Synthesis of Thienylboronic Acids. Reagents and Conditions: (i) 1. nBuLi, 0°C, 2. 
TMB, -78°C. 3. Aq. Work-up. (ii) 1. nBuLi, -78°C, 2. TMB, -78°C. 3. Aq. Work-up. 35-100% for 
24 and 25. 
The parent thiophene can be used to generate 2-lithiothiophene via metal-hydrogen 
exchange, due to the high reactivity of the 2-position. In order to generate 3-
lithiothiophene the metal-halogen exchange route has to be employed. The 2-lithio-
derivative can be formed at temperatures as high as 0°C,59 but the 3-lithio-derivative has 
to be formed at low temperature, usually -78°C, 60 because of its instability at higher 
temperature, which can lead to ring opening.9 
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Similar to furylboronic acids, the main applications of thienylboronic acids involve the 
Suzuki cross-coupling reaction. Over the years it has become apparent that this 
methodology is a key step in the generation of various pharmaceuticals,61 fungicides62 
and materials. 63 For example, in the synthesis of functionalised pyridones (26), which 
are known to have widespread pharmaceutical use including analgesic, hypnotic, 
antifungal and cardiotonic actions.64 An example is illustrated in Scheme 1.24. 
0 
on 
i) 
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0 
OMe 
26 
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// 
67% 
Scheme 1.24: Synthesis of a Functionalised Pyridone. Reagents and Conditions: (i) 25, Pd(PPh3) 4, 
NazC03, DME-H20, 100°C. 
The product of this reaction has the potential for being a selective ligand for the 
benzodiazepine binding site ofGABA-A receptors. 
Methyl (E)-2-aryl-3-methoxypropenoates are important in the synthesis of fungicides, 
because the ,6-methoxypropenoate unit is active in this context.62 Again, the Suzuki 
methodology can generate a whole host of compounds containing this unit. Scheme 
1.25 shows an example involving 24 in the formation of compound 27. 
i) Meo2c~ 35% 
OMe 
27 
Scheme 1.25: Synthesis of a Methyl (E)-2-thienyl-3-methoxypropenoates. Reagents and Conditions: 
(i) 24, Pd(PPh3) 4, K3P04, dioxane, 80°C. 
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Over the last two decades studies into the synthesis and characterization of molecules 
with extended 7!"-electron delocalisation have increased.65 This class of compound can 
be applied to areas such as optoelectronics, polyn1eric light emitting diodes and 
displays. Thienylboronic acids are used to produce 7!"-conjugated structures. 66'67 It has 
been proposed that these new structures offer enhanced material properties, easier 
processing and even higher stability. An example of the application of 25 in the 
synthesis of such systems is illustrated in Scheme 1.26. 66 ' 67 
1 \ 
s 
n 
ii) 
iv) 
Br 
Br Br 
Scheme 1.26: Synthesis and Polymerisation of Thiophene Monomer. Reagents and Conditions: (i) 
25, Pd(PPh3) 4, K3P04, toluene, 85°C (85%), (ii) NBS, DMF (90%), (iii) NBS, DMF (74%), (iv) Ni(O), 
2,2'-bipyridyl, DMF (74%). 
Another interesting application of the Suzuki reaction is in the area of forensic science. 
This reaction is used to produce ninhydrins, which are used in the chemical 
enhancement of latent fingerprints. 68 This involves post-ninhydrin treatment with metal 
salts, followed by illumination with an appropriate light source. This is a practical and 
affordable technique adopted by the majority of forensic laboratories. The Suzuki cross-
coupling reaction serves to modify the ninhydrins, by enhancing their chromogenic and 
luminescent properties. 69 An example of ninhydrin formation is illustrated in Scheme 
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1.27, showing the cross-coupling of 25 with 5-bromo-2,2-dimethoxy-1 ,3-indandione 
(28). 
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Br~OMe ----'i) _ ___.. 
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Scheme 1.27: Synthesis of Ninhydrins. Reagents and Conditions: (i) 25, Pd(PPh3) 4, 2M Na2C03, 
EtOH-Benzene (55%), (ii) HBr, HOAc, ..:1, H 20. 
Like furylboronic acids, thienylboronic acids have other uses apart from the Suzuki 
reaction. For example, they can be employed in a one-pot 3-component condensation 
reaction with an amine and a carbonyl compound, in order to form anti-a-
(difluoromethyl)-{3-amino alcohols (29) (Scheme 1.28).70 
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Scheme 1.28: Synthesis of anti-a-(Ditluoromethyl)-{j-amino alcohols. 
These are an important class of compound as they contain functional handles that allow 
diverse interactions within biologically active molecules. The added importance of this 
reaction is that it yields a fluorinated molecule. This is synthetically interesting because 
of the scarcity of fluorinated molecules in nature and their increasing applications in 
pharmaceuticals and new materials. 70 
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1. 4. 3 Pyrrolylboronic Acid 
Martina et aF 1 were the first to publish the synthesis of a pyrrolylboronic acid 
derivative in 1991. They synthesised (1-tert-butoxycarbonylpyrrol-2-yl)boronic acid 
(30) for use in the synthesis of polymers. 
~B(OH)2 
I 
BOC 
30 
BOC = 
They adopted the standard route in boronic acid synthesis; the reactions of a freshly 
generated organometallic reagent, in this case a lithic-derivative, with TMB (Scheme 
1.29). 
Route A 
ii) 
0 ~ ![}_ i) 0 ~Li iv) N N N B(OH)2 I I ~ I I H BOC BOC BOC 
iii) 
Route B 
Scheme 1.29: Synthesis of BOC-protected Boronic Acid. Reagents and Conditions: (i) (BOC)20, 
CH3CN, DMAP (71 %), (ii) tert-butyllithium, -78°C (69%), (iii) lithium 2,2,6,6-
tetramethylpiperidide, -78°C, (iv) 1. TMB, -78°C, 2. HCI (60%). 
The BOC protecting group is required because the lithiation reaction is complicated by 
the presence of the acidic hydrogen on the N atom of pyrrole. When choosing a suitable 
protecting group for this reaction the following criteria have to be met: 72 
• Stable to strongly basic conditions 
• Easily removable under neutral conditions 
The protecting group of choice in this reaction was tert-butoxycarbonyl CBOC) which: 
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• Can be easily removed (hydrolytically) 
• Withdraws electrons from the ring, further enhancing the acidity of the a-
hydrogen on the pyrrole ring 
• Stabilises the lithio-derivative via chelation (Figure 1.6) 
Figure 1.6: Stabilisation by Chelation. 
(}___ 
N ~i A :' Chelation 
0 0 
+ 
For the lithiation stage, Martina et al adopted two possible routes as described by Hasan 
et al. Route A employed tert-butyllithium CBuLi) as the lithiating reagent and route B 
used lithium 2,2,6,6-tetramethylpiperidide (LTMP). LTMP was found to be the more 
desirable lithiating reagent, due to the fact that 1BuLi led to unsatisfactory product 
mixtures, whereas LTMP gave better incorporation oflithium.72 
Boronic acid 30 can be used in the generation of boc-prolineboronic acid (31),73 which 
has attracted interest because peptides that incorporate this unit are potent inhibitors of 
certain post-proline cleaving enzymes implicated in both bacterial infection and 
regulation of the immune sytem.73 Acid 31 is simply formed by the reduction of 30 
(Scheme 1.30). 
(J__ --'--i) ---- [}_ 97% 
N B(OHh N B(OHh 
I I 
BOG BOG 
30 31 
Scheme 1.30: Synthesis of BOC-Prolineboronic acid. Reagents and Conditions: (i) H2, Pt-C, 
EtOAc. 
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Pyrrolylboronic acid has been employed in the Suzuki cross-coupling reaction in order 
to generate polymers and pharmaceuticals. For example, in the attempted synthesis of 
stmcturally perfect poly(2,5-pyrrole) (32), one of the best electrically conducting 
polymers, when in its oxidised form. 71 b 
016--Q 
H H 
32 
This was achieved by coupling an excess of pyrrolylboronic acid with 2,5-
dibromopyrrole and polymerisation of 2-bromo-5-pyrrolylboronic acid (34), the 
synthesis ofwhich is illustrated in Scheme 1.31.71 
0 i) -0-- ii) -0--
N Br N Br Br N B(OMeb 33 
I I I 
BOG BOG BOG j iii) 
-0--Br N B(OHb 34 
I 
BOG 
Scheme 1.31: Synthesis of 2-Bromo-5-pyrrolylboronic acid. Reagents and Conditions: (i) NBS, 
THF (55%), (ii) nBuLi, TMB, -78"C, Aq. Work-up (80%), (iii) HCI. 
34 was found to be unstable and decomposes upon removal of the solvent, so 33 was 
used in the reaction. Derivatives of 32 are synthetic targets because although the 
molecular stmcture of polymerised polypyrrole is not known for certain, it is believed to 
have imperfections. 
The Suzuki cross-coupling reaction of pyrrolylboronic acid is known to be a key step in 
the synthesis of many pharmaceuticals, for example undecylprodigiosine (35) (Scheme 
1.32), an immunosuppressive agent known to inhibit T-cell proliferation. 74 This 
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compound is a member of the Prodigiosins, a class of natural pigments produced by 
Streptomyces Genus. These compounds are characterised by a 2,2'-
bipyrrolylpirromethene skeleton. 
OMe OMe 
TfO i) 
73% 
35 
Scheme 1.32: Synthesis of Undecylprodigiosine. Reagents and Conditions: (i) 30, Pd(PPh3) 4, 
K2C03, dioxane, 90°C. 
This methodology is also applied to the synthesis of drugs to combat schizophrenia, 
which are believed to exert their antipyschotic effects by blocking dopamine receptors 
(Scheme 1.33).75 
Br 
~OMe_----'i)_~ 
RS02)l) 
ii) 
OMe 
OMe 
R = NH2, PhNH 
Ph 0-CHO 
36 
Scheme 1.33: Synthesis of Dopamine Receptor Blockers. Reagents and Conditions:- (i) 1. 30, 
Pd(PPh3) 4, Na2C03, DME, 2. TFA, DCM, (ii) Vilsmeier reagent derived from 36, followed by the in 
situ reduction of N aBH4• 
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30 has also been employed in the stereocontrolled synthesis of !3-aminoalcohols (37) via 
a one-pot, three-component reaction involving the boronic acid, an amine, and an a-
hydroxy aldehyde to give directly the corresponding !3-amino alcohol (Scheme 1.34).76 
~ 
l(N/--B(OHh 
I 
BOC 
0 
YoH 
OH 
i) CXCOH 
'soc 
37 
Scheme 1.34: Synthesis of fJ-Amino Alcohols. Reagents and Conditions: (i) EtOH, 25"C. 
73% 
!3-aminoalcohols are highly versatile functionalities as they can be converted to other 
molecules, such as amino acids and can be useful as chiral auxiliaries and transition 
metal ligands. 
1. 4. 4 Benzofurylboronic Acid 
The benzo[b ]furan system is known to occur in a range of plant- and microbial-derived 
natural products.9 For example, aureusin (38), a member of the aurones, a group of 
plant pigments. Griseofulvin (39), which is obtained from Penicillium griseofulvum, 
can be used in the production of medicines, such as antifungal agents. 
OH OMe 
GluO M eO 
OH 
38 39 
There are two known isomers of this boronic acid; 2- ( 40) and 3-benzofurylboronic acid 
(41). There is no known isomer with the boronic acid functional group on the phenyl 
ring. There are only a few examples of the use of the 2-isomer in the literature.77 
Although work is unpublished, the 3-isomer is obtainable.78 
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~B(OH)2 
~-~ 0 
41 
There appears to be no detailed preparation of either boronic acid in the literature. The 
2-isomer was reported by Huang et al in 1995.77a The 2-lithio species of benzofuran, 
generated by the action of nBuLi on benzofuran, was reacted with TMB, followed by a 
hydrolytic work-up, yielding the desired boronic acid (Scheme 1.35). Extreme low 
temperatures are not required, as the lithiation is known to be possible at 0°C.9 
QJ 
0 
_ _!_i) ~ en_ 
0 Li 
------'-ii) ~ en_ 
0 B(OHb 
Scheme 1.35: Synthesis of 2-Benzofurylboronic Acid. Reagents and Conditions: (i) nBuLi, 0°C, (ii) 
TMB, Hydrolytic Work-up. 
This relatively new boronic acid is now commercially available from Lancaster. The 
synthesis of the 3-isomer should be possible to synthesise via a metal-halogen exchange 
procedure, followed by the addition of an alkylborate, i.e. TMB. However, the 3-lithio-
derivative should be formed and used at low temperature, i.e. -78°C,9 because it is 
known to fragment at room temperature with the production of 2-
hydroxyphenylacetylene ( 42) (Scheme 1.36).79 
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QjB' __ i),__...._ 
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Scheme 1.36: Possible Route and Practical Considerations in the Synthesis of 3-
Benzofuranylboronic Acid. Reagents and conditions: (i) nBuLi, r.t., (ii) H 20, (iii) 1. nBuLi, -78°C, 
2. TMB, Work-up. 
Like the previOus boronic acids, 40 has been used in the Suzuki cross-coupling 
reaction,77 predominantly in the formation of possible pharmaceuticals,77 for example, 
benzofuran derivative (43), an antioxidant (Scheme 1.37),80 isolated from various 
yeasts. Compound 43 has been tested for its inhibition of haemolysis of red blood cells. 
~ ~->--- + 0 B(OHh i) 100% 
Scheme 1.37: Synthesis of Antioxidant (43). Reagents and Conditions: (i) 40, ;Pr2NEt, Pd2(dbah, 
DMF. 
Acid 40 has also been employed in the synthesis of spiropyran analogues, which are 
used in photochromic indolinobenzopyran dyes (Scheme 1.38) of use in new 
technologies that include rewritable optical memory and optical switching, non-linear 
optics and real-time holography. 81 The stability and properties of this spiropyran 
structure are dependent on the substituents attached to it. 
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+ 
i) 
Scheme 1.38: Synthesis of Spiropyran Analogue. Reagents and Conditions: (i) 40, Pd(OAch, 
Na2C03, DMF. 
40 has also been employed in the synthesis of anti-a-(trifluoromethyl)-1)-aminoalcohols 
(44),55 without the need for the Suzuki methodology (Scheme 1.39). The importance of 
fluorinated compounds has been noted in a previous section. 
~ ~-)-_ EtOH 75% 
O B(OHh 
44 
Scheme 1.39: Synthesis of anti-0'-(Trifluoromethyl)-P-aminoalcohols. 
1.4.5 Benzothienylboronic Acid 
Benzo[b ]thiophene has been incorporated into a number of new compounds of 
pharmaceutical interest, such as Raloxifene (45). This compound has been shown to 
have the potential for preventing osteoporosis, and to bring about a reduction in the 
incidence of breast cancer.9 
0 
HO '\ 0 
45 
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Again there are two known isomers of benzothienylboronic acid; 2- (46) and 3-
benzothienylboronic acid (47). There is no known isomer with the boronic acid 
functional group on the phenyl ring. 
There are only a few literature references to this class of boronic acid, and there is no 
detailed preparation of either boronic acid in the literature. Hedberg et a/82 synthesised 
the 2-isomer by a method described by Thompson and Gaudino,50 which involves the 
reaction of the 2-lithio derivative with TPB, followed by a hydrolytic work-up. The 2-
lithio-derivative can be generated by the metal-hydrogen exchange reaction. The 3-
isomer is probably generated by the same method, only the lithio-derivative is generated 
by a metal-halogen exchange reaction (Scheme 1.40). 
Qj i) lli lli \ s s Li s B(OHh 
iii) 46 OjBr Coli OjB(OH), ii) \ 
s s s 
47 
Scheme 1.40: Synthesis of Benzothiopheneboronic Acids. Reagents and Conditions: (i) nBuLi, 0~ 
-25°C, (ii) nBuLi, low temperature, i.e. -78°C, (iii) 1. TPB, -78°C. 2. Aq. Work-up. 
These acids are used predominantly in the Suzuki cross-coupling reaction m the 
synthesis of medicinally useful compounds.82•83 The 2-isomer is used more; there is only 
one literature reference showing the use of the 3-isomer. This could be due to the fact 
that the 2-isomer is commercially available from Lancaster. An example of the use of 
the 2-isomer is in the modification of morphine ( 48) (Scheme 1.41 ). 
31 
l11troduction to Heterocyclic Boronic Acids 
i) 79% 
48 
Scheme 1.41: Synthesis of a Morphine Derivative. Reagents and Conditions: (i) 46, Pd(PPh3) 4, 
LiCI, 2M Na2C03, EtOH, DME, 9s·c. 
This is an important reaction because numerous structure-activity studies have been 
undertaken on morphine derivatives in connection with pharmacological effects. 82 
1.4.6 Indolylboronic Acid 
Indoles are probably the most widely distributed heterocyclic compounds in nature.9•84 
For example, tryptophan (49) is an essential amino acid and serotonin (50) (5-
hydroxytryptamine) is a very important neurotransmitter in the central nervous system. 
HO ttr'NH, 
N 
I 
H 
49 50 
There are six known isomers of indolylboronic acid; four isomers related to the phenyl 
ring of indole, 4- (51), 5- (52), 6- (53), and 7-indolylboronic acid (54), and two related 
to the heterocyclic ring of indole, N-protected 2- (55) and 3-indoleboronic acid (56). 
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Acids 51, 52, 53 and 54 are synthesised by the reaction of the corresponding lithic-
derivative, generated by the metal-halogen exchange reaction, with TMB (Scheme 
1.42).84 
x,~ ~.J 
N 
I 
H 
X= 5-Br, 6-Br, 7-Br 
i) 
(HOhB,~ 
----"~J~~ ~ ) 
N 
I 
H 
Scheme 1.42: Synthesis of Phenyl Ring Substituted Indole Boronic Acids. Reagents and 
Conditions: (i) 1. KH, Et20, 0°C. 2. 1BuLi, -78°C. (ii) 1. TMB. 2. Aq. Work-up. 
The lithio derivatives were generated following the preparation described by Moyer et 
a/.85 The Iithiation, using 1BuLi, is facilitated by the removal of the acidic hydrogen on 
the nitrogen by the action of KH, giving the potassium salt. 
The 2-isomer is prepared by the action of the corresponding lithio-derivative, generated 
by a metal-hydrogen exchange reaction of N-protected (BOC) indole, with TPB 
(Scheme 1.43). 86 The BOC group aids the reaction in ways describ~d earlier for 
pyrrole. 
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en i) (A ii) (A 100% \ N N B(OHh I N Li 
BOC I I BOC BOC 
55 
Schemel.43: Synthesis of N-Protected 2-Indolylboronic Acid. Reagents and Conditions: (i) LiTMP, 
THF, -78°C. (ii) TPB, H+, HzO. 
The formation of the 3-isomer is not detailed in the literature, but it probably follows 
the same path as that described for the 2-isomer, except the lithio-derivative is generated 
by metal-halogen exchange reaction of N-protected- (B~C)-3-bromoindole (Scheme 
1.44).9 
Q-§Br -~i)'-----_. 
N 
I 
BOC 
ii) 
Q-§B(OH), 
N 
I 
BOC 
56 
Scheme 1.44: Synthesis of N-Protected 3-Indolylboronic Acid. Reagents and Conditions: (i) 'BuLi, 
Et20, -78°C. (ii) TPB, H\ H 20. 
These boronic acids are useful in Suzuki cross-coupling reactions to produce a variety 
of substituted indoles of potential medicinal value. For example, 5-indolylboronic acid 
is used in the synthesis of 5-arylated indoles (Scheme 1.45).87 The 6- and 7-isomers 
have been employed in the same manner. 
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73% 59% 
Scheme 1.45: Synthesis of 5-Arylated Indoles. Reagents and Conditions: (i) Pd(PPh3) 4 , N aHC03, 
DME, reflux. 
A wide variety of phenyl-substituted indoles are naturally occurring and are biologically 
active. 85 These are important intermediates in the synthesis of agonists and antagonists 
of the CNS neurotransmitter serotonin. 87 
The cross-coupling reaction of indolylboronic acids has been used as a key step in the 
synthesis ofbenzo[a]carbazoles and pyrido[2,3-a]carbazoles, for example elliptinum 58, 
used clinically for the treatment of cancer. The cross-coupling reaction of 55 forms the 
intermediate 57, a precursor to pyridocarbazoles (Scheme 1.46).86b 
en N B(OHh + 
I 
BOC 
55 
Br--p 
Me 
i) 
Scheme 1.46: Key Step in the Synthesis of Pyrido[2,3-a)carbazoles. Reagents and Conditions: (i) 
10% Pd(PPh3) 4, Na2C03, DME, reflux. 
35 
Introduction to Heterocyclic Boronic Acids 
3-Indolylboronic acid plays a key role in the synthesis of 2,4-di(3-indolyl) lH-imidazole 
(59), a marine alkaloid with antifungal properties. 88 This class of compound is a 
member of the Nortopsentins. Again the Suzuki reaction is utilized, but on this 
occasion a dual cross-coupling takes place (Scheme 1.47). 
Q-§B(OH), + 
N 
I 
X 
2 equivs. 56 
X = Protecting Group 
R = Silyl Protecting Group 
Br )-N 
Br N)l_Br 
~OR 
i) 
Ar= 
rN Ar~N)\_Ar 67% 
~ 59 
Q-§ 
N 
I 
H 
Scheme 1.47: Synthesis of 2,4-Di(3-indolyi)1H-imidazole. Reagents and Conditions: (i) 1. Pd(O), 
Na2C03, Solvent. 2. nBuLi, H 20. 3. Bu"4NF. 
1.4. 7 Benzo-fused Pyridines: Quinolyl- and Isoquinolylboronic Acid 
Quinolines occur widely in nature and have valuable chemotherapeutic, tumour-
inhibiting and fungicidal properties. 89 This has led to interest in the synthesis of 
substituted quinolines, which has resulted in the synthesis of antimalerial drugs such as 
chloroquine (60),90 for example. Quinoline compounds also provided the first 
photographic film sensitizers. The cyanine dye ethyl red (61) extended photography 
from the blue into the green spectral region and then in 1904, with pinacyanol ( 62), into 
the red.9 
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61 62 
Isoquinoline occurs in a large number of alkaloids, e.g. papaverine (63), a member of 
the opium poppy alkaloids. 91 This compound is a muscle relaxant and can therefore be 
useful as a coronary vasodilator. 
M eO 
M eO 
OMe 
OMe 
63 
These facts indicate that quinolinyl- and isoquinolinylboronic acids could be 
advantageous in the synthesis of compounds containing these ring systems. 
There are numerous isomers of quinolinylboronic acid, whose syntheses are mainly 
reported in patents. The 3- (64),92 4- (65),93 5- (66),93•94 6- (67)95 and 8-
quinolinylboronic (68)96 isomers exist, but no literature reference has been found to the · 
2- and 7-isomers. The 3-isomer has been reported the most in the literature. 
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Trova et al2 described the synthesis of 64 v1a the 3-lithio-derivative, which was 
generated by the metal-halogen exchange reaction and subsequent reaction with TMB, 
followed by the appropriate work-up to yield the desired boronic acid. They did not 
purify this acid and reacted it directly in a Suzuki cross-coupling reaction aimed at the 
synthesis of a heterobiaryl-pyridoquinazolinone derivative (69) (Scheme 1.48), which is 
a potential anti-cancer agent. 
roB_r __ ~ij~~ 
N 
~Li __ __.:._~ ~~.) ii) 
N 
0 
~B(OHh 
~N) Crude 
1 iii)
69 
Scheme 1.48: The Use of 3-Quinolinylboronic Acid in the Synthesis of Hetero-biaryl-
pyridoquinazolinone derivative. Reagents and Conditions: (i) nBuLi, Et20, -40"C, (ii) TMB, (iii) 
Pd(PPh3) 4,N-[2-( dimethylamino )ethyl)-2-iodo-11-oxo-11H -pyrido [2,1-b) quinazoline-6-carboxamide, 
2M Na2C03, toluene, uo·c. 
Variations and improvements have been made on this preparation. Recently, Li et ar 
reported the efficient synthesis of 64, involving the use of an in situ quench procedure. 
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64 was generated by the addition of nBuLi to a solution of 3-bromoquinoline and TPB 
in toluene at -70°C (Scheme 1.49). 
~B(OHh 
~ ... .J 79% 
N 
64 
Scheme 1.49: Synthesis of 64. Reagents and Conditions: (i) nBuLi, toluene, -70"C, aq. work-up. 
The primary function of 64 has been in the production of pharmaceutical targets via the 
palladium-catalysed cross-coupling reactions. For example, in the synthesis of a 
derivative of a 3-pyridyl ether compound (70) (Scheme 1.50).98 This class of compound 
has been identified as potent cholinergic channel modulators, and they have the 
therapeutic potential for the treatment of CNS disorders. 
~o~Br i) ~ ~- .J __ .:.,____... 
Me N 
~0 
N 
I 
Me 
I~ 
./. 
N 
70 
Scheme 1.50: Synthesis of Substituted-3-Pyridyl Ether. Reagents and Conditions: (i) 64, Pd(PPh3) 4• 
64 also has potential in the synthesis of protected heteroaryl amidines (71).99 The 
amidine functional group is found in many biological molecules. The amine group is 
firstly protected by deprotonation with NaH followed by treatment with SEM chloride. 
This protected species can then be reacted with the boronic acid using an extension of 
the Liebeskind-Srogl thioether cross-coupling methodology (Scheme 1.51). 100 
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Scheme 1.51: Synthesis of a Protected Heteroaryl Amidine, 71. Reagents and Conditions: (i) 1. 
NaH, DMF, 2. SEMCI. (ii) 63, CuTC (Cu(I)thiophene-2-carboxylate, Pd2(dba)3, TFP (tri-2-
furylphosphine), THF, 65°C. 
The only known isomer of isoquinolylboronic acid (72) is the 4-isomer, and there are 
only a few references related to this compound. 101 The only description of its formation 
is in a patent. Phebus et a/101 a synthesised the 4-isomer for use in the synthesis of 
compounds for the treatment of anxiety disorders. The acid was formed via a sequential 
addition of reagents method. The lithio-derivative was generated at -1 00°C by the 
metal-halogen exchange reaction, involving nBuLi. The lithio-derivative was then 
reacted with TPB to yield the desired boronic acid (Scheme 1.52). 
~ ~~ i) 
~Hh 
~~ 
72 
34% 
Scheme 1.52: Synthesis of 4-Isoquinolinylboronic Acid. Reagents and Conditions: (i) 1. nBuLi, 
THF, -100°C. 2. TPB. 3. Aq. Work-up. 
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This acid has also been employed in the synthesis of 2-aryltryptamines, IOib a moiety that 
is present in many natural products and medicinal chemistry targets that possess various 
biological activities. The isoquinolyl moiety is introduced into the 2-position of 
protected-tryptamine (73) via a Suzuki reaction (Scheme 1.53). 
~Hh 
~~ + 
o-N MJ:: I
)--[ i) QC 0 ----'------):> 
N Br 
86% 
I 
H 
73 
Scheme 1.53: Synthesis of 2-Isoquinolinyltryptamine. Reagents and Conditions: (i) Pd(PPh3) 4, 
Na2C03, LiCI. 
1.4.8 Pyridylboronic Acids 
The bulk of the work in this thesis concerns the synthesis and application of substituted-
pyridylboronic acids. A review of the background of the parent systems of 
pyridylboronic acid gives the rationale behind this research. 
At the outset of our project there was very little published about the synthesis of 
pyridylboronic acids. 18 Pyridine derivatives occur widely in nature. For example, the 
highly toxic alkaloid nicotine (74), a major component in tobacco, which is one of the 
most addictive drugs known. 102 Also, the unique alkaloid epibatidine (75), isolated 
from the Ecuadorian poison frog Epipedobates tricolor, exhibits high analgesic 
. . 103 
activity. 
~D [_J ~ NMe 
N 
74 75 
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Synthetic pyridine derivatives also have important therapeutic properties. For example, 
in compounds such as Isoniazide (76), a major antituberculosis agent, and Amlodipine 
(77), one of several antihypertensive 1 ,4-dihydropyridines. 9 
76 77 
Therefore, like the previously reviewed heterocyclic ring systems, pyridylboronic acids 
should provide a route into aryl/heteroaryl substituted-pyridines. Such compounds also 
enjoy various applications in materials science and supramolecular chemistry.22b 
Until recently only one literature reference published in 1965 18 described the synthesis 
of the 3- (13) and 4-pyridylboronic acids (78). The 3-isomer was obtained via a 
Grignard reagent and the 4-isomer via a lithio-derivative from their corresponding 
bromo-compounds. These organometallic species were then reacted with TBB and 
TMB, respectively, to form 13 and 78 (Scheme 1.54). 
Q-sr 
N 
i) 
o-MgBr 
N 
N~Br iii) N~Li 
ii) 
iv) 
Q-s(OHh 28% 
N 
13 
N~B(OHh 20% 
78 
Scheme 1.54: Fischer and Havinga's Synthesis of 3- and 4-Pyridylboronic Acid. Reagents and 
Conditions: (i) Mg turnings, Et20, 20°C, (ii) 1. TBB, -60°C. 2. Work-up, (iii) nBuLi, -60°C, (iv) 1. 
TMB, -60°C. 2. Work-up. 
The problems with these reactions are that they are both low yielding (28 and 20%), 
require conditions that are not suitable for scale-up, i.e. in the case of the 3-isomer a 
tedious work-up procedure is required (a 2-week ether extraction), and low temperatures 
are needed for the formation of the 4-isomer. Also, the analytical data was restricted to 
the nitrogen content of the compound, hardly conclusive evidence of purity. We 
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repeated these reactions only to obtain a lower yield for 13 (7%) and obtained no 
product in the synthesis of 78. 
The factors involved in these reactions, such as reaction times and conditions required 
are not acceptable by modem standards, i.e. the need for a high throughput of 
compounds. These acids have been used in various reactions, such as Suzuki cross-
coupling reactions since their discovery, but only recently have improved procedures for 
their formation have been published. Cai et az23•97 in 2002 published a more efficient 
synthesis of both 13 and 78 involving an in situ quench procedure. This method 
involved the addition of nBuLi to a solution of bromopyridine and TPB in toluene, a 
non-coordinating solvent (Scheme 1.55). 
i) C4 B(OHh )3 
N 
13 90-95% 
78 60% 
Scheme 1.55: Synthesis of 3- and 4-Pyridylboronic Acid. Reagents and Conditions: (i) 1. nBuLi, 
toluene, -70"C. 2. HCI, -20"C. 
Previous experiments revealed that in the case of 3-bromopyridine the use of toluene 
gave an almost quantitative conversion to 3-lithiopyridine.23 Usually, the metal-halogen 
exchange reaction needs a coordinating solvent, such as THF, to dissociate the BuLi 
aggregate, but with toluene, the pyridine N serves to activate the metal-halogen 
exchange reaction.23 The explanation behind the success of this reaction is that the 
metal-halogen exchange reaction is faster than any reaction between nBuLi and TPB. 
Also, the lithio-derivatives generated react immediately with TPB, thus minimizing side 
reactions.97 
Other groups have also attempted an improved synthesis of the 4-pyridylboronic acid. 
Dreos et a/104 have synthesised 78 via a sequential addition of reagents method. The 
lithiation was achieved using nBuLi as the lithiating reagent in the presence of 
N,N,N' ,N' -tetramethyl-1 ,2-ethylendiamine (TMEDA), an activating agent, at very low 
temperature ( -11 0°C). These conditions were required in order to avoid nucleophilic 
addition to the 4-bromopyridine. The lithio-derivative was then reacted with TMB to 
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yield 78. They only slightly improved on Fischer and Havinga's synthesis (34%), but 
they obtained full characterisation for the compound. Lamothe et at 05 used a sequential 
addition method for the formation of the 78 and have improved on the syntheses 
described by all the previous laboratories. They used nBuLi in the lithiation of 4-
bromopyridine at -78°C, followed by the addition of TPB to give 78 in 65% yield, but 
they did not quote full characterization for the compound. 
To date, there has been no description of the synthesis of the 2-isomer (79). We 
attempted the synthesis of this acid via the routes described by Fischer and Havinga, 18 
i.e. via the Grignard- and lithio-species, both to no avail. In 1974, whilst studying the 
chemical properties of pyridylboronic acids, Fischer and Havinga found that 
pyridylboronic acids undergo easy protodeboronation. 106 They proposed that this was 
the reason behind the failure in the synthesis of 79. They observed that upon UV 
irradiation in neutral and slightly basic conditions, 107 and attempted quatemisation with 
Mel in MeOH, 13 and 78 decomposed to pyridine and boric acid. On attempted 
synthesis of 79, they noticed that the 2-pyridylboronate was unstable. After dissolving 
the supposed lithium tributyl-2-pyridineboronate, resulting from the reaction of 2-
lithiopyridine with TBB in protic solvents, they observed the formation of pyridine and 
boric acid (Scheme 1.56). These reactions can be described as Se1 substitution 
reactions, which are known to occur in pyridine and pyridinium ions. This observation 
is analogous to the decarboxylation of2-pyridylcarboxylic acid, or picolinic acid.8'9 
Protodeboronation: 
Scheme 1.56: Decomposition of 79. 
Due to the early difficulties experienced in the synthesis of pyridylboronic acids the 
related pyridylboronic esters were studied. While studying the Pd-catalysed cross-
coupling reactions of organoboron compounds with organic triflates Oh-e et al 
synthesised 2-(3-pyridyl)-1 ,3,2-dioxaboronane (80). 108 The boronic acid was firstly 
fom1ed via metal-halogen exchange reaction of3-bromopyridine with nBuLi, followed 
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by the addition of TMB. 1 ,3-Propanediol was then added in order to form 80. Oh-e et 
al obtained 80 good yield (60%), and applied this compound in the Suzuki cross-
coupling reaction to give 81 (Scheme 1.57). We repeated the synthesis of 80, but only 
managed to obtain a 17% yield. 
o-Br i) o-s~) (GO%) + no-Q-oMe 
80 
~OMe 46% 
81 
Scheme 1.57: Synthesis and Application of 2-(3-Pyridyl)-1,3,2-dioxaboronan, 80. Reagents and 
Conditions: (i) 1. nBuLi, Et20, -78°C. 2. TMB, -78°C. 3. 1,3-Propanediol, ooc; (ii) Pd(PPh3)4, 
K3P04, dioxane, ss·c. 
The synthesis of 2-( 4-pyridyl)-4,4,5,5-tetramethyl-1 ,3-dioxaborolane (84) has also been 
investigated by Coudret in the course of the design ofphotochromic bridging ligands for 
molecular electronics. 109 The route to 84 involved the metal-halogen exchange reaction 
of 4-iodopyridine (83), which is known to be a convenient source of 4-pyridyl 
organometallic reagents. The 4-iodopyridine was formed from 4-aminopyridine (82) 
via a Sandmeyer reaction and then lithiated using nBuLi followed by treatment with 
TBB, pinacol and AcOH to neutralize the reaction (Scheme 1.58). This gave the ester 
in good yield (74%). As before we repeated the synthesis of this ester and obtained a 
21% yield. 
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Scheme 1.58: Synthesis of 2-(4-Pyridyl)-4,4,5,5-tetramethyl-1,3-dioxaborolane. Reagents and 
Conditions: (i) 1. NaN02, HBF4, -lO"C. 2. KI, acetone-H20, (ii) 1. nBuLi, Et20, -78"C. 2. TBB,-
78"C. 3. Pinacol, then AcOH. 
We are not aware of any literature report on the synthesis of the 2-pyridylboronic ester. 
Another option in the synthesis of pyridylboronic esters is the use of diethanolamine, 
which can stabilise cyclic boronic esters by N-B bond coordination (Scheme 1.59).110 
However, to the best of our knowledge this reagent has not been reported in the 
synthesis of pyridylboronic esters. 
Coordination 
H"'- n ,Ar 
~~\ 
Scheme 1.59: Possible Stabilisation of Pyridylboronic Esters by Coordination. 
The ester can sometimes have an advantage over its corresponding acid. Chan et al 
have reported the successful application of 80 in the copper promoted cross-coupling 
reaction used for the preparation of a range of heteroaryl amines (Scheme 1.60). 111 
~N:o 
54% 
 ~ i) o-~0) i) N~-o a ~N \;, 47% ~N=o N~ N 0 ~N-H N N h I 80 H 
Scheme 1.60: Application of 80 in the Copper Mediated Cross-Coupling Reaction. Reagents and 
Conditions: (i) Cu(OAc)2, pyridine, DCM, rt. 
In direct companson, no reaction was observed when 13 was used under identical 
conditions. This is a useful procedure as it operates under mild conditions and can 
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tolerate base sensitive functionalities. This was the first reported C-N cross-coupling 
involving a heterocyclic boronic acid system. 
Interesting pyridylboronic esters are obtained by the reaction of 13 with saccharides. 
Medically, this is a very significant reaction as the boronic acid acts as an artificial 
sugar receptor in order to transport saccharides through lipid bilayers. 112 Boronic acids 
are of particular interest as they can rapidly form reversible covalent complexes at 
ambient temperature in aqueous solution. 113 The proposed mechanism for the formation 
of such esters is illustrated in Scheme 1.61. 
Ar-B(OH), + ~ 
HO OH 
Scheme 1.61: Boronic Acid-Saccharide Interaction. 
This is a very important process when you understand that selective transportation of 
saccharides across cell membranes is a ubiquitous cellular activity. For example, a 
typical human red cell contains around 200,000 glucose transport molecules. A defect 
in these transportation processes could lead to serious medical problems. 
The main application of the parent boronic acids has been there involvement in the 
Suzuki cross-coupling reaction, 114 e.g. in the synthesis of substituted pyrazines and 
bipyridines (Scheme 1.62).44 
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Ar 1 = 3-Pyridyl 67% 
4-Pyridyl 65% 
A(l- = 3-Pyridyl 89% 
4-Pyridyl 88% 
Scheme 1.62: Synthesis of Substituted Pyrazines and Substituted Bipyridines. Reagents and 
Conditions: (i) Pd(dppt)(0Ac)2, DMF, Et3N, 90°C. 
Substituted pyrazines occur widely in nature and are valuable heterocyclic nuclei for the 
design of pharmaceutical agents. The bipyridine is an important moiety, for example, 
the 2,2 '-bipyridyl ligand plays an important role in organic and inorganic chemistry, 
photochemistry, and materials science. 115 The formation of substituted bipyridine 
compounds is also an important step in the synthesis of new drug targets. For example, 
a key step in the formation of cytisine (85), a nicotine partial agonist, involves the 'in 
situ' Suzuki coupling to form a bipyridine (Scheme 1.63). 116 
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Scheme 1.63: Synthesis of Cytisine. Reagents and Conditions: (i) Et20, -40"C, (ii) TMB, Et20, (iii) 
Pd(PPh3)4, CsF, DME, 85"C. 
This reaction gives further evidence of the difficulty of synthesising 2-pyridylboronic 
acids as the intermediate lithium salt was used for the reaction. 
1.5 Conclusions 
With the variety of heterocyclic boronic acids available, coupled with their application 
in the Suzuki cross-coupling reaction, we have shown heterocyclic boronic acids to be 
very versatile reagents and beneficial to organic synthesis. Since its discovery in 1981 
the Suzuki reaction has been heavily investigated and is still undergoing improvements 
to meet the demands of the modem chemical industry. For example, combinatorial 
chemistry has become an important aspect of the drug discovery process. 117 Solid-
phase organic synthesis (SPOS) has attracted much attention over the past decade, as a 
powerful tool in the rapid synthesis of small molecule combinatorial libraries for drug 
discovery. 118 The solid-phase Suzuki cross-coupling reaction has recently been widely 
investigated. 119 Scheme 1.64 shows an example of the Pd-catalysed cross-coupling 
reaction of 3-thienylboronic acid with a novel resin bound CF 3-containing building 
block to give 86, thus illustrating another method of fluorine incorporation. 118 
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i) ii) 
86 
Scheme 1.64: Suzuki Cross-Coupling Reaction of Resin-Bound CFrContaining Building Block. 
Reagents and Conditions: (i) Pd(PPh3) 4, 3-Thienylboronic Acid, 2M Na2C03, Xylene/EtOH, SO"C, 
(ii) MeONa, MeOH/THF. 
The advantages of using SPOS are: 117 
• Ease at which reagents and solvents are removed. 
• Technique allows easy automation. 
• Produces a high throughput of compounds. 
A polystyrene-bound 13 has been synthesised. A pyridylboronic acid was used in this 
manner following the ~uccess Y amamoto et a/120 had with employing arylboronic acids 
as amidation catalyts, as many boron-based components such as ClB(OMe)2, HB(iPr)2 
and catecholborane are known to activate carboxylic acids for amidation reactions via 
mixed anhydrides. This polystyrene-bound acid has been shown to be an efficient, high 
yielding, easily recoverable and reusable amidation catalyst providing the first example 
of a pyridylboronic acid being used in this process (Scheme 1.65). 121 
PS = Polystyrene 
R = Ph- 95% 
NC-o--·87% 
Ph~ 97% 
Scheme 1.65: Application of PS-Bound 3-Pyridylboronic Acid. 
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These examples highlight the scope and possibilities of the Suzuki reaction, which in 
turn suggests the need for new boronic acids. 
The versatility of the Suzuki reaction and the fact that the synthesis of pyridylboronic 
acids is still a relatively unexplored area of organic chemistry, led us to consider new 
substituted-pyridylboronic acids to be interesting targets for our research. 
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2.0 §yiiDtlhlesis annd AppHicatnon of Halogennatedl-JPyridlyHboronic Acids 
2.1 lintrodnnction 
At the beginning of this project no halopyridylboronic acids had been reported in the 
literature. In 1999 Schliiter et a/1 synthesised a bromo-substituted pyridylboronic acid, 
but only obtained it in its crude form. They then converted the acid into its 
corresponding ester, {2-[3-(6-bromo )pyridine]-4,4'5,5 '-tetramethyl-1 ,3-dioxaborolane} 
(87), using pinacol, in order to purify the compound. This ester has been applied in the 
construction of terpyridines (88), which are employed in transition metal complexation 
and supramolecular assembly. This initial Stille cross-coupling reaction leaves the 
reactive boronic ester moiety free to undergo further cross-coupling reactions to give 
89, as illustrated in Scheme 2.1. 
_()_ +0,-o-+ B Br 
Me3Sn N SnMe3 0 -N 
~ i) 87 
+~8 "-':: p* .....:; ~ /; BO 55% -N N N 
88 
OH ex ~ ii) OH ex 
41% 
89 Br 
Scheme 2.1: Synthesis and Functionalisation of Terpyridines. Reagents and Conditions: (i) 
Pd(PPh3) 4, KF, toluene, reflux, (ii) 1-Bromo-3-hexyloxymethyl-5-iodobenzene, Pd(PPh3) 4, 1M 
Na2C03, toluene, reflux. 
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During the course of our work a detailed synthesis of halopyridylboronic acids was 
reported in the literature. Rault et aP published a series of papers detailing the 
halopyridylboronic acids and esters (Figure 2.1 ). 
(RO)zB~ (RO)zB~ 
~--A ~ .. J N Hal Hal N 
~R)z 
lN~Hal 
Ha I 
(RO)zB~ 
l . .J 
(RO)zB~Hal 
~-) N 
B(OR)z 
~Hal 
l .. J N 
R=H,± 
Hal = Br, Cl, F 
N 
Figure 2.1 :Halopyridylboronic Acids and Esters Synthesised by Rault et al. 
This chapter will describe in detail our synthesis of various Br, Cl and F substituted-
pyridylboronic acids. Iodine-substituted pyridylboronic acid was ruled out at an early 
stage, due to the fact that iodine is known to be a very good leaving group in the Suzuki 
cross-coupling reaction (see Chapter 1). This could lead to further complications upon 
the cross-coupling of such a substituted boronic acid, i.e. unwanted extended cross-
coupling (or polymerization). 
2.2 Synthesis of Halogenated Pyridylboronic Acids 
2. 2.1 Synthesis of Bromo-Substituted Pyridylboronic Acids 
At the beginning of this work we aimed to synthesise vanous bromo-substituted 
pyridylboronic acids, with the hope of preparing a bromo-substituted 2-pyridylboronic 
acid. In the preparation of these acids we avoided the use of Grignard reagents as 
pyridyl Grignard reagents are difficult to form (see Chapter 1) and lithiated 
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intermediates are known to be preferable. The routes we adopted in the synthesis of 
these acids involved either 1) metal-halogen or 2) metal-hydrogen exchange reactions. 
2.2.1.1 Via Metal-Halogen Exchange 
Our initial target was 2-bromo-5-pyridylboronic acid (92). The reasons behind this 
choice were: 1) the precursor 2,5-dibromopyridine (90) was commercially available and 
cheap, 2) the bromo substituent would allow further synthetic modification after the 
cross-coupling reaction. 
In the preparation of acid 92 we used the classical method for the preparation of a 
boronic acid, i.e. generation of the corresponding organolithium reagent at low 
temperature, followed by the addition of an alkylborate, in this case TPB, in order to 
introduce the boronic acid group (Scheme 2.2). 
-o- i) Br ~ !J Br --.:.L.-__.. N 
90 
Br-Q--Li 
N 
91 
ii) .. 
Br-Q--B(OHh 79% 
N 
92 
Scheme 2.2: Synthesis of 2-Bromo-5-pyridylboronic Acid. Reagents and Conditions: (i) nBuLi, 
Et20, -78°C, (ii) TPB, -78°C, (iii) Aqueous Work-up. 
This procedure gave acid 92 in good yield and it was found to be a shelf-stable 
compound. Comparing this synthesis to that of 3-pyridylboronic acid seemed to 
indicate that the presence of the bromine on the pyridine ring plays an important role in 
the synthesis of this acid. The lithio-species employed in this reaction was generated 
via the metal-halogen exchange reaction. This reaction is known to efficiently produce 
2-bromo-5-lithiopyridine (91). 3 Wang et af have reported that the selectivity of the 
lithiation reaction of 90 is strongly influenced by the choice of solvent and 
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concentration of the substrate. They found that 91 is produced when Et20 is used as the 
solvent for the lithiation. Bolm et at reported that THF gave complex mixtures when 
used as the solvent for this reaction. The aqueous work-up yielded 92 without the need 
for further purification. 
Following the success of the above reaction, we attempted the synthesis of other bromo-
substituted pyridylboronic acids. We again used 90, but in this case we aimed to 
introduce the boronic acid group at the 2-position of the pyridine ring, a usually 
inaccessible compound. Recalling the findings of Wang et a!, they found that the 
metal-halogen exchange reaction of 90 at the 2-position is possible in toluene at a 
concentration of 0.085M at .:78°C. Unfortunately the corresponding boronic acid (93) 
could not be isolated (Scheme 2.3). 
X i) (HOhB-o-\:( Br 
N-
93 
Scheme 2.3: Attempted Synthesis of 5-Bromo-2-pyridylboronic Acid. Reagents and Conditions: (i) 
1. Substrate cone.: 0.085M, nBuLi, toluene, -78"C, 2. TPB, -78"C, 3. Aqueous Work-up. 
There are 2 possible explanations behind this failure. Firstly, the reaction may have 
worked, but the boronic acid underwent protodeboronation, the proposed reason behind 
the failure in the synthesis of 2-pyridylboronic acid.6 Secondly, it has been reported 
that the 2-pyridyl anion, that is generated via the metal-halogen exchange reaction is 
destabilised by electrostatic repulsion between the lone pair on the nitrogen and the 
adjacent anion.7 
The above explanation could also apply in the failure to synthesise 2-bromo-6-
pyridylboronic acid (95). Bolm et a! have reported the lithiation of commercially 
available 2,6-dibromopyridine, a key step in the synthesis of bipyridines (94) (Scheme 
2.4).5 
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q-Br i) q-u ii) q-t 85% N H 
Br Br Br 
1 iii)
;; ~ 
-N 50% 
OH 
94 
Scheme 2.4: Application of 2,6-Dibromopyridine in the Synthesis of Bipyridines. Reagents and 
Conditions: (i) nBuLi, Et20, -78°C, (ii) 'BuCHO, (iii) NiC1z·6H20, Zn. PPh3, DMF, 70·c. 
Following our usual methodology, i.e. addition of TPB to generated lithio-species, 
followed by aqueous work-up, we were unable to fonn the corresponding boronic acid 
(Scheme 2.5). Also the use of TMB did not lead to the desired boronic acid, i.e. no 
precipitation from aqueous layer. A better route to this lithio-species could be to adopt 
an 'inverse addition' procedure, i.e. addition of the halide to a solution ofnBuLi.8 
q-Br 
Br 
X i) q-B(OH), 
Br 
95 
Scheme 2.5: Attempted Synthesis of 2-Bromo-6-Pyridylboronic Acid. Reagents and Conditions: (i) 
1. nBuLi, Et20, -78°C, 2. TPB, -78°C, 3, Aqueous Work-up. 
We then attempted the formation of 3-bromo-5-pyridylboronic acid (97), using 3,5-
dibromopyridine (96) as the starting material. We applied the same conditions that had 
been successful in the formation of 92 (Scheme 2.6). This reaction gave 97 in good 
yield. Rault et al undertook a similar route in the synthesis of this acid, i.e. employing 
the metal-halogen exchange reaction, using nBuLi in Et20 at -78°C. The difference 
between the reactions is a different work up procedure. 
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Br b-Br i) 
96 
Br b-B(OH)2 
97 
74% 
Scheme 2.6: Synthesis of 3-Bromo-5-pyridylboronic Acid. Reagents and Conditions: (i) nBuLi, 
Et20, -78°C, 2. TPB, -78°C, 3, Aqueous Work-up. 
2.2.1.2 Via Metal-Hydrogen Exchange 
Thus far all of the above reactions have involved the generation (or attempted 
generation) of the corresponding lithio-species, via the metal-halogen exchange 
reaction, in order to form the boronic acid. The following reactions involve the 
application of the metal-hydrogen exchange reaction in a bid to form boronic acids. 
An interesting application of this technique was the attempted synthesis of a dibromo-
substituted pyridylboronic acid. Gu et at have reported the successful generation of 
3,5-dibromo-4-lithiopyridine by the action of LDA. This reaction is an example of a 
DoM reaction. They then used this derivative to yield an alkyl-substituted 3,5-
dibromopyridine (98) (Scheme 2. 7). 
Br b-Br 
96 
Br6Me __ i_,_i) __.. 1 ~ Br N-
98 
89% 
Scheme 2.7: Generation of 3,5-Dibromo-4-Iithiopyridine. Reagents and Conditions: (i) LDA, THF, 
-78°C, (ii) Mel. 
We employed this protocol but were unable to obtain 99 even when we deviated from 
our standard conditions. For example, we used TMB, a less bulky alkylborate, rather 
than TPB, plus we followed a different reaction work-up procedure (Scheme 2.8). 10 
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Br BrHB(OHh b-Br --:X*-_i)'---~• \J-sr 
99 
Scheme 2.8: Attempted Synthesis of 3,5-Dibromo-4-pyridylboronic acid. Reagents and Conditions: 
(i) 1. LDA, THF, -78"C, 2. TPB or TMB, -78"C, 3. Aqueous work-up or alternate work-up (See ref 
10). 
We also used DoM methodology with mono-brominated pyridines, as halopyridines, 
particularly chloro- and fluoro-pyridines, and even bromo-pyridines, are known to 
undergo lithiation by deprotonation ortho to the halogen, normally using LDA as the 
lithiating reagent.8a Gribble and Saulnier11 described the synthesis of 4-lithio-3-
halopyridines using this methodology. Furthermore, Effenberger et a/12 have reported 
that the lithiation of 2-bromopyridine proceeds mainly at the 3-position, with partial 
lithiation at the 4-position (Scheme 2.9). 
Q-sr __ i)'--.,.. Li Q-sr Li Q-sr + 
Major Minor 
Scheme 2.9: Lithiation of 2-Bromopyridine. Reagents and Conditions: (i) LDA, THF, -78"C. 
We employed their procedure in the attempted synthesis of acids 100 and 101. Again, 
the reaction failed to yield the desired boronic acid, even when alternate reagents and 
reaction work-up were employed (Scheme 2.1 0). 
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100 = 3-Br, 4-B(OH)2 
101 = 2-Br, 3-B(OH)2 
Scheme 2.10: Attempted Synthesis of Acids 100 and 101. Reagents and Conditions: (i) 1. LDA, 
THF, -78"C, 2. TPB or TMB, -78"C, 3. Aqueous work-up or alternate work-up (See ref 10). 
All of the lithiation reactions are known to be successful, as the vanous groups 
described above have managed to trap the lithio-species with various electrophiles. 
However, it is known for pyridyllithium reagents with bromo substituents to be 
unstable, which results in the formation of pyridyne and lithium bromide (Scheme 
2.11). 13 
Scheme 2.11: Decomposition of 2-Bromopyridyllithium. 
Also, these reactions have all been carried out using a sequential addition method. 
Following an in situ quench pathway may facilitate the formation of the desired boronic 
acids. Plus, there are the reagents used and reaction work-up to consider. For example, 
Rault et a! used freshly generated LDA, formed from the reaction between 
diisopropylamine and nBuLi at ooc, in the synthesis of their catalogue ofboronic acids.2 
They also paid particular attention to the reaction work-up. For example, the reaction 
was 'quenched' very slowly using NaOH, and they carried out their acidification stage 
using aq. HCl ensuring that the temperature did not go above 5°C in order to prevent 
protodeboronation. 14 Whereas we used commercial reagents, such as LDA, and even 
though our work-up was applicable to certain bromo-substituted boronic acids, it may 
have been too harsh for others. 
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2.2.2 Synthesis of 2-Chloro-5-Pyridylboronic Acid 
We targeted 2-chloro-5-pyridylboronic acid (103) following the successful synthesis of 
92. 
We aimed to follow the same strategy as for 92. However, at the time 5-bromo-2-
chloropyridine (1 05) was not available commercially. So, for time and convenience we 
attempted the reaction using 2,5-dichloropyridine (102), following exactly the same 
procedure as we had used for the bromo derivative (Scheme 2.12). 
Cl-o-CI 
N 
102 
X i) ... Cl-o-B(OHh 
N 
103 
Scheme 2.12: Attempted Synthesis of 2-Chloro-5-Pyridylboronic Acid. Reagents and Conditions: 
(i) nBuLi, Et20, -78°C, (ii) TPB, -78°C, (iii) Aqueous Work-up. 
Bromo- or iodo- derivatives are known to react rapidly with alkyllithiums, at 
temperatures ranging from rt ~ -1 00°C, to give the lithic-derivative. Exchange of 
chlorine is rare, but nonetheless we carried out this reaction. 103 was not formed. 
A literature search on 105 revealed that Shiao et a/15 conveniently prepared this 
compound by the transformation of 5-bromo-2-methoxypyridine (104) under Vilsmeier-
Haack conditions (Scheme 2.13). 
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Meo---<J--sr 
N 
104 
j 
Generation of Vilsmeier Reagent: 
i) 
Cl-o-Br 71% 
N 
105 
Cl 
H~NMe2 8 
Vilsmeier Reagent 
Scheme 2.13: Formation of 5-Bromo-2-chloropyridine via the Vilsmeier Reagent. Reagents and 
Conditions: (i) POCh, DMF. 
Johnson and Sirisoma16 successfully lithiated 105 at the 5-position, Le. 105 can 
successfully undergo bromo-lithium exchange (Scheme 2.14). 
Cl--o-Br 
i) 
Cl-o-Li 
N 
Scheme2.14: Lithiation of 5-Bromo-2-chloropyridine. Reagents and Conditions: (i) nBuLi, THF,-
78°C. 
We then applied this methodology in the synthesis of 103, following a sequential 
addition method, i.e. starting material ~ nBuLi ~ TPB, which, surprisingly, did not 
yield 103 (Scheme 2.15). 
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Cl-o-Br -:0(~r--i,_) -t>- Cl-o-B(OHh 
105 103 
Scheme2.15: Attempted Synthesis of 2-Chloro-5-pyridyl boronic Acid. Reagents and Conditions: 
(i) 1. nBuLi, -78°C, THF, 2. TPB, -78°C, 3. Aqueous Work-up. 
We then turned to an in situ quench method, i.e. addition of nBuLi to a solution of the 
bromide and TPB, followed by our standard work-up. This method gave boronic acid 
103 in good yield (Scheme 2.16). 
Cl-o-B(OHh 61% 
N 
103 
Scheme2.16: Successful Synthesis of 2-Chloro-5-pyridylboronic Acid. Reagents and Conditions: (i) 
nBuLi, -78°C, THF, (ii) Aqueous Work-up. 
After completion of our work, Rault et al reported the synthesis of this acid using the 
sequential addition method. The differences being that they used Et20 as the solvent for 
the reaction and they applied a different work-up procedure.2 
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2.2.3 Synthesis of 2-Fluoro-5-pyridylboronic Acid 
The synthesis of a fluoropyridylboronic acid was seen as completing the set of halo-
substituted boronic acids. 
The route that we adopted to 2-fluoro-5-pyridylboronic acid (108) was to firstly prepare 
2-fluoro-5-bromopyridine (107) from 2-amino-5-bromopyridine (106), via a Balz-
Schiemann reaction, 17 then the in situ quench method gave 108 in 51% yield (Scheme 
2.17). 
H2N---<J-Br F-o-Br11% 
~0 
i) 
+ o-- 8--o~ N N A 106 107 
1 ii) 
Li 
CB 
51% F-o-B(OHh 
iii) F-o-~(OiPrb 
N N 
108 
Scheme2.17: Synthesis of 2-Fluoro-5-pyridylboronic Acid. Reagents and Conditions: (i) HBF4, 
NaN02, OOC, (ii) nBuLi, -78°C, THF, (ii) Aqueous Work-up. 
2.3 X- Ray Crystal Structures of Halo-Substituted Pyridylboronic Acids 92 & 
103 
A survey of the April2002 version of the Cambridge Crystallographic Database18 found 
17 structures containing a C(sp2)-B(OHh fragment, viz. PhB(OH)2 19 and its various 
derivatives, including 4-BrC6H4B(OH)2,20 but no heterocyclic derivatives. This finding 
prompted us to grow crystals of our halo-substituted pyridylboronic acids. 
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In all boronic acids, the boron atom has nearly planar trigonal coordination. In the 
absence of bulky substituents in the ortho positions, the CB02 plane is often coplanar 
with the benzene ring, but occasionally the twist around the C-B bond (1) can be as 
large as 28°. The two independent molecules in the structure of PhB(OH)2 display 
widely different 1 of 6.6° and 21.4°. Thus the rotation around the C-B bond is not 
hindered much. Crystals of 92 and 103 were obtained from an EtOH/H20 solvent 
system and their structures solved by Dr. A Batsanov. Figures 2.2 and 2.3 show that 
these acids have substantially different crystal structures, notwithstanding the similar 
size of the Cl and Br atoms (van der Waals radii 1. 76 and 1.87 A, respectively). 21 This 
can often produce isomorphous derivatives. 92 has the same structure at 295 and 120 
K, i.e. there is no evidence that the crystallographic difference between 92 and 103 is 
linked to temperature dependent polymorphism. 
~'I I 
I 
I 
I 
~1'1 
\ 
I 
\ 
Figure 2.2: X-ray Structure of Br, at 120 K (top) and 295 K (bottom), showing 50% Thermal 
Ellipsoids and Hydrogen Bonds. Atoms Generated by an n plane are Primed, those Generated by 
an Inversion Centre Double Primed. 
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N11'~ 
I 
J 
012"1 
Figure 2.3: X-ray Structure of Cl, Showing 50% Thermal Ellipsoids and Hydrogen Bonds. Atoms 
Generated by a 21 Axis are Primed, those Generated by an Inversion Centre Double-Primed. 
92 and 103 adopt slightly twisted conformations: in Br r-=10.5° (295 K) and 10.9° (120 
K), in Clr =4.0°. The C-B bond distances in Brand Cl are equal [1.573(2) A at 120 K] 
and close to that in PhB(OH)2 after libration correction [1.565(3) A]. As with the latter 
structure, molecules of 92 and 103 related by an inversion· centre, form hydrogen-
bonded dimers, broadly similar to those existing in the crystals of organic acids. The 
hydroxyl H atoms not engaged in dimerization, form hydrogen bonds with the 0 atoms 
of adjacent dimmers in PhB(OH)2 and with heterocyclic N atoms in 92 and 103. Due to 
the latter, the crystal architecture of 92 and 103 is quite different from that of 4-
BrC6H4B(OH)2. In both 92 and 103, the 0(1) atom acts as both a donor and an acceptor 
of hydrogen bonds, and 0(2) as a donor only. Correspondingly, the B-0(1) bond is 
marginally longer than B-0(2): 1.363(2) vs. 1.357(2) A in 92, 1.362(2) vs. 1.352(2) A 
in 103, comparing the average of 1.371(7) A in PhB(OH)2, where both 0 atoms act like 
0(1). 
However, the two OH ... N bonds (donated and accepted) by the same molecule, in 92 
are in a cis, and in 103 in a trans orientation with respect to the B ... Br(Cl) axis of the 
molecule (see Figures 2.2 and 2.3). In 92 these bonds link the molecules symmetrically 
related by an n glide plane, in 103 those related by a 21 axis, giving rise to rather 
different crystal packing. 
To date we have been unable to grow crystals of2-fluoro-5-pyridylboronic acid (108). 
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2.4 Application of Halopyridylboronic Acids 
As we have shown in Chapter 1, the main application of a boronic acid is the Suzuki 
cross-coupling reaction, so we applied our halo-substituted pyridylboronic acids in this 
reaction. There are many different solvents, bases, temperatures and catalyst 
combinations available for this reaction, and we decided on two sets of reaction 
conditions. Conditions A: DMF as the solvent, Na2C03 as the base, Pd(PPh3) 4 as the 
catalyst and a reaction temperature of 80°C. Conditions B: 1 ,4-dioxane as the solvent, 
Cs2C03 as the base, Pd(PPh3) 2Clz as the catalyst and a reaction temperature of 95°C. 
Having a choice of reaction conditions allowed us to check the results of our cross-
coupling reactions to see if the conditions had an effect on the reaction yield. 
We cross-coupled our acids with different heteroaryl bromides as the other coupling 
partner. Scheme 2.18 is a general representation of these reactions. 
XF\_ ~___;-B(OHh + Ar-Y 
Conditions A 
Conditions B 
X= Br, Cl, F 
Scheme 2.18: General Illustration of our Suzuki Cross-Coupling Reactions. 
2. 4.1 Application of Bromo-Substituted Pyridylboronic Acid in the Suzuki Cross-
Coupling Reaction 
We initially studied the bromo-substituted pyridylboronic acids. The results are shown 
in Table 2.1. 
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Boronic Isolated Yield/% Entry 
Acid Ar-Y Product Conditions Conditions 
A B 
··-et> ~ 92 Br 32 14 - ~ ~ 109 
2 92 Br-o Br-G--0 11 N N-
110 
3 92 sr-(J sr-{)-(N~ 10 N -N 
111 
4 97 
··-et> _JP - ~ /; Br N 
112 
Table 2.1: The Suzuki Cross-Coupling Reactions of 92 and 97. 
Table 2.1 shows that we have successfully attached different heteroaryl ring systems to 
the pyridine ring, albeit in low yield, using both sets of reaction conditions. Upon 
investigation into possible causes behind these low yields we found that, with respect to 
entry two of Table 2.1, extended cross-coupling was occurring between the remaining 
boronic acid and the product bromide, i.e. there was competition between the two 
bromides for the remaining boronic acid, resulting in the low yield of the biheteroaryl 
target (Scheme 2.19). 
In support of this theory, TLC of the reaction mixtures indicated an extra product being 
produced in this reaction, which upon isolation was shown by 1H NMR and mass 
spectrometry data to be 113 (Figure 2.4). 
Br 
113 
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Br F\_ ~,___y-Ar 
N 
( Competition \ 
Br-zf)-B(OHh 
N 
1 
Br F\_ ~,___y-Ar 
N 
Br~J---0--Ar 
N N 
1 
Further Cross-Coupling 
Scheme 2.19: An Illustration of Extended Cross-Coupling. 
Ar-Br 
On the positive side, we are able to produce bromo-substituted heterobiaryls, which can 
now be used as the halo-coupling partner in the Suzuki reaction. This can lead to 
further functionalisation of our pyridyl systems. 
2.4.2 Application of Chloro-Substituted Pyridylboronic Acid m the Suzuki Cross-
Coupling Reaction 
The synthesis of a chloro-substituted pyridylboronic acid was seen as a way of 
combating the extended cross-coupling observed with the bromo-substituted 
pyridylboronic acid 92, because the boronic acid would be less reactive towards the 
chloro product (see Chapter 1 ). Also, at the beginning of this project no chloro-
substituted pyridylboronic acids had been published. 
We firstly used 3-bromoquinoline as the coupling partner m our cross-coupling 
reaction, because we had used this successfully with 92 & 97. We thought th~t the use 
of this particular reagent would provide a good benchmark to gauge the success of the 
reaction. The reaction of 103 with 3-bromoquinoline showed an improvement on the 
analogous bromo reaction (55% yield compared to 32% yield). From this initial success 
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we carried out similar reactions with different heteroaryl bromides. Table 2.2 shows the 
results from these cross-coupling reactions. 
These analogous reactions with the chloro-substituted boronic acid were found to be 
much cleaner and more efficient (higher yielding) than the bromo-substituted boronic 
acids (no TLC evidence of extended cross-coupling). 
Entry 
Boronic 
Ar-Y Product Isolated Yields/% Acid Conditions A 
103 
"'<b Ci-cccb 55 64 - ~ N - ~ 114 -
2 103 Br-o Cl-{}--0 61 N N-
115 
3 103 sr-(} Cl-o--cN~ 38 N -N 
116 
4 103 sr---fJ-No s 2 
ci-{J-Q-No2 N- S 53 
117 
5 103 sr--0 0 Cl--()-() N- 0 66 
118 119 
Table 1.2: Results from the Suzuki Cross-Coupling Reactions of 2-Chloro-5-pyridylboronic Acid. 
The 2-bromofuran (118) is not available commercially and was formed from the 
decarboxylation of 2-bromo-5-furoic acid (Scheme 2.20). 22 
Br~COOH 
0 
i) Br-0 
0 
47% 
118 
Scheme 1.20: Synthesis of 2-Bromofuran. Reagents and Conditions: (i) Cu powder, quinoline, .1. 
Investigating this chemistry further, we decided to test the cross-coupling reaction of 
103 with heteroaryl chlorides. This follows reports in the literature that 
chloropyrimidines are good substrates for the Suzuki couplings with phenyl- and 
substituted-phenylboronic acids.23 Therefore, we treated 103 with 2,4-
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dichloropyrimidine, using our coupling reagents and conditions, and obtained 120 in 
23% yield (Scheme 2.21 ). 
CI---<J--B(OHh + 
N 
103 
i) 
Cl 
-o-c=< Cl N 23% N 
120 
Scheme 2.21: Suzuki Cross-Coupling of 103 with 2,4-Dichloropyrimidine. Reagents and 
Conditions: Conditions A: (i) Pd(PPh3) 4, DMF, Na2C03, 80°C. 
We are confident the cross-coupling reaction of 2,4-dichloropyrimidine takes place at 
the 4 position of the pyrimidine ring and not the 2-position for two reasons: 1) the 
precedent for such a reaction is that the halogen at C4 is more reactive than the halogen 
at C2 of the pyrimidine ring,233 and 2) the observed respons~ of 120 in a NOESY 
spectrum between the proton at C5 of the pyrimidine with the protons at C2 and C4 of 
the pyridine ring confirms that 120 is the correct isomer structure (Figure 2.5). 
~N=<CI 
Cl- )N~~N 
He Hd He 
Figure 2.5: NOESY Spectrum of 120. 
15 
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This reaction verifies the fact that cross-coupling reaction can be carried out using 
chlorides, and that this reaction has lead 120 with 2 chlorines present, which have the 
potential to be reactive handles for further cross-coupling reactions. 
2.4.3 Application of 2-Fluoro-5-pyridylboronic Acid in the Suzuki Cross-Coupling 
Reaction 
We have proved that the cross-coupling reaction of103 is more efficient than 92 and 97. 
We would expect the cross-coupling of the fluoro-boronic acid (108) to be analogous 
with the chloro-boronic acid. So, rather than give numerous examples of cross-coupling 
reactions of this acid, we cross-coupled 108 with 3-bromoquinoline for comparison to 
the other boronic acids. We used conditions A & B, and obtain 121 in 41% and 57% 
respectively (Scheme 2.22). 
F-o-B(OHh 
Br~ 
+ ~~~~ N 
Conditions A ~~h 
Conditions B F ~_j ~
121 
Scheme2.22: Cross-Coupling Reaction of 108 with 3-Bromoquinoline. 
41% & 57% 
This reaction indicates that we can potentially introduce a variety of heteroaryl ring 
systems to this fluorinated pyridine, following the success of this reaction. The 
importance of such a reaction, i.e. production of fluorinated compounds, has already 
been addressed in Chapter 1. 
2.5 Conclusions 
Rault et al, and ourselves, have independently and concurrently shown that a variety of 
halo-substituted pyridylboronic acids can be formed in high yields and be isolated in 
their pure state making use of metal-halogen exchange and DoM methodology. We 
believe this methodology could be extended to give dihalo-substituted pyridylboronic 
acids, which to date are unknown compounds. 
Both research groups have proven that these acids can be applied in the Suzuki cross-
coupling reaction, to great effect. However, Rault et al cross-coupled their acids with a 
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variety of substituted phenyl rings, whereas we used only heteroaryl ring systems. We 
avoided substituted-phenyl ring systems as many of their corresponding boronic acids 
are known to be available commercially, and thus could be used in the cross-coupling 
reactions with heteroaryl bromides. We chose heteroaryl bromides as our coupling 
partners as their boronic acids are difficult to form; therefore, we are producing novel 
heteroarylpyridines in our work. 
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3.0 Synthesis of Pyridylboronic Acids with Varying Substituents 
3.1 Introduction 
At the beginning of this project very little had been published about the parent 
pyridylboronic acids let alone substituted pyridylboronic acids. After our successes in 
the synthesis of various halogenated pyridylboronic acids, we turned to the synthesis of 
various mono- and di-substituted pyridylboronic acids. Our aims were to produce 
boronic acids with the substituent and the B(OH)2 groups at varying positions around 
the pyridine ring. These would be new boronic acids, which could then be applied in 
the Suzuki cross-coupling reaction to yield new, functionalised heteroaryl systems. The 
routes adopted in the synthesis of these boronic acids involve the methodologies 
described in Chapter 1, i.e. lithiation via metal-hydrogen or metal-hydrogen exchange. 
3.2 Synthesis of Mono-Substituted Pyridylboronic Acids 
3.2.1 Alkmy-Substituted Pyridylboronic Acids 
3.2.1.1 Via Metal-Halogen Exchange 
Our initial target, namely 2-methoxy-5-pyridylboronic acid (123) was chosen for two 
reasons: (i) the starting material, 5-bromo-2-methoxypyridine (104) was readily 
available, and (ii) 104 is known to undergo the metal-halogen exchange reaction to give 
the corresponding lithio-species. 1 
The route we employed proceeded v1a the reactive lithio intermediate 122 for 
subsequent reaction with the electrophile, i.e. TPB (Scheme 3.1 ). 
MeO-o-Br 
104 
i) 
MeO-o-Li 
122 
ii) 
MeO-o-B(OHh 65% 
123 
Scheme 3.1: Synthesis of 2-Methoxy-pyridylboronic Acid. Reagents and Conditions: (i) nBuLi, 
Et20,-78"C, (ii) 1. TPB, -78"C, 2. Aqueous Work-up. 
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The whole procedure followed the sequential addition of reagents and gave 123 in 65% 
yield. 
The low temperature, i.e. -78°C, used to carry out this initial reaction is difficult to 
realise on an industrial scale. Therefore, we repeated this reaction at a series of elevated 
temperatures, whilst the other factors, i.e. solvent and reagent quantities, remained the 
same for each experiment. Table 3.1 shows the results from these experiments. 
Reaction No. Temp./ oc Yield/% 3 
1 -78 65 
2 -50 63 
3 -20 69 
4 0 51 
5 5 45 
Table 3.1: Results from Formation of 123 at Varying Temperature. 
Notably the yield of 123 did not vary significantly between -78°C and -20°C. This is an 
interesting observation that has potential benefits for industrial applications, as -20°C is 
a temperature that can be realised on an industrial scale. Reactions 4 & 5 then gave the 
expected reductions in the yield of this reaction, but still gave 123 in workable yields. 
These findings demonstrate that this reaction is not restricted to very low temperature, 
i.e. -78°C, in order to achieve significantly useful results. 
We then decided to attempt the synthesis of a similar boronic acid having an ethoxy 
group rather than a methoxy group, to give another example of an alkoxy substituted 
pyridylboronic acid. At the time this work was carried out, 5-bromo-2-ethoxypyridine 
124 was not commercially available. Therefore, 124 was produced from 2,5-
dibromopyridine by the method described by Den Hertog et al. 2 The corresponding 
boronic acid (125) was then produced via the same methodology that gave 123 (Scheme 
3.2). 
• 
1H NMR detennined identification and purity of the products. 
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sr-Q-sr 
N 
90 
i) 
EtO-o-Br 33% 
124 
ii) 
EtO-o-B(OHb 61% 
125 
Scheme 3.2: Synthesis of 2-Ethoxy-5-pyridylboronic Acid. Reagents and Conditions: (i) EtOH, 
NaOH, A, (ii) 1. nBuLi, Et20,-78"C, 2. TPB, -78"C, 3. Aqueous Work-up. 
Scheme 3.2 shows that 125 is produced in similar yield to that of 123. Both acids are 
shelf-stable and they represent the first alkoxypyridylboronic acids. 
3.2.1.2 Via Metal-Hydrogen Exchange 
We then progressed to the formation of other derivatives of 123. The DoM reaction 
provides a mechanism that would enable us to vary the positions of the methoxy and 
boronic acid functional groups around the pyridine ring. Queguiner et aP have 
employed this methodology in the ortho lithiation of 2-methoxypyridine (126) in order 
to produce 3-lithio-2-methoxypyridine (127) using LDA as the lithiating reagent 
(Scheme 3.3). 
Q 
OMe 
126 
i) Q-u 
OMe 
127 
Scheme 3.3: Ortho Lithiation of 2-Methoxypyridine. Reagents and Conditions: (i) LDA, THF, -
78"C. 
This reaction is possible due to the chelating effect of the methoxy group, which 
stabilises the lithio intermediate. This concept was described in Chapter 1. However, it 
was the work of Comins and LaMunyon4 that really attracted our interest. They 
lithiated 2-, 3- and 4-methoxypyridine, ortho to the methoxy group, using LDA at ooc; 
which they then trapped with trimethylsilylchloride (TMSCI) (Scheme 3.4), 
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ii) M eO!=)( TMS -----=---~ ~y 
128 2-MeO, 3-TMS 83% 
129 3-MeO, 4-TMS 42% 
130 4-MeO, 3-TMS 61% 
Scheme 3.4:Trimethysilyllation of Methoxypyridine. Reagents and Conditions: (i) LDA, THF, ooc, 
(ii) TMSCI. 
The attraction of these reactions is that ooc is an industrially applicable temperature. 
We used these conditions in the attempted synthesis of new pyridylboronic acids. 
Firstly, we aimed to synthesise 2-methoxy-3-pyridylboronic acid (131) via the 
sequential addition of reagents. The lithio-species generated was reacted with TMB 
followed by an aqueous work-up to give 131 in 13% yield (Scheme 3.5). 
Q 
OMe 
126 
i) Q-B(OH)2 13% 
OMe 
131 
Scheme 3.5: Synthesis of 2-methoxy-3-pyridylboronic Acid. Reagents and Conditions: (i) 1. LDA, 
THF, ooc, 2. TMB, ooc, 3. Aqueous Work-up. 
The use of TMB instead of TPB as the electrophile of choice was influenced by the 
possibility of the increased steric hindrance ifTPB was to be used in the reaction. 
The same reaction was attempted using 4-methoxypyridine (132), only this reaction 
gave none of the desired boronic acid (133). The use of sequential addition and in situ 
quench methodology was employed using both TMB and TPB as the electrophile for 
the reaction to no avail (Scheme 3.6). 
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OMe OMe 
d X i) .. 6-B(OH), N 
132 133 
OMe OMe 
0 + X ii) o-B(OH)2 E .. 
Scheme 3.6: Attempted Synthesis of 4-Methoxy-3-pyridylboronic Acid. Reagents and Conditions: 
(i) 1. LDA, THF, O"C, 2. TMB or TPB, O"C, 3. Aqueous Work-up, (ii) 1. E = TMB or TPB, LDA, 
THF, O"C, 3. Aqueous Work-up. 
3.2.2 Synthesis of Di-Substituted Pyridylboronic Acids: Alkoxy- and Halogen-
Substituted Pyridylboronic Acids 
Having synthesised various mono-substituted halogen and alkoxy pyridylboronic acids, 
respectively, we believed that a di-substituted pyridylboronic acid, containing both of 
these functional groups, would be a realistic target. Therefore, following a method 
described by Leeson and Emmett,5 we utilised DoM methodology to introduce the 
boronic acid functional group at the 4-position of various alkoxy- and halogen-
substituted pyridine rings. 
Firstly, we attempted the DoM reaction on 104, a commercially available substrate. 
The lithiated species generated by the action of LDA was quenched with TPB followed 
by an aqueous work-up to give 134 in 39% yield (Scheme 3.7). Evidence eH NMR) 
indicates that the compound we have isolated is 134. 
M eO ~-!J Br _ __;_--l~> 
-o- i) N 
104 
B(OHh 
MeO~Br 39% 
N 
134 
Scheme 3.7: Synthesis of 3-Bromo-6-methoxy-4-pyridylboronic Acid. Reagents and Conditions: (i) 
1. LDA, THF, -78"C, 2. TPB, -78"C, 3. Aqueous Work-up. 
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To obtain the chloro-analogue we needed 136, which was not commercially available at 
the time of this work. Therefore, following a method described by Bargar et a/,6 we 
successfully produced 136 in 31% yield from 2,5-dichloropyridine (135) and 
subsequently, we subjected 136 to the same conditions as 104 which gave 137 in 48% 
yield, a slight improvement on the Br derivative (Scheme 3.8). 
Cl-o-CI 
N 
135 
i) _J\__ -----'---~ Meo-\J-cl 31% 
136 
ii) 
B(OHh 
MeO~CI 48% 
N 
137 
Scheme 3.8: Synthesis of 3-Chloro-6-methoxy-4-pyridylboronic Acid. Reagents and Conditions: (i) 
25% NaOMe (MeOH), MeOH, 4, (ii) 1. LDA, THF, -78°C, 2. TPB, -78°C, 3. Aqueous Work-up. 
We next employed 124 in our di-substituted pyridylboronic acid reactions, and 
following the same route as the previous two boronic acids we were able to generate 
138 in 23% yield (Scheme 3.9). 
Eto-Q-sr 
124 
i) 
B(OH)2 
EIO~Br 23% 
138 
Scheme 3.9: Synthesis of 3-Bromo-6-ethoxy-4-pyridylboronic Acid. Reagents and Conditions: (i) 1. 
LDA, THF, -78°C, 2. TPB, -78°C, 3. Aqueous Work-up. 
3.3 Application of the Suzuki Cross-Coupling Reaction 
The main purpose in obtaining these new boronic acids was to explore their applications 
in Suzuki cross-coupling reactions. Therefore, from our successes with the cross-
coupling reactions of our other substituted pyridylboronic acids, we decided to utilise 
the same conditions as described in Chapter 2 for the cross-coupling reactions of these 
new classes of boronic acids (Scheme 3.1 0). 
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/=".t<B(OHh 
R'\\ _j-R" + Ar-Y 
N 
Conditions A /="/.Ar 
R'\\_j-R" 
N 
R' = MeO, EtO 
R"= H, Br, Cl 
Scheme3.10: General Illustration of the Suzuki Cross-Coupling Reaction. Reagents and 
Conditions: Conditions A: Pd(PPh3) 4, DMF, Na2C03, 80"C. 
3.3.1 Application of Mono-Substituted Pyridylboronic Acid in the Suzuki Cross-
Coupling Reaction 
3. 3.1.1 Using halobenzenes as the substrate 
We initially used phenyl halides to test the cross-coupling reaction using acid 123. 
Table 3.2 highlights our initial findings. 
Entry Boronic Ar-Y Product Isolated Yield;/% Acid Conditions A 
123 Br--o MeO-o-o 65 
139 F F 
2 123 Br-Q-F MeO-o-Q-F 67 
F 140 F 
3 123 sr-Q-ocF3 Me0-o-o-OCF3 48 
141 
Table 3.2: Results from the Cross-Coupling of acid 123 with Various Substituted Halides. 
We began our series of cross-coupling reactions with simple ring systems, as they were 
readily available and produced new products. Compound 139 is an example of the 
incorporation of the simplest phenyl halide, bromobenzene. With compounds 140 and 
141 we see the easy production of fluorine containing systems. The significance of 
such a reaction has already been highlighted in Chapter 1. 
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3.3.1.2 Using halopyridines and 3-bromoquinoline as the substrate 
Table 3.3 highlights our findings using this series of cross-coupling partners. 
Boronic Isolated Entry Acid Ar-Y Product Yields/% 
Conditions A 
123 
··-et> MeO-cccb 76 - ~ 142 -
2 123 Br-o Meo---c}{) 50 N N-
143 
3 123 Br-Q M eo--{)---() 58 N -N 
144 
4 123 sr-Q-oMe 
MeO~OMe 83 
-N N -N 145 
5 123 Br--{)--CF3 Meo-o-0-cF3 32 N- N N-146 
6 123 sr-Q-No2 MeO~N02 66 
-N N -N 147 
N02 NOz 
7 123 Br-d--NH2 Meov-d-NH2 45 
-N N -N 
148 
··-et> COb 8 ~ 61 131 - ~ OMe 
149 
9 
··-et> EtO~ 49 125 - ~ N - ~ 150 -
Table 3.3: Results from the Cross-Coupling Reactions of 123, 125 & 131 with Various Substituted 
Pyridyl Bromides. 
As seen from Table 3.3 we have produced many different biheteroaryl and quinolyl 
systems with a variety of substituents, with each substituent chosen to have a different 
electronic effect on the ring system. For example, the alkoxy and amine groups are 
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electron donating, whereas the nitro and trifluoromethyl groups are electron 
withdrawing. 
3.3.1.3 Using electron deficient halides as the substrates 
We decided to investigate what effect more electron deficient heterocyclic halides 
would have on the Suzuki reaction. We therefore used pyrimidine and pyrazine 
derivatives as they are known to be more electron deficient than pyridine as the 
additional nitrogens in the ring lowers the energies of the 1r molecular orbitals, which 
results in the increasing difficulty of such systems to undergo electrophilic attack on the 
ring carbon atoms, therefore allowing the increased ease of nucleophilic attack. 
Table 3.4 highlights the results from our cross-coupling reactions. 
Entry Boronic Ar-Y Product Isolated Yiehk/% Acid Conditions A 
123 Br-{) Meo-(}--<\N) 28 N N 
151 
2 123 sr--(~) Mea-{)-{:~) 35 N N N 152 
3 123 Br~-=f-NH2 Meo---o--(-=f-NH2 26 N N N 153 
Table 3.4: Results from the Cross-Coupling of 123 with Various Electron Deficient Ring Systems. 
Table 3.4 clearly shows the trend that when an electron deficient substrate is applied in 
the Suzuki cross-coupling reaction, under conditions A, the desired product is formed in 
lower yield. 
3.3.1.4 Using five membered ring halides as the substrate 
In contrast to the previous section, when an electron rich system, such as a thiazole, 
thiophene or furan ring is employed in the Suzuki reaction, again using conditions A, 
notably higher product yields are obtained (Table 3.5). 
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Entry Boronic Ar-Y Product Isolated Yields/% 
Acid Conditions A 
123 BrJt) 
s 
Meo-{)--Z) N S 85 
154 
2 Br-0 Meo-o--Q 123 ~ ;J s 87 
s 
155 
3 123 Br---Cs MeO-o-cS 77 
156 
4 Br--l:J-No -Q---10- 94 MeO N02 123 s 2 N 
157 
5 123 Br-0 0 
Meo-D--Q N 0 67 
158 
6 123 Br---Co MeO-o-cO 54 
159 
Table 3.5: Results from the Cross-Coupling of acid 123 with five-membered ring bromides. 
123 has also been proved as a suitable reagent for the synthesis of a tris(heteroaryl) 
derivative, which has been illustrated by the two-fold reaction of 123 with 2,5-
dibromothiophene, which gave 160 in 34% yield (Scheme 3.11). 
MeO---()--B(OHh 
N 
123 
i) M eO OMe 34% 
160 
Scheme 3.11: Synthesis of a Tris(heteroaryl) Derivative (160). Reagents and Conditions: (i) 2,5-
dibromothiophene, Pd(PPh3) 4, DMF, 1M Na2C03, 80°C. 
This reaction has important implications as linear oligo(heteroaryl) systems of this type 
are important materials for optoelectronic device applications.7 
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3.3.2 Application of Di-Substituted Pyridylboronic Acid in the Suzuki Cross-Coupling 
Reaction 
This section gives the results from the Suzuki reactions of our di-substituted 
pyridylboronic acids 134 and 137, using reaction conditions A. Table 3.6 illustrates our 
findings. 
Entry 
2 
3 
Boronic 
Acid Ar-Y 
134 Br-<=b 
137 
137 
Br-o 
sr-0-~ NO s 2 
Product 
161 
M eO NO-o 
Cl 
162 
••:q-o-No, 
Cl 
163 
Isolated Yields/% 
Conditions A 
50 
35 
28 
Table 3.6: Results from the Cross-Coupling of acids 134 & 137 with Various Bromide Substrates. 
The yields of the reactions were lower than anticipated, as the corresponding reactions 
involving the mono-substituted pyridylboronic acid were relatively high yielding. We 
believe this outcome could be a result of three possible factors: 
1. The substituent ortho to the boronic acid functional group may sterically hinder 
the cross-coupling. 
2. The set reagents and conditions we have used so far with our coupling reactions 
may be unsuitable for the reactions involving this class ofboronic acid. 
3. There is also the possibility that further cross-coupling of our products may be 
occumng 
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In an attempt to improve upon the yields of not only the above reactions, but also 
attempt the synthesis of more novel heteroaryl derivatives using both the mono- and di-
substituted pyridylboronic acids, we explored the application of our alternative reaction 
conditions, conditions B, which we had used earlier in this work (Scheme 3.12). Table 
3.7 highlights the results from our cross-coupling reactions under these conditions. 
Conditions B 
Boronic Acid + Ar-Y Product 
Scheme 3.12: General Illustration of our Cross-Coupling Reaction using Conditions B. Reagents 
and Conditions: (i) Conditions B: Pd(PPh3)2C(z, 1,4-dioxane, 1M Cs2C03, 95"C. 
Entry Boronic Ar-Y Product Isolated Yields/% Acid Condltions B 
M eO 
134 Br-<b N~ 50 Br -
161 
M eO 
2 137 Br-<b N~ 60 
Cl -
164 EIOQ--o-
3 138 Br~NO N N02 44 s 2 Br 
165 
M eO 
0 NQ--o 4 137 Br-(); 30 
Cl 
166 
co:b 5 131 Br-<b 77 OMe 
149 
6 125 Br-<b EtO-cccb 59 
150 -
0 MeO--o-o 7 123 Br-(); 91 
158 
Table 3.7: Results of Suzuki Reactions using our Alternative Conditions (Conditions B). 
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The table clearly shows vast improvements in the yields of some reactions and the 
production of new, interesting bisheteroaryl systems. 
3.4 Conclusions 
In summary, judging by the data from each of our reactions, we can clearly state that 
these classes of substituted pyridylboronic acids are versatile reagents for the production 
of novel heteroarylpyridine derivatives, which can contain different ring systems 
varying from pyridyl, quinolyl, pyrimidyl, pyrazinyl, thienyl, thiazoyl and furyl. An 
added advantage of these reactions, in particular reactions involving the di-substituted 
pyridylboronic acids, is that the products obtained are able to undergo further 
functionalisation. For instance, the compounds that contain a halogen can now be 
employed as the halo substrate for further cross-coupling reactions, which can lead to 
numerous possibilities for further functionalisation. An example showing the 
possibility of such a reaction was highlighted in Chapter 2. 
Furthermore, the alkoxy group of the compounds is suitable for functional group 
interconversion. As an example of such a conversion, we converted the MeO group of 
142 into a Cl group to give 167 in 45% yield, following the method described by Shiao 
et a/8, which involves Vilsmeier-Haack conditions (Scheme 3.13). 
M eO 
i) 
Cl 45% 
142 167 
Scheme 3.13: Conversion of MeO-+ Cl under Vilsmeier-Haack Conditions. Reagents and 
Conditions: (i) POCI3, DMF, 4. 
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4.0 Synthesis and Application of 5-Formylfuran-2-boronic Acid 
4.1 Introduction 
The prevwus chapters have involved the synthesis and application of new 
pyridylboronic acids. In this chapter we investigate the synthesis and application of 5-
formylfuran-boronic acid (170). This compound had previously been reported in the 
literature and is now commercially available. Our aim was to expand on the work 
previously carried by Starling et al1 by firstly isolating, and then employing 170 in the 
production of novel, functionalised heteroaryl substituted furyl derivatives. We then 
intended to investigate methods for increasing further the functionality of these systems. 
4.2 Synthesis of 5-Formylfuran-2-boronic Acid 
As we detailed in Chapter 1, furylboronic acids have been known for some time. The 
attraction of 170 is that the aldehyde substituent can be used as a reactive handle for 
increasing the functionalisation of the furan ring. 
The synthesis of 170 by a lithiation mechanism could be complicated by the presence of 
the aldehyde group being susceptible to attack from the organolithium reagent at its o+ 
centre. Therefore, following the method described by Thames et al, 2 we firstly 
protected the aldehyde group on our starting material, 2-furaldehyde (168), using 
triethylorthoformate, which gave the corresponding acetal (169) in 70% yield which 
would be resistant to attack by an organolithium reagent, and can be cleaved after the 
reaction by acid hydrolysis. Reaction of an organolithium reagent with 169 allows 
substitution to occur mainly at the 5-position of the furan ring. We obtained acid 170 
pure in 52% yield following the method described Starling et al. 1 This route involved 
the generation of the reactive lithium species, by the reaction of nBuLi with 169, 
followed by quenching the reaction with TMB, a suitable electrophile (Scheme 4.1 ). 
OHC~ 
0 
168 
i) (EtOhHC~ 70% 
0 
169 
ii) 
OHC-0-B(OHh 52% 
0 
170 
Scheme 4.1: Synthesis of 5-Formylfuran-2-boronic Acid (170). Reagents and Conditions: (i) 
Triethylorthoformate, 130°C, (ii) 1. nBuLi, -78°C, THF, 2. TMB, -78°C, 3. Aqueous Work-up. 
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We significantly modified the work-up described by Starling et al. During our aqueous 
work-up the protecting group is cleaved and an aldehyde is regenerated. We also found 
that in order to obtain 170 in a pure state, a post aqueous work-up wash with DCM 
removes tarry by-products. This procedure is simple, yet effective. 
These practical differences have allowed us to obtain 170 in its pure form prior to its 
application in the Suzuki cross-coupling reaction, whereas Starling et al reacted 170 in 
its crude state. 
4.3 Application of 5-Formylfurarn-2-borornic Acid in the SuzuBd Cross-Coupling 
Reaction 
Following the isolation of pure 170 the main area of interest we envisaged was the 
formation of various heteroaryl substituted furyl systems, following our Suzuki cross-
coupling conditions (Scheme 4.2). 
OHC~B(OHh 
0 
170 
+ 
Conditions A n 
Ar-Y OHC~_/-Ar 
Conditions B 0 
Scheme 4.2: General Scheme of the Suzuki Cross-Coupling Reactions of 170. Reagents and 
Conditions:Conditions A: Pd(PPh3) 4, DMF, Na2C03, 80°C, Conditions B: Pd(PPh3) 2Cl2, 1,4-
dioxane, Cs2C03, 95°C, 
The products would be novel and the -CHO group present in the system should allow 
continued functionalisation of the furyl systems. 
Initially, we used conditions A in the production of 171-174 and found that the yield of 
each cross-coupling reaction was low, in comparison to the good to moderate yields we 
achieved previously with our pyridyl systems using conditions A. We then repeated the 
cross-coupling reactions for 171-174 using conditions B. In general, except for 174, the 
results were vastly improved. This prompted us to attempt the synthesis of other 
analogous systems; again using conditions B. Table 4.1 highlights the results from all 
our Suzuki reactions using both sets of reaction conditions. 
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Boronic Isolated Yield/% Entry Acid Ar-Y Product Conditions Conditions 
A B 
Br-0 OHC--Q----0 170 0 ~ h 34 64 
0 
171 
2 sr-0 OHC-f)---() 170 0 ~ h 30 61 
s 172 
3 sr--Q-oMe OHC~OMe 170 0 ~ ~ 16 52 
N 173 
4 170 Br--o--CF3 -()--0-OHC CF3 0 N 24 31 
174 
5 170 Br--o OHC---Q--D 0 N 57 
175 
CN CN 
6 170 Br-Q OHC--f)---Q 
15 
0 ~ ~ 
N 176 
7 170 sr--Q-No2 
N 
~ OHC N02 0 N 44 
177 
8 Br-fJ-No -Q--0-- 54 OHC N02 170 s 2 
178 
Table 4.1: Results from the Suzuki Cross-Coupling Reaction of 170. 
The yields were moderate except for compound 176. As observed with our pyridyl 
systems, the reaction is low yielding when an electron deficient halide is employed in 
the Suzuki cross-coupling reaction. This has been a consistent finding throughout our 
work, a fact that should be considered for future cross-coupling reactions. 
The 3-bromo-5-cyanopyridine (181), used in the synthesis of 176, was not 
commercially available at the time this work was carried out. We felt that the synthesis 
of 176 would not only provide further evidence regarding the work involving electron 
deficient halides, but would also lead to a new, interesting heteroaryl substituted furyl 
system. Therefore, we obtained the 3-bromo-5-cyanopyridine by the formation of the 
amide 180 by the reaction of concentrated ammonia on 179. 179 was then dehydrated 
using P205 to give 181 in 25% yield (Scheme 4.3).3 
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H2N(O)C b-sr 85% 
N 
180 
ii) 
NC b-Br 25% 
N 
181 
Scheme 4.3: Synthesis of 3-Bromo-5-cyanopyridine (181). Reagents and Conditions: (i) c.NH3, rt, 
(ii) P20s, .il. 
4.4 Functionalisation of Heteroaryl Substituted Furyl Derivatives via Wittig 
Chemistry 
From our catalogue of functionalised heteroaryl substituted furyl systems we aimed to 
increase the functionality around the furan ring by the action of a Wittig reagent at the 
CHO group.4 Therefore, following a method described by Pandey et al5 we 
successfully synthesised compounds 183-185 by Wittig olefination, usmg 
(ethoxycarbonylmethylene)triphenylphosphorane (182) as the Witting reagent, under 
simple conditions (Scheme 4.4). The results ofthese experiments, which are illustrated 
in Table 4.2, revealed this method of functionalisation to be high yielding and versatile, 
as the reaction tolerates different functionalities on the heteroaryl substituted furyl 
systems. 
i) 
EtO J)_Ar );---11 "o" 
0 182 
Scheme 4.4: General Illustration of the Wittig Olefination of Heteroaryl Substituted Fury I Systems. 
Reagents and Conditions: (i) CH3CN, reflux. 
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Entry Heteroaryl Substituted Product Isolated Furyl System Yields/% 
OHc--()---0-oMe ~ 0 ~ ~ EIO OMe 82 173 0 183 
2 -{)-0- ~ 92 OHC CF3 0 N BO C~ 
174 0 184 
3 OHC--f)--0 0)--0 0 ~ /; EIO 75 
175 0 185 
Table 1.2: Results from the Wittig Olefination Experiments. 
To study more elaborate Wittig reactions we turned to the dithiole reagents 186 and 
188, which are readily available in our laboratory. Products containing the 1,3-dithiole 
heterocycle would be novel conjugated chromophores that contain electron donor and 
electron acceptor (D-1r-A) substituents. We aimed to synthesise these compounds for 
the following reasons: 
1. Use of compound 174 would provide a novel acceptor system, due to the 
presence of the highly electronegative CF3 group. 
2. The dithiole ring moiety has been previously applied as the donor component in 
D-1r-A systems.6 
3. The chemistry of 1,3-dithiole heterocycles is well established in our group. 
Compounds 187 and 189 were formed by standard routes.7 The corresponding 
carbanions required for the Wittig and Horner-Wadsworth-Emmons reaction with the 
carbonyl group, are generated by the removal of the proton using nBuLi at low 
temperature (Scheme 4.5). 
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CB Meo,cXs Meo,cXs Ps i) I X UJ 1>-
I >=u-o-Me02C S H Me02C S \ h ~ /; CF3 51% 
8 
186 BF4 187 
0 Me 11 M•Xs XsxP(oMeh i) 
I> I - o -
Me s>=u-o-cF, 11% Me S H 
188 189 
Scheme 4.5: Formation of Compounds 187 and 189. Reagents and Conditions: (i) 1. nBuLi, THF, -
78°C, 2. 174, THF, -78°C, 3. -78°C--+ rt, reflux. 
At this time we cannot fully explain why the yield of 189 is so low when past examples 
have shown that the use of phosphonate esters in such reactions usually give products in 
reasonably high yield. 8 However, we can state that 188 is known to be not as stable as 
186, resulting in 188 having to be stored in cold conditions. This reasoning could be a 
factor in the reaction being low yielding. This theory can be further substantiated by the 
fact that the production of 187 proceeds more cleanly than that of 189 (more by-
products present for 189 than 187 (TLC evidence). 
4.4. 1 Intramolecular Conjugation in the Dithiole Heteroaryl Substituted Fury! 
Derivatives 
We targeted 187 and 189 as the substituents on the dithiole rings are known to impart 
differing donor abilities, i.e. 4,5-dimethyl > 4,5-dimethoxycarbonyl (Figure 4.1). 
R s':) x~/0, 1\ 
R S (..,~~CF3 
CB 
R S x~/0, 1\ 
R S \\J-\ N•J_f /; CF3 
8 
Figure 4.1: Illustration of Proposed Intramolecular Charge Transfer. 
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The methyl substituents have the greater donor ability due to their inductive effects. 
Therefore, taking UV-Vis spectroscopic measurements of our starting material 183, 187 
and 189, we expected to observe a bathochromic shift (or red shift) in 'A max values as 
the donor strength of the dithiole increases. Figure 4.2 illustrates our findings, which 
concur with our preliminary theories on these experiments. 
We might also expect a downfield shift in the proton adjacent to N of the pyridine ring 
of compound 189, as a result of the inductive effect of the methyl groups (Figure 4.1). 
No such shift was observed. 
3.5 
3 · 
2.5 CoJlllOUnd 174 
2 
vi 
.Q 
cl: 1.5 
0 .J-
300 320 340 360 380 
CoJlllOUnd 189 
CoJlllound187 430nm 
403nm 
400 420 440 
Wavelength/nm 
460 480 500 
Figure 4.2: UV-Visible Absorption Spectra of Compounds 174,187, and 189 in DCM at rt. All UV 
measurements were carried out in DCM and at varying concentrations: 174 (Black Line) lxl0-4 M, 
187 (Blue Line) lx10-4 M and 189 (Red Line) 5.5x10-4 M. 
4.5 Conclusions 
In summary, we have synthesised a number of different functionalised heteroaryl 
substituted furyl systems by firstly cross-coupling methodology, which can then 
subsequently be extended via Wittig chemistry; the boundaries of which we have 
explored by the synthesis of 187 and 189, which display interesting intramolecular 
charge-transfer properties. 
However, there is still more scope for further functionalisation, as Wittig chemistry is 
not the only means of functionalisation of such systems. For example, Diels-Alder 
chemistry is also another route into f~sation of these heteroaryl substituted 
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furyl systems, as it has been well documented that furan, either substituted or non-
substituted, can be employed as the diene in a Diels-Alder reaction.9 Scheme 4.6 is an 
example of such a reaction. 10 
~0 + i) 
Et 
Scheme 4.6: Diels-Alder Chemistry involving Furan as the Diene. Reagents and Conditions: (i) A. 
This example illustrates one of numerous possibilities that are available for extending 
the synthetic chemistry on these new furan-containing systems. 
4.6 
2 
3 
4 
5 
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Chapter 5 
Experimental Procedures 
Experime11tal Procedures 
5.0 ExperJimeJmtaiJProcedures 
This chapter provides the experimental procedures and analytical data for each of the 
novel compounds presented in this thesis. This chapter also includes the experimental 
procedures for compounds, which are already known in the literature, that were used in 
the production of this work. All references given in this chapter correspond to 
references listed at the end of each chapter. 
5.1 Generan Methods 
All reactions which required inert or dry atmosphere, were carried out under a blanket 
of argon, which was dried by passage through a column of phosphorus pentoxide. All 
reagents employed were of standard reagent grade and purchased from Aldrich, 
Lancaster, Avocado, Fluka, Fluorchem or Merck and used as supplied unless otherwise 
stated. The following solvents were dried and distilled immediately prior to use: 
acetone, over Drierite (CaS04); acetonitrile and DCM, over calcium hydride; diethyl 
ether and toluene, over sodium metal; THF, over potassium metal. Ethanol and 
methanol were dried and distilled over magnesium turnings. DMF was dried by 
standing over 4A molecular sieves for at least 48 h and was not distilled prior to use. 
1 ,4-Dioxane was distilled prior to its use in the cross-coupling reactions. All other 
solvents used in the production of this work were used without prior purification. 
Column chromatography was carried out on silica (40-60 11m mesh). Solvents used for 
chromatography were distilled prior to use. 
1H NMR spectra were recorded on a Varian Unity 200, 250 or 300 at 200, 250 or 300 
MHz, respectively, or a V arian VXR 400s at 400 MHz or a Varian Inova 500 at 500 
MHz using the deuteriated solvent as lock. Chemical shifts are quoted in ppm, relative 
to tetramethylsilane (TMS), using TMS or the residual solvent as internal reference. 13C 
NMR were recorded using broad band decoupling on a Varian Unity 200, 250 or 300 at 
50, 63 or 75 MHz, respectively, or a Varian VXR 400s or Varian Inova 500 at 100 MHz 
and 125 MHz, respectively. The following abbreviations are used in listing NMR 
spectra: s = singlet, d =doublet, t =triplet, q = quartet, br = broad. 
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Electron Impact (El) mass spectra were recorded on a Micromass Autospec 
spectrometer operating at 70 eV with the ionization mode as indicated. 
Elemental analyses were obtained on an Exeter Analytical Inc. CE-440 elemental 
analyzer. 
UV-vis spectra were recorded usmg a Shimadzu UV-2101 spectrophotometer at 
ambient temperature. 
Melting points were recorded on a Stuart Scientific SMP3 melting point apparatus and 
are uncorrected. 
General Procedure for all the Cross-Coupling Reactions 
The boronic acid, the halide, and the catalyst (5 mol% relative to the boronic acid) were 
added sequentially to degassed solvent (10 mL) and the mixture was stirred at rt for 30-
60 min. Degassed aqueous base solution was added and the mixture was heated under 
N2 until tlc monitoring showed that the reaction was complete. Solvent was evaporated 
in vacuo and ethyl acetate was added. Then the organic layer was purified by column 
chromatography on silica gel. 
Conditions B: Pd(PPh3)2Ch, Cs2C03, 1 ,4-dioxane, 95°C. 
Note: No carbons attached to boron atoms are observed owing to the effects of the 
quadrupole moment. 
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5.2 Experimental Procedures of Chapter 1 
3-Pyridylboronic Acid (13) 18 
To magnesium turnings (3.0 g, 123.4 mmol) suspended in THF (50 
Q-s(OHb mL) a solution of 3-bromopyridine (8.1 g, 51.2 mmol) and 1,2-
N dibromoethane (9.6 g, 51.1 mmol) in THF (50 mL) was added 
portionwise over a period of a few hours at 25 °C. The reaction mixture was then 
cooled to -78 °C then TBB (11.9 g, 52.0 mmol) was added over a period of 1 h, 
warmed to 25 °C and then a citric acid solution (25 g in 50 rnL of water) was added. 
The reaction mixture was taken to pH 3 (HCl) and was washed with diethyl ether 
(lx100 mL). The reaction mixture was then taken to pH 10 (Na2C03) and was again 
washed with diethyl ether (lx100 mL). The reaction mixture was then taken to pH 6 
(HCl) and was concentrated until NaCl began to precipitate out. The NaCl was then 
removed via filtration and the filtrate underwent a continuous extraction for 2 weeks. 
This gave a yellow solid which was recrystallised from methanol to give 13 as a white 
solid (464 mg, 7%), mp >300 °C (lit mp = >300 °C) 18 ; 1H NMR (300 MHz, CD30D) o 
8.61 (lH, s), 8.52 (1H, d, J = 5.7 Hz), 8.39 (IH, d, J = 6.9 Hz), 7.67 (1H, t, J = 5.7 Hz); 
13C NMR (75 MHz, DMSO-d6) o 155.24, 151.41, 142.28, 123.80. 
2-(3-Pyridyl)-1, 3, 2-dioxaboronane (80) 108 
To a solution of 3-bromopyridine (7.3 g, 40.1 mmol) in anhydrous 
o- P) ether (100 mL) at -78 °C, nBuLi (1.6 M in hexane, 29.0 mL, 46.4 ~ ~ B, N 0 rnrnol) was added dropwise. The reaction mixture was then allowed 
to stir at this temperature for 2 h then TPB (9.0 g, 47.7 rnrnol) was added dropwise. The 
reaction mixture was stirred for a further 2 h at -78 oc. The reaction mixture was then 
allowed to warm to 25 oc and stir overnight. The solution was then cooled to 0 °C and 
1 ,3-propanediol (3. 7 g, 48.4 mmol) was added. The solution was then stirred for 1 h. 
Methanesulfonic acid ( 4.4 g , 46.2 rnrnol) was then added to the solution and was stirred 
for another hour. Celite (10 g) was added to the reaction mixture and was stirred 
vigourously for 30 mins at 25 °C. The solid was then filtered off and the filtrate was 
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evaporated to dryness. The crude ester was then recrystallised form ethyl acetate to 
give 80 as a white powder (1.1 g, 17%), mp 99-101 ac (lit mp = 96 °C) 108; 1H NMR 
(250 MHz, CDCb) 8 8.89 (lH, s), 8.60 (1H, dd, J = 1.5 Hz, J = 1.5 Hz), 8.00-7.97 (1H, 
m), 7.23-7.19 (lH, m), 4.18-4.13 (4H, m), 2.08-2.04 (2H, m); 13C NMR (63 MHz, 
CDCb) 8 154.71, 151.30, 141.21, 122.91, 61.98(2C), 27.35. Anal. Calcd for 
CsH10BN02: C, 58.95%; H, 6.18%; N, 8.59%. Found: C, 58.76%; H, 6.17%; N, 8.59%. 
2-(4-Pyridyl)-4, 4, 4, 5-tetramethyl-1, 3-dioxaborolane (84) 109 
To a slurry of 4-iodopyridine (1.5 g, 7.1 mmol) in anhydrous ether 
NJ--(0~ (100 mL) at -78 °C nBuLi(l.6 M in hexane, 5.5 mL, 8.9 mmol) 
0 
followed 30 minutes later by TPB (1.6 g, 8.7 mmol). The 
temperature was allowed to rise to 25 °C over a period of 2 h. Pinacol (1.1 g, 9.5 mmol) 
was then added and 10 minutes later acetic acid (420 mg, 7.0 mmol) was also added. 
The resulting slurry was filtered through celite, the filter washed with ether. The 
combined filtrates were then evaporated in vacuo. The crude ester was then 
recrystallised from cyclohexane to give 84 as a white crystalline powder (308 mg, 
21%), mp 150-152 ac (lit mp= 151 °C) 109; 1H NMR (300 MHz, CDCb) 8 8.64 (2H, d, 
J = 5.6 Hz), 7.63 (2H, d, J = 5.6 Hz), 1.36 (12H, s); 13C NMR (100 MHz, acetone-d6) 8 
153.26(2C), 132.86(2C), 88.65, 29.01(4C), 28.75(2C); MS (El) mlz 205 (M+, 71 %). 
Anal. Calcd for C 11 H16BN02: C, 64.43%; H, 7.86%; N, 6.83%. Found: C, 63.95%; H, 
7.74%; N, 6.53%. 
5.3 Experimental Procedures of Chapter 2 
2-Bromo-5-pyridylboronic acid (92) 
To a solution of 2,5-dibromopyridine (1 0.0 g, 42.2 mmol) in 
Br-()---B(OHh anhydrous ether (30 mL) at -78 ac was added nBuLi (1.6 M in 
N 
hexane, 30.0 mL, 48.0 mmol) dropwise. The reaction mixture 
was stirred for 2 hat -78 °C. TPB (18.6 g, 99.7 mmol) was then added quickly. The 
reaction mixture was stirred at -78 oc for a further 2 h then allowed to warm to 20 °C 
and was quenched with water (50 mL). The reaction mixture was stirred overnight. 
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The organic solvent was evaporated in vacuo and the remaining aqueous layer was 
taken to pH 10 (with 5% NaOH), and was washed with diethyl ether (3x100 mL). The 
aqueous layer was then carefully acidified to pH 4 (with 48% HBr) to give 92 as a white 
solid (6.7 g, 79%), mp 167-169 °C (lit mp 198 °C) 2; 1H NMR (200 MHz, DMSO-d6) 8 
8.63 (1H, d, J = 1.8 Hz), 8.47 (2H, OH, s), 7.99 (1H, dd, J = 2.2 Hz, J = 2.2 Hz), 7.61 
(1H, d, J= 8.0 Hz); 13C NMR (50 MHz, DMSO-d6) 8 156.51, 145.65, 144.52, 128.30. 
Anal. Calcd for C5H5BBrN02 : C, 29.76%; H, 2.50%; N, 6.94%. Found: C, 29.83%; H, 
2.60%; N, 6.83%. Crystals for X-ray analysis were grown from aqueous EtOH solution. 
3-Bromo-5-pyridylboronic acid (97) 
Br To a solution of 3,5-dibromopyridine (2.0 g, 8.4 mmol) in anhydrous 
b- ether (30 mL) at -78 °C was added nBuLi (1.6 M in hexane, 6.0 mL, ~ /; B(OHh 
N 10.0 mmol) dropwise. The reaction mixture was stirred for 2 h at 
-78 °C. TPB (3.3 g, 17.3 mmol) was then added quickly. The reaction mixture was 
stirred at -78 °C for a further 2 h then allowed to warm to 20 oc and was quenched with 
water (50 mL). The reaction mixture was stirred overnight. Workup as described for 
92 gave 97 as an off-white solid (1.3 g, 74%), mp >300 oc (lit mp = dec 210 °C) 2; 1H 
NMR (200 MHz, DMSO-d6) 8 8.80 (1H, d, J = 1.4 Hz), 8.68 (lH, d, J = 2.4 Hz), 8.56 
(2H, OH, s), 8.25-8.23 (1H, m); 13C NMR (50 MHz, DMSO-~) 8 153.76, 152.15, 
144.79, 121.38. Anal. Calcd for C5H5BBrN02 : C, 29.76%; H, 2.50%; N, 6.94%. 
Found: C, 29.48%; H, 1.75%; N, 6.77%. 
5-Bromo-2-chloro pyridine (105) 15 
Phosphoryl chloride (773 mg, 5.0mmol) was added dropwise to stirred 
ci-{)-Br solution of 5-bromo-2-methoxy pyridine (189 mg, 1.0 mmol) in dry 
N 
DMF at 0 °C. The stirring was continued for 1 h then the mixture was 
heated at 110 oc for 19 h. It was cooled to 0 °C and was quenched with saturated 
sodium acetate solution (25 mL). The mixture was extracted with EtOAc (4x50 mL). 
The organic layer was then washed with water (3x100 mL) and was dried over MgS04. 
The residue was chromatographed through a silica gel column; eluent EtOAc:Petroleum 
Ether(40-60°C) (7:3 v/v) to give 105 as a white solid (136 mg, 71%), mp 70-71 oc (lit 
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mp = 70-71 °C) 15 ; 1H NMR (300 MHz, CDCb) 8 8.47 (lH, d, J= 2.1 Hz), 7.77 (lH, 
dd, J = 2.4 Hz, J = 2.4 Hz), 7.25 (lH, d, J = 8.4 Hz); 13C NMR (125 MHz, CDCh) 8 
150.71, 150.07, 141.23, 125.66, 119.11; MS (El) m/z 192 (M+, 100%). Anal. Calcd for 
C5H3BrCl: C, 31.21%; H, 1.57%; N, 7.28%. Found: C, 31.59%; H, 1.65%; N, 7.09%. 
2-Chloro-5-pyridylboronic acid (1 03) 
To a solution of 2-chloro-5-bromopyridine (742 mg, 3.9 mmol) 
CI--()-B(OHh and TPB (1.5 g, 7.8 mmol) in anhydrous THF (10 mL) at -78 oc 
N 
was added nBuLi (1.6 M in hexane, 2.5 mL, 4.0 mmol), dropwise. 
The reaction mixture was stirred for 5 h at -78 oc then quenched with water (10 mL) 
and allowed to warm to 20 oc with stirring overnight. Workup as described for 92 gave 
103 as a white solid (370 mg, 61 %), mp 166-167 °C (lit mp 190 °C)2; 1H NMR (300 
MHz, acetone-d6) 8 8.76 (1H, d, J= 1.8 Hz), 8.17 (1H, dd, J= 2.1 Hz, J= 2.1 Hz), 7.61 
(2H, OH, s), 7.43 (1H, d, J = 8.1 Hz); 13C NMR (75 MHz, acetone-d6) 8 155.85, 152.76, 
145.72, 124.26. Anal. Calcd for C5H5BC1N02: C, 38.16%; H, 3.20%; N, 8.90%. 
Found: C, 37.82%; H, 3.28%; N, 8.79%. Crystals for X-ray analysis were grown from 
aqueous EtOH solution. 
2-Fluoro-5-bromopyridine (107) 17 
2-Amino-5-bromopyridine (9.8 g, 56.8 mmol) was added portionwise 
F-()---Br to 50% fluoroboric acid. This did not readily dissolve so the mixture 
N 
was heated until it dissolved. The mixture was then cooled to 0 °C, 
which gave a slurry. Sodium nitrite (4.8 g, 70.0 mmol) was then added slowly. The 
mixture was stirred at 0 oc for 30 mins. The mixture was then warmed to ~50 oc and 
then cooled back down to 0 °C. The mixture was then poured onto ice and was 
neutralized using Na2C03. The mixture was then steam, distilled. The distillate was 
then washed with diethyl ether and was dried using MgS04. The distillate was 
concentrated in vacuo and was distilled under reduced pressure to give 107 as a clear 
liquid (1.1 g, 11 %). 1H NMR (200 MHz, CDCb) 8 8.21 (1H, s), 7.86-7.70 (1H, m), 
6.81 (1H, dd,J= 3.3 Hz,J= 3.3 Hz); 13C NMR(63 MHz, acetone-d6) 8165.62 (J= 
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237.8 Hz), 149.69 (J = 15.7 Hz), 145.40 (J = 8.2 Hz), 117.48 (J = 5.7 Hz), 113.03 (J = 
39.6 Hz); MS (El) m/z 176 (M+, 100%). 
2-Fluoro-5-pyridylboronic acid (1 08) 
To a solution of 2-fluoro-5-bromo pyridine (599 mg, 3.4 mmol) 
F--{J-B(OHh and TPB (1.3 g, 6.9 mmol) in anhydrous THF (10 mL) at -78 oc 
N 
was added nBuLi (1.6 M in hexane, 2.2 mL, 3.5 mmol), dropwise. 
The reaction mixture was stirred for 4 h at -78 °C then quenched with water (10 mL) 
and allowed to warm to 20 oc with stirring overnight. Workup as described for 92 gave 
108 as a white solid (245 mg, 51%), mp 170-171 oc (lit mp 172 °C) 2; 1H NMR (400 
MHz, acetone-d6) 8 8.52 (lH, d, J= 2.0 Hz), 8.41 (2H, s, OH), 8.27-8.23 (lH, m), 7.14-
7.11 (1H, m); 13C NMR (125 MHz, acetone-d6) 8 165.44 (J = 238.0 Hz), 154.02 (J = 
14.8 Hz), 147.51 (J= 7.7 Hz), 108.76 (J= 36.0 Hz). Anal. Calcd for C5H5BFN02 : C, 
42.62%; H, 3.58%; N, 9.94%. Found: C, 42.32%; H, 3.57%; N, 9.81%. 
3-( 6-Bromo-pyridin-3-yl)-quinoline (1 09) 
Br 
Conditions A: 92 (222 mg, 1.1 mmol), 3-bromoquinoline 
(153 mg, 0. 7 mmol), tetrakis(triphenylphosphino )palladium 
(56 mg), DMF and Na2C03 (1 M, 3.5 mL); reaction time 43 
h; eluent petroleum ether (bp 40-60 °C):Et0Ac (3:2 v/v) gave 109 as a white solid (63 
mg, 32%). Conditions B: 92 (100 mg, 0.5 mmol), 3-bromoquinoline (123 mg, 0.6 
mmol), Pd(PPh3)2Ch (18 mg), 1,4-dioxane and Cs2C03 (1 M, 1.5 mL); reaction time 43 
h; eluent petroleum ether (bp 40-60 °C):Et0Ac (3:2 v/v) gave 109 as a white solid (20 
mg, 14%), mp 178-179 °C; 1H NMR (500 MHz, CDCb) 8 9.13 (1H, d, J= 2.0 Hz), 8.74 
(lH, d, J = 2.5 Hz), 8.33 (1H, d, J = 2.5 Hz), 8.18 (lH, d, J = 8.5 Hz), 7.93 (1H, d, J = 
8.0 Hz), 7.89 (1H, dd, J= 2.8 Hz, J= 2.8 Hz), 7.80 (lH, t, J= 7.0 Hz), 8 7.67-7.63 (2H, 
m); 13C NMR (125 MHz, CDCh) 8 150.40, 148.97, 147.99, 142.17, 137.33, 134.03, 
133.20, 130.56, 129.59, 128.69, 128.32(3C), 127.95, 127.85; MS (El) m/z 286 (M+, 
100%). HRMS (El) calcd for C14H9BrN2 (M+) 283.9950, found 283.9949. 
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6' -Bromo-[2,3 ']bipyridinyl (11 0) 
Conditions A: 92 (222 mg, 1.1 mmol), 2-bromopyridine ( 163 mg, 
sr--(J----{J 0.7 mmol), tetrakis(triphenylphosphino) palladium (56 mg), DMF 
N N and Na2C03 (1 M, 3.5 mL); reaction time 43 h; eluent petroleum 
ether (bp 40-60 °C):Et0Ac (3:2 v/v) gave 110 as a white solid (18 mg, 11 %), mp 78-82 
oc; 1H NMR (500 MHz, CDCh) 15 8.94 (1H, s), 8.77 (1H, s), 8.31 (1H, d, J= 8.0 Hz), 
7.92 (lH, t, J= 7.0 Hz), 7.81 (1H, d, J= 7.5 Hz), 7.64 (1H, d, J= 8.0 Hz), 15 7.50-7.34 
(1H, m); 13C NMR (125 MHz, CDCh) 15 153.00, 149.20, 148.53, 143.23, 138.41, 
137.16, 128.32, 123.56(2C), 121.08; MS (ED m/z 234 (M+, 100%). HRMS(EI) calcd 
for C10H7BrN2 (M+) 233.9793, found 233.9795. Compound 113 is a by-product of this 
reaction. 
5-( 6-Bromo-pyridin-3-yl)-pyrimidine (111) 
Conditions A: 92 (162 mg, 0.8 mmol), 5-bromopyridine (111 mg, 
Br-o-c~) 0.7 mmol), tetrakis(triphenylphosphino)palladium (40 mg), DMF 
N N d . 
an Na2C03 (1 M, 2.5 rnL); reaction time 22 h; eluent petroleum 
ether (bp 40-60 °C): EtOAc (1 :4 v/v) gave 111 as a white solid (16 mg, 10%), mp 178-
179 °C; 1H NMR (500 MHz, CDCh) 15 9.32 (lH, s), 8.97 (2H, s), 8.63 (lH, s), 7.78 
(lH, dd, J= 2.2 Hz, J= 2.2 Hz), 7.69 (lH, d, J= 8.0 Hz); 13C NMR (125 MHz, CDCh) 
15 158.82, 155.05, 148.38, 143.32, 136.94, 130.66, 129.77, 129.01; MS (El) m/z 235 
(M+, 100%). HRMS(EI) calcd for C9H6BrN3 (M+) 234.9746, found 233.9744. 
3-(5-Bromo-pyridin-3-yl)-quinoline (112) 
Conditions B: 97 (100 mg, 0.4 mmol), 3-bromoquinoline (153 
mg, 0.7 mmol), Pd(PPh3)2Ch (15 mg) and Cs2C03 (1 M, 1.2 
mL); reaction time 68 h; eluent Et0Ac:CH2Ch (7:3 v/v) gave 
112 as a white solid (11 mg, 8%), mp 180-182 oc; 1H NMR 
(500 MHz, CDCh) 15 9.07 (IH, s), 8.86 (IH, s), 8. 71 (IH, s), 8.27 (IH, s), 8.11 (2H, d, J 
= 8.0 Hz), 7.86 (1H, d, J = 8.5 Hz), 7.73 (IH, t, J = 7.0 Hz), 15 7.58 (1H, t, J = 7.5 Hz); 
13C NMR (125 MHz, CDCb) 15 149.20, 147.79, 146.87(2C), 145.44, 136.12, 133.10, 
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129.39, 128.38(3C), 127.11, 126.60(2C); MS (El) mlz 284 (M+, 100%). HRMS (El) 
calcd for C14H9BrN2 (M+) 283.9949, found 285.9931. 
6"-Bromo-[2,3 ';6' ,3 "]terpyridine (113) 
Br 
1H NMR (250 MHz, CDCh) o 9.28 (lH, d, J = 2.0 Hz), 
9.01 (lH, d, J= 2.3 Hz), 8.75 (1H, d, J= 6.0 Hz), 8.45 
(1H, dd, J = 2.0 Hz, J = 2.0 Hz), 8.27 (1H, dd, J = 2.5 
Hz, J = 2.5 Hz), 7.87-7.81 (3H, m), 7.61 (lH, d, J = 8.3 Hz), 7.36-7.30 (1H, m); MS 
(El) m/z 311 (M+, 100%). 
3-(6-Chloro-pyridin-3-yl)-quinoline (114) 
Cl 
Conditions A: 103 (1 00 mg, 0.6 mmol), 3-bromoquinoline 
(153 mg, 0.7 mmol), tetrakis(triphenylphosphino)palladium 
(37 mg), DMF and Na2C03 (1 M, 2.0 mL); reaction time 70 
h; eluent DCM: EtOAc (3:7 v/v) gave 114 as a white solid (84 mg, 55%). Conditions 
B: 103 (100 mg, 0.6 mmol), 3-bromoquinoline (153 mg, 0.7 mmol), Pd(PPh3)2Ch (23 
mg), 1,4-dioxane and Cs2C03; eluent DCM: EtOAc (3:7 v/v) gave 114 as a white solid 
(99 mg, 64%), mp 180-181 oc; 1H NMR (300 MHz, acetone-d6) o 9.13 (1H, d, J= 2.4 
Hz), 8.77 (lH, d, J= 2.1 Hz), 8.55 (1H, d, J= 1.8 Hz), 8.20 (1H, dd, J= 2.7 Hz, J= 2.7 
Hz), 7.99-7.92 (2H, m), 7.72-7.66 (lH, m), 7.60-7.50 (2H, m); 13C NMR (125 MHz, 
CDCh) o 151.29, 148.88, 148.17, 147.48, 137.34, 133.71(2C), 132.60, 130.22, 129.38, 
128.05, 127.68, 127.51, 124.59; MS (El) mlz 240 (M\ 100%). Anal. Calcd for 
C14H9ClN2: C, 69.86%; H, 3.77%; N, 11.64%. Found: C, 69.40%; H, 3.80%; N, 
11.53%. 
6' -Chloro-[2,3 ']bipyridinyl (115) 
Conditions A: 103 (100 mg, 0.6 mmol), 2-bromopyridine (163 
Cl~ mg, 0.7 mmol), tetrakis(triphenylphosphino)palladium (37 mg), 
N N DMF and Na2C03 (1 M, 2.0 mL); reaction time 70 h; eluent 
DCM:EtOAc (7:3 v/v) gave 115 as a white solid (75 mg, 61 %), mp 71-72 °C; 1H NMR 
(300 MHz, acetone-d6) o 9.10 (1H, d, J= 2.4 Hz), 8.73-8.71 (lH, m), 8.51 (1H, dd, J= 
112 
Experimental Procedures 
2.4 Hz, J= 2.4 Hz), 8.03 (1H, dd, J= 0.9 Hz, J= 0.9 Hz), 7.96-7.90 (lH,m), 7.57 (1H, 
d, J = 8.4 Hz), 7.44-7.39 (IH, m); 13C NMR (100 MHz, CDCh) o 153.42, 151.53, 
150.27, 148.31, 137.54, 137.44, 134.19, 124.40, 123.60, 120.71; MS (El) m/z 192 
([M+2t, 41 %), 190 (M+, 100%). Anal. Calcd for C10H7ClN2: C, 63.01 %; H, 3.70%; N, 
14.70%. Found: C, 63.19%; H, 3.84%; N, 14.45%. 
5-( 6-Chloropyridin-3-yl)-pyrimidine (116) 
Conditions A: 103 (50 mg, 0.3 mmol), 5-bromopyrimidine (115 
Cl----()--(~) mg, 0.7 mmol), tetrakis(triphenylphosphino) palladium (37 mg), 
N N DMF and Na2C03 (1 M, 2.0 mL); reaction time 70 h; eluent 
petroleum ether (bp 40-60 °C) : EtOAc (2:3 v/v) gave 116 as a white solid (24 mg, 
38%), mp 177-178.5 °C; 1H NMR (400 MHz, acetone-d6) o 9.22 (1H, s), 9.16 (2H, s), 
8.84 (1H, d, J = 2.4 Hz), 8.28 (1H, dd, J = 2.4 Hz, J = 2.8 Hz), 7.66 (1H, dd, J = 0.8 Hz, 
J = 0.8 Hz); 13C NMR (100 MHz, acetone-d6) o 158.42, 155.25 (2C), 151.68, 148.36, 
138.08, 130.49, 130.00, 124.85; MS (El) m/z 193 ([M+2t, 33%), 191 (M+, 100%). 
Anal. Calcd for C9H6ClN3: C, 56.41 %; H, 3.16%; N, 21.93%. Found: C, 56.48%; H, 
3.33%; N, 21.43%. 
2-Chloro-5-(5-nitrothien-2-yl)-pyridine (117) 
Conditions A: 103 (100 mg, 0.6 mmol), 2-bromo-5-
CI---Q-LrNo2 nitrothiophene (115 mg, 0.6 mmol), 
tetrakis(triphenylphosphino) palladium (37 mg), DMF and 
Na2C03 (1 M, 2.0 mL); reaction time 70 h; eluent DCM gave 117 as a yellow solid (132 
mg, 53%), mp 190-191 °C; 1H NMR (500 MHz, acetone-d6) o 8.74 (IH, d, J= 3.0 Hz), 
8.13 (1H, dd, J= 2.5 Hz, J= 2.5 Hz), 7.98 (IH, d, J= 4.5 Hz), 7.60 (IH, d, J= 4.0 Hz), 
13 . 7.49 (IH, d, J = 8.5 Hz); C NMR (125 MHz, acetone-d6) o 152.16, 147.40, 146.38, 
137.10(2C), 130.43, 127.89, 125.42, 125.05, 122.95; MS (El) mlz 242 ([M+2t, 38%), 
240 (M+, 100%). Anal. Calcd for C9H5ClN20 2S: C, 44.92%; H, 2.09%; N, 11.64%. 
Found: C, 44.81%; H, 2.19%; N, 11.38%. 
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2-Bromofuran O 18) 22 
5-Bromo-2-furoic acid (12.0 g, 62.8 mmol), copper powder (3.0 g, 47.2 
0 usr mmol) and quinoline (49.2 g, 380.8 mmol) were added together and 
underwent a fractional distillation. The distillate collected was fractionally 
distilled at a reduced pressure to give 118 as a clear liquid (4.3 g, 47%). 1H NMR (250 
MHz, acetone-d6) 8 7.64-7.63 (1H, m), 6.50-6.48 (lH, m), 6.46-6.44 (1H, m); 13C NMR 
(63 MHz, acetone-d6) 8 146.19, 122.55, 113.83, 112.56; MS (El) mlz 148 ([M+2t, 
100%), 146 (M+, 94%). 
5-(6-Cbloro-pyridinyl-3-yl)-furan-2-carbaldehyde (119) 
Conditions B: 103 (200 mg, 1.3 mmol), 2-bromofuran (165 mg, 
c1--Q--(); 1.1 mmol), Pd(PPh3)2Ch ( 46 mg) and Cs2C03 (1M, 4.0 mL). 
N Reaction time 64 h. Eluent used, DCM gave 119 as a white solid 
(133 mg, 66%), mp 54-56 oc; 1H NMR (400 MHz, acetone-d6) 8 8.62 (1H, d, J= 2.4 
Hz), 7.98 (lH, dd, J= 2.4 Hz, J= 2.4 Hz), 7.61-7.60 (1H, m), 7.37 (1H, dd, J= 0.8 Hz, 
J = 0.8 Hz), 6.94-6.93 (1H, m), 6.50-6.49 (1H, m); 13C NMR (100 MHz, acetone-d6) 8 
150.09, 149.43, 145.07, 144.05, 134.06, 126.32, 124.57, 112.37, 107.85; MS (El) rnlz 
181 ([M+2t, 30%), 179 (M+, 100%). Anal. Calcd for C9H6ClNO: C, 60.19%; H, 
3.37%; N, 7.80%. Found: C, 60.13%; H, 3.51%; N, 7.74 %. 
2-Chloro-4-( 6-chloropyridin-3-yl)-pyrimidine (120) 
Cl 
Conditions A: 103 (91 mg, 0.6 mmol), 2,4-dichloropyrimidine 
(75 mg, 0.5mmol), tetrakis(triphenylphosphino) palladium (34 
___F\__;N=< 
CI~~~N mg) and Na2C03 (lM, 2.0 mL); reaction time 65 h; eluent 
DCM:EtOAc; (4:1 v/v) gave 120 as a white solid (26 mg, 23%), 
mp 188-190°C; 1H NMR (200 MHz, acetone-d6) 8 9.06 (1H, d, J= 1.8 Hz), 8.74 (lH, 
d, J = 5.4 Hz), 8.48 (1H, dd, J = 2.6 Hz, J = 2.6 Hz), 8.04 (1H, d, J = 5.2 Hz), 7.56 
(1H, d, J= 8.4 Hz); 13C NMR (100 MHz, acetone-d6) 8 163.91, 161.64, 161.54, 154.17, 
149.17, 138.21, 130.61, 124.94, 116.42; MS (El) m/z 226 ([M+2t, 70%), 224 (M+, 
100%). HRMS(El) calcd for C9H5ChN3 (M+) 224.9861, found 224.9861. 
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3-(6-.!Fluoro -pyridhn-3-yl)-quinoline (121) 
Conditions A: 108 (72 mg, 0.6 mmol), 2,4-dichloropyrimidine 
(199 mg, 1.0 mmol), tetrakis(triphenylphosphino) palladium 
(40 mg) and Na2C03 (2M, 1.0 mL); reaction time 65 h; eluent, 
DCM:EtOAc; (1:1 v/v) gave 121 as a white solid (47 mg, 41%) Conditions B: 108 (100 
mg, 0.7 mmol), 3-bromoquinoline (199 mg, 1.0 mmol), Pd(PPh3) 2Ch (25mg) and 
Cs2C03 (1M, 2.0 mL); reaction time 67 h; eluent, DCM:EtOAc; (1: 1 v/v) gave 121 as a 
white solid (91 mg, 57%), mp 126-127°C; 1H NMR (400 MHz, acetone-d6) 8 9.12 (1H, 
d, J= 2.4 Hz), 8.60-8.59 (1H, m), 8.52 (1H, d, J= 2.0 Hz), 8.36-8.31 (lH, m), 7.99-7.91 
(2H, m), 7.70-7.66 (lH, m), 7.56-7.52 (1H, m), 7.18-7.15 (1H, m); 13C NMR (100 
MHz, acetone-d6) () 164.94 (J = 237.3 Hz), 149.43, 147.99, 146.60 (J = 15.1 Hz), 
140.86 (J = 8.0 Hz), 133.67, 132.25 (J = 4.0 Hz), 130.00, 129.77, 129.42, 128.57, 
128.09, 127.43, 110.16 (J = 38.2 Hz); MS (El) rn/z 224 (M+, 100%). Anal. Calcd for 
C14H9FN2: C, 74.99%; H, 4.05%; N, 12.49%. Found: C, 74.54%; H, 4.16%; N, 
12.38%. 
5.4 Experimental Procedures of Chapter 3 
2-Methoxy-5-pyridylboronic acid (123) 
To a solution of 5-bromo-2-methoxypyridine (727 mg, 3.9 
Meo--()---s(OH)2 mmol) in anhydrous ether (10 mL) at -78 oc was added nBuLi 
N 
(1.6 M in hexane, 2.5 mL, 4.0 mmol), dropwise. The reaction 
mixture was stirred for 1 hat -78 ac then TPB (1.5 g, 7.8 mmol) was added quickly. 
The reaction mixture was stirred at -78 °C for another 1 h, then quenched with water 
(15 mL) and allowed to warm to 20 °C with stirring overnight. Workup as described for 
92 gave 123 as a white solid (382 mg, 65%), mp 137-138 °C; 1H NMR (250 MHz, 
acetone-~) 8 8.62 (lH, d, J = 1.3 Hz), 8.05 (1H, dd, J = 2.0 Hz, J = 2.0 Hz), 7.27 (2H, 
OH, s), 6.73 (1H, d, J= 10.0 Hz); 13C NMR (100 MHz, acetone-d6) 8 166.31, 154.23, 
144.85, 110.49, 53.23. Anal. Calcd for C6H8BN03: C, 47.12%; H, 5.27%; N, 9.16%. 
Found: C, 46.87%; H, 5.30%; N, 8.99%. 
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5-Bromo-2-etllwxy pyridhne (12.:3) 2 
2,5-Dibromopyridine (5.0 g, 21.1 mmol) was refluxed in a solution 
Eto--Q-sr of sodium hydroxide (2.5 g, 62.5 mmol) in absolute ethanol (20 mL) 
N for 18 h. Concentrated hydrochloric acid was then added to give a 
faint acidic reaction. Filtered the reaction mixture. The residue was then steam distilled 
to give 12.:3 as a white solid (1.4 g, 33%), mp 35-37 oc (lit mp = 34-35 °C) 2; 1H NMR 
(200 MHz, acetone-d6) 8 8.20 (IH, d, J= 2.6 Hz), 7.80 (1H, dd, J= 2.7 Hz, J= 2.7 Hz), 
6.75 (1H, d, J = 8.8 Hz), 4.31 (2H, q, J = 7.0 Hz), 1.33 (3H, t, J = 7.2 Hz); 13C NMR 
(50 MHz, acetone-d6) 8 163.05, 147.60, 141.44, 113.08, 111.32, 61.94, 14.10; MS (El) 
mlz 202 (M+, 38%). 
2-Ethoxy-5-pyridylboronic acid (125) 
To a solution of 2-ethoxy-5-bromopyridine (200 mg, 1.0 mmol) 
Eto--Q-B(OHh in anhydrous ether (5 mL) at -78 oc was added nBuLi (1.6 M in 
N 
hexane, 0.6 mL, 1.0 mmol), dropwise. The reaction mixture was 
stirred for 1h at -78 oc then TPB (375 mg, 2.0 mmol) was added dropwise. The 
reaction mixture was stirred for another 1 hat -78 °C. The reaction was then quenched 
with water (5 mL) and was then allowed to warm to 20 °C and stir overnight. Workup 
as described for 92 gave 125 as a white solid (101 mg, 61 %), mp 131-134 oc; 1H NMR 
(300 MHz, acetone-d6) 8 8.59 (1H, d, J = 1.8 Hz), 8.03 (1H, dd, J = 2.0 Hz, J = 2.0 Hz), 
7.18 (2H, s, OH), 6.69 (1H, d, J= 8.1 Hz), 4.35 (2H, q, J= 4.2 Hz), 1.33 (3H, t, J= 5.1 
Hz); 13C NMR (100 MHz, acetone-d6) 8 165.56, 153.79, 144.38, 110.16, 61.25, 14.27. 
Anal. Calcd for C7H10BN03 : C, 50.35%; H, 6.04%; N, 8.39%. Found: C, 50.09%; H, 
6.10%; N, 8.26%. 
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2-Methoxy-3-pyridylboronic acid (131) 
To a solution of 2-methoxypyridine (1.2 g, 11.4 mmol) in anhydrous 
r\--s(OHh THF (10 mL) at 0 oc was added LDA (2.0 M in 
'N~ heptane/THF/ethylbenzene, 6.9 mL, 13.8 mmol), dropwise. The 
OMe 
reaction mixture was stirred for 3 h at 0 oc then TMB (2.4 g, 23.2 
mmol) was added dropwise. The reaction mixture was allowed to warm to 20 oc then 
was quenched with water (10 mL) and allowed to stir overnight. Workup as described 
for 92 gave 131 as a white solid (235 mg, 13%), mp 143-145 °C; 1H NMR (300 MHz, 
acetone-d6) 8 8.24 (lH, dd, J = 2.1 Hz, J = 2.1 Hz), 8.12 (lH, dd, J = 2.0 Hz, J = 2.0 
Hz), 7.10 (2H, s, OH), 7.02-6.98 (1H, m), 3.99 (3H, OCH3, s); 13C NMR (125 MHz, 
acetone-d6) 8 168.26, 150.09, 146.70, 118.08, 53.56. Anal. Calcd for C6H8BN03: C, 
47.12%; H, 5.27%; N, 9.16%. Found: C, 46.78%; H, 5.18%; N, 8.94%. 
3-Bromo-6-methoxy-4-pyridylboronic acid (134) 
To a solution of 5-bromo-2-methoxypyridine (727 mg, 3.9 mmol) 
in anhydrous THF (10 mL) at -78 °C was added LDA (2.0 M in 
heptane/THF/ethylbenzene, 2.0 mL, 4.0 mmol), dropwise. The 
reaction mixture was stirred for 1 hat -78 oc then TPB (1.5 g, 7.8 
mmol) was added dropwise. The reaction mixture was allowed to stir for another hour 
then quenched with water (10 mL) and allowed to warm to 20 oc and stir overnight. 
Workup as described for 92a gave 134 as a white solid (351 mg, 39%), mp 97-99 °C; 
1H NMR (300 MHz, acetone-d6) 8 8.16 (lH, s), 7.76 (2H, s, OH), 6.84 (1H, s), 3.85 
(3H, OCH3, s); 13C NMR (100 MHz, acetone-d6) 8 162.79, 147.44, 115.67, 114.92, 
53.17. Anal. Calcd for C6H7BBrN03: C, 31.08%; H, 3.04%; N, 6.04%. Found: C, 
31.09%; H, 2.90%; N, 6.00%. 
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5-Ciblloro-2-metllnoxypyridiHJJ.e (136) 
To a stirred suspension of 2,5-dichloropyridine (12.1 g, 81.6 mmol) 
Meo-()-cl in methanol (60 mL) was added a 25% solution of sodium 
N methoxide in methanol (30 mL). The mixture was refluxed under an 
inert atmosphere for 24 h. More of the 25% solution of sodium methoxide in methanol 
(30 mL) was added and refluxing was continued for a further 80 h. Precipitated sodium 
chloride was removed via filtration and the filtrate was concentrated in vacuo to about 
V.. its original volume and was partitioned between ether and water. The aqueous layer 
was extracted with more ether (4x50 mL). The combined ether layers were then washed 
with brine and dried using MgS04. This was then concentrated to give a brown oil 
which was distilled under reduced pressure to give 136 as a clear liquid (3.6 g, 31 %). 
1H NMR (300 MHz, acetone-d6) o 8.12 (1H, d, J= 2.7 Hz), 7.68 (1H, dd, J= 2.7 Hz, J 
= 2.7 Hz), 6.79 (1H, d, J= 8.1 Hz), 3.87 (3H, OCH3, s); 13C NMR (100 MHz, CDCb) o 
162.97, 145.22, 138.79, 123.92, 112.29, 53.33; MS (El) mlz 143 (M+, 90%). Anal. 
Calcd for C6H6ClNO: C, 50.19%; H, 4.21%; N, 9.76%. Found: C, 50.07%; H, 4.19%; 
N, 9.76%. 
3-Cbloro-6-methoxy-4-pyridylboronic acid (137) 
B(OHh 
Meo---(:)-cl 
N 
To a solution of 5-chloro-2-methoxypyridine (437 mg, 3.0 mmol) 
in anhydrous THF (10 mL) at -78 oc was added LDA (2.0 M in 
heptane/THF/ethylbenzene, 1.8 mL, 3.6 mmol), dropwise. The 
reaction mixture was stirred for 4 h then TPB (1.4 mL, 6.1 mmol) 
was added quickly. The reaction mixture was stirred for a further 3 h then quenched 
with water (10 mL) at -78 oc and allowed to warm to 20 oc with stirring overnight. 
Workup as described for 92 gave 137 as a white solid (275 mg, 48%), mp 123-125 °C; 
1H NMR (250 MHz, acetone-d6) o 8.07 (1H, s), 7.72 (2H, OH, s), 6.89 (1H, s), 3.86 
(3H, OMe, s); 13C NMR (63 MHz, acetone-d6) o 163.42, 145.94, 127.58, 116.35, 54.07. 
Anal. Calcd for C6H7BC1N03: C, 38.46%; H, 3.77%; N, 7.47%. Found: C, 38.22%; H, 
3.64%; N, 7.43%. 
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3-Bromo-6-ethoxy-4-pyridylboronic acid (138) 
B(OHb 
EIO~Br 
N 
To a solution of 5-bromo-2-ethoxypyridine (261 mg, 1.3 mmol) in 
anhydrous THF (10 mL) at -78°C was added LDA (2.0 M in 
heptane/THF/ethylbenzene, 0.8 mL, 1.5 mmol), dropwise. The 
reaction mixture was stirred for 1 h at -78 oc then TPB ( 489 mg, 
2.6 mmol) was added dropwise. The reaction mixture was allowed to stir for another 
hour then quenched with water (1 mL) and allowed to warm to 20 oc and stir overnight. 
Workup as described for 92 gave 138 as a white solid (74 mg, 23%), mp 103-105 oc; 
1H NMR (400 MHz, acetone-d6) 8 8.15 (1H, s), 7.70 (2H, s, OH), 6.81 (1H, s), 4.30 
(2H, q, J= 7.2 Hz), 1.32 (3H, t, J= 6.8 Hz); 13C NMR (100 MHz, acetone-d6) 8 162.48, 
147.45, 115.86, 114.67, 61.72, 14.15. Anal. Calcd for C7H9BBrN03 : C, 34.20%; H, 
3.69%; N, 5.70%. Found: C, 34.90%; H, 3.25%; N, 5.90%. 
2-Metboxy-5-phenyl-pyridine (139) 
Conditions A: 123 (100 mg, 0.7 mmol), bromobenzene (149 MeO-o-o mg, 1.0 mmol), tetrakis(triphenylphosphino) palladium (38 mg) 
and Na2C03 (lM, 2.0 mL); reaction time 68h; eluent, 
Petroleum Ether (40-60): EtOAc (9:1 v/v) gave 139 as a yellow oil (79 mg, 65%); 1H 
NMR (400 MHz, acetone-d6) 8 8.44 (1H, d, J = 2.2 Hz), 7.94 (lH, dd, J = 2.8 Hz, J = 
2.8 Hz), 7.64-7.61 (2H, m), 7.48-7.44 (2H, m), 7.38-7.34 (1H, m), 3.93 (3H, OCH3, s); 
13C NMR (100 MHz, acetone-d6) 8 163.86, 145.10, 137.99, 137.59, 130.10, 129.22(2C), 
127.50, 126.70(2C), 110.86, 53.00; MS (El) m/z 185 (M+, 100%). Anal. Calcd for 
C12H 11NO: C, 77.81%; H, 5.99%; N, 7.56%. Found: C, 77.53%; H, 6.00%; N, 7.54%. 
2-Metboxy-5-(3,4,5-trifluoro-pbenyl)-pyridine (140) 
F MeOv-Q-F 
F 
Conditions A: (1 00 mg, 0. 7 mmol), 5-bromo-1 ,2,3-trifluoro-
benzene (177 mg, 0.8 mmol), tetrakis(triphenylphosphino) 
palladium (38 mg) and Na2C03 (1M, 2.0 mL); reaction time 
68 h; eluent, Petroleum Ether (40-60): EtOAc (9: 1 v/v) gave 
140 as a white solid (104 mg, 67%), mp 102-103 °C; 1H NMR (500 MHz, acetone-d6) 8 
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8.52 (lH, d, J=2.5 Hz), 8.04 (lH, dd, J = 2.5 Hz, J = 2.5 Hz), 7.56-7.53 (2H, m), 6.90 
(1H, d, J = 8.5 Hz), 3.96 (3H, OCH3, s); 13C NMR (125 MHz, acetone-d6) 8 164.51, 
152.53 (J= 3.8 Hz), 150.57 (J= 5.0 Hz), 145.51, 140.04 (J= 15.1 Hz), 138.06 (J= 15.1 
Hz), 137.61, 134.93 (J= 3.8 Hz), 127.11 (J= 1.4 Hz), 111.06,110.97 (J= 17.3 Hz), 
53.18; MS (El) m/z 239 (M+, 100%). Anal. Calcd for C12H8F3NO: C, 60.26%; H, 
3.37%; N, 5.86%. Found: C, 60.20%; H, 3.40%; N, 5.82%. 
2-Methoxy-5-(3,4,5-trifluoro-phenyi)-pyridine (141) 
Conditions A: 123 (100 mg, 0.7 mmol), 1-bromo-4-
Meo---<J---O-ocF3 trifluoromethoxy-benzene (195 mg, 0.8 mmol), 
N tetrakis( triphenylphosphino) palladium (3 8 m g) and 
NazC03 (1M, 2.0 mL); reaction time 68 h; eluent, Petroleum Ether (40-60): EtOAc (9:1 
v/v) gave 141 as a clear oil (84 mg, 48%); 1H NMR (400 MHz, acetone-d6) 8 8.46 (1H, 
d, J=2.4 Hz), 7.98 (1H, dd, J=2.6 Hz, J= 2.6 Hz), 7.78-7.75 (2H, m), 7.44-7.42 (2H, m), 
6.87 (lH, d, J=8.0 Hz), 3.94 (3H, OCH3, s); 13C NMR (100 MHz, acetone-d6) 8 164.11, 
148.64 (J = 1.9 Hz), 145.31, 137.65, 137.30, 128.69, 128.45(2C), 121.79(2C), 120.82 (J 
= 255.4 Hz), 110.97, 53.06; MS (El) m/z 269 (M+, 100%). Anal. Calcd for 
C13H10F3NOz: C, 58.00%; H, 3.74%; N, 5.20%. Found: C, 58.19%; H, 3.78%; N, 
5.28%. 
3-(6-Methoxypyridin-3-yl)-quinoline (142) 
M eO 
Conditions A: 123 (122 mg, 0.8 mmol), 3-bromoquinoline 
(307mg, 1.1 mmol), tetrakis(triphenylphosphino )palladium 
(56 mg), DMF and Na2C03 (1 M, 2.5 mL); reaction time 
70 h; eluent petroleum ether (bp 40-60 °C):Et0Ac (3:7 v/v) gave 142 as a white solid 
(144 mg, 76%), mp 125-126 °C; 1H NMR (300 MHz, CDCh) 8 9.13 (1H, d, J = 2.4 
Hz), 8.52 (1H, d, J = 2.4 Hz), 8.26 (1H, d, J = 1.8 Hz), 8.14 (1H, d, J = 8.7 Hz), 7.94-
7.88 (2H, m), 7.76-7.71 (1H, m), 7.62-7.57 (lH, m), 4.02 (3H, OMe, s); 13C NMR (100 
MHz, CDCh) 8 164.11, 149.32, 147.29, 145.43, 137.54, 132.70, 130.70, 129.51, 
129.27, 127.95, 127.89, 127.19, 126.89, 111.37, 53.70; MS (El) m/z 236 (M+, 100%). 
Anal. Calcd for C15H12N20: C, 76.25%; H, 5.12%; N, 11.86%. Found: C, 75.99%; H, 
5.08%; N, 11.64%. 
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6'-Methoxy-[2,3 ']bipyridinyl (143) 
· Conditions A: 123 (50 mg, 0.3 mmol), 2-bromopyridine (163 
Meo---n-D mg, 1.0 mmol), tetrakis(triphenylphosphino )palladium (26 mg), \~__§'\~_// 
DMF and Na2C03 (1 M, 1.0 mL); reaction time 22 h; eluent 
petroleum ether (bp 40-60 °C):Et0Ac (7:3 v/v) gave 143 as a dark red oil (28 mg, 
50%). 1H NMR (300 MHz, CDCh) 8 8.73 (1H, d, J= 2.4 Hz), 8.68-8.66 (1H, m), 8.24 
(1H, dd, J= 2.6 Hz, J= 2.6 Hz), 7.78-7.72 (IH, m), 7.66 (1H, d, J= 7.8 Hz), 7.25-7.20 
(lH, m), 8 6.84 (lH, d, J = 8.4 Hz), 3.99 (3H, OMe, s); 13C NMR (125 MHz, D20) 8 
167.48, 157.45, 152.59, 148.43, 139.99, 131.33, 125.02(2C), 122.29, 113.35, 55.76; MS 
(El) m/z 186 (M+, 100%). HRMS(El) calcd for C11H 10N20 (M+) 186.0793, found 
186.0795. 
6-Methoxy-[3,3']-bipyridinyi (144) 
Conditions A: 123 (100 mg, 0.7 mmol), 3-bromopyridine (162 
Meo--()----0 mg, 1.0 mmol), tetrakis(triphenylphosphino)palladium (56 mg), 
N N DMF and Na2C03 (1 M, 2.0 mL); reaction time 48 h; eluent 
E~OAc gave 144 as a white solid (71 mg, 58%), mp 62-63 oc; 1H NMR (300 MHz, 
acetone-d6) 8 8.86 (lH, d, J = 2.4 Hz), 8.57 (1H, d, J = 4.8 Hz), 8.49 (1H, d, J = 2.4 
Hz), 8.02 (1H, dd, J= 1.8 Hz, J= 1.8 Hz), 7.48-7.43 (1H, m), 6.90 (1H, d, J= 8.4 Hz), 
3.95 (3H, OMe, s); 13C NMR (63 MHz, acetone-d6) 8 165.23, 149.65, 148.76, 146.30, 
138.62, 134.75, 134.44, 128.00, 124.83, 112.06, 54.00; MS (El) m/z 186 (M+, 100%). 
Anal. Calcd for C11H10N20: C, 70.95%; H, 5.41 %; N, 15.04%. Found: C, 70.52%; H, 
5.32%; N, 15.05%. 
6,6'-Dimetboxy-[3,3 ']bipyridinyl (145) 
Conditions A: 123 (150 mg, 1.0 mmol), 5-bromo-2-
Meo-D----0-oMe methoxypyridine (145 mg, 0.8 mmol), 
N N 
tetrakis(triphenylphosphino) palladium (50 mg), DMF 
and Na2C03 (1 M, 3.0 mL); reaction time 65 h; eluent , petroleum ether (bp 40-60 
°C):Et0Ac 4:1 v/v gave 145 as a white solid (138 mg, 83%), mp 104.5-106 oc (lit. mp 
104-105 °C)2; 1H NMR (300 MHz, CDCh) 8 8.33 (2H, d, J= 2.1 Hz), 7.72 (2H, dd, J= 
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2.4 Hz, J = 2.4 Hz), 6.83 (2H, d, J = 8.7 Hz), 3.98 (6H, OMe, s); 13C NMR (75 MHz, 
CDCh) 8 163.86(2C), 144.76(2C), 137.70(2C), 127.17(2C), 111.33(2C), 53.83(2C); 
MS (El) m/z 216 (M+, 100%). Anal. Calcd for C12H 12N20 2: C, 66.65%; H, 5.59%; N, 
12.96%. Found: C, 66.42%; H, 5.62%; N, 12.97%. 
6'-Methoxy-5-trifluoromethyl-[2,3']-bipyridinyl (146) 
Conditions A: 123 (100 mg, 0.7 mmol), 2-bromo-5-
Meo-Q--0-/; ~ /; CF3 (trifluoromethyl)pyridine (170 mg, 0.8 mmol), 
N N 
tetrakis(triphenylphosphino)palladium (38 mg), DMF and 
Na2C03 (1 M, 2.0 mL); reaction time 70 h; eluent DCM:EtOAc (9: 1 v/v) gave 146 as a 
yellow solid (53 mg, 32%), mp 78-80 °C; 1H NMR (400 MHz, acetone-d6) 8 8.98 (2H, 
dd, J = 0.8 Hz, J = 0.8 Hz), 8.47 (1H, dd, J = 2.6 Hz, J = 2.6 Hz), 8.23-8.15 (2H, m), 
6.93 (1H, dd, J = 0.8 Hz, J = 0.8 Hz), 3.98 (3H, OMe, s); 13C NMR (1 00 MHz, acetone-
d6) 8 165.56, 158.56, 146.59 (J= 3.9 Hz), 145.75, 137.74, 134.61 (J= 3.5 Hz), 134.54 
(J= 3.5 Hz), 127.28, 124.37 (J= 117.3 Hz), 119.62, 111.04, 53.31; MS (El) m/z 253 
(M+, 100%). Anal. Calcd for C12H9F3N20: C, 56.70%; H, 3.57%; N, 11.02%. Found: 
C, 56.78%; H, 3.61 %; N, 10.72%. 
6-Methoxy-6'-nitro-[3,3']bipyridinyl (147) 
Conditions A: 123 (100 mg, 0.7 mmol), 5-bromo-2-
Meo---n---D-No2 nitropyridine (140 mg, 0.7 mmol), ~___r'Lr 
tetrakis(triphenylphosphino )palladium (30 mg), DMF and 
Na2C03 (1 M, 2.0 mL); reaction time 65 h; eluent petroleum ether (bp 40-60 
°C):Et0Ac (3:2 v/v) gave 147 as a yellow solid (150 mg, 66%), mp 191-192 oc; 1H 
NMR (300 MHz, CDCh) 8 8.81 (1H, d, J= 1.8 Hz), 8.48 (1H, d, J= 2.1 Hz), 8.36 (1H, 
d, J= 8.7 Hz), 8 8.16 (1H, dd, J= 2.3 Hz, J= 2.3 Hz), 7.86 (1H, dd, J= 2.6 Hz, J= 2.6 
Hz), 6.93 (lH, d, J= 8.4 Hz), 4.02 (3H, OMe, s); 13C NMR (75 MHz, CDCh) 8 165.31, 
156.35, 146.71, 146.08, 139.68, 137.50, 137.21, 124.60, 118.62, 112.13, 54.17; 
53.83(2C); MS (El) mlz 231 (M+, 100%). Anal. Calcd for Ct 1H9N303: C, 57.14%; H, 
3.92%; N, 18.17%. Found: C, 56.94%; H, 3.97%; N, 17.92%. 
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6'-Methoxy-5-nitro-[3,3']bipyridinyl-6-ylamine (148) 
Conditions A: 123 (100 mg, 0.7 mmol), 2-amino-5-
bromo-2-nitropyridine (109 mg, 0.7 mmol), 
tetrakis(triphenylphosphino)palladium (38 mg), DMF and 
Na2C03 (1 M, 2.0 mL); reaction time 69 h; eluent 
petroleum ether (bp 40-60 °C):Et0Ac (2:3 v/v) gave 148 as an orange solid (55 mg, 
45%), mp 230-231 °C; 1H NMR (200 MHz, DMSO) 8 8.74 (1H, d, J = 2.0 Hz), 8.52 
(2H, dd, J= 2.3 Hz, J= 2.3 Hz), 8.07-7.99 (3H, m), 6.88 (1H, d, J= 8.6 Hz), 3.86 (3H, 
OMe, s); 13C NMR (50 MHz, CDCh) 8 163.73, 154.88, 153.49, 144.93, 137.81, 132.19, 
125.75, 122.57, 117.27, 111.36, 53.97; MS (El) m/z 246 (M+, 100%). Anal. Calcd for 
CttHION403: C, 53.66%; H, 4.09%; N, 22.75%. Found: C, 53.56%; H, 4.13%; N, 
22.45%. 
3-(2-Methoxy-pyridin-3-yl)-quinoline (149) 
Conditions A: 131 (50 mg, 0.3 mmol), 3-bromoquinoline (1 07 
mg, 0.5 mmol), tetrakis(triphenylphosphino )palladium ( 19 m g), 
DMF, Na2C03 (1 M, 1.0 mL); reaction time 68 h; eluent 
petroleum ether (bp 40-60 °C):Et0Ac (3:7 v/v) gave 149 as an 
white solid (47 mg, 61 %). Conditions B: 131 (100 mg, 0.7 mmol), 3-bromoquinoline 
(153 mg, 0.7 mmol), Pd(PPh3)2Ch (20 mg) and Cs2C03 (lM, 2.0 mL); reaction time 95 
h; eluent, EtOAc:DCM (1:1 v/v) gave 149 as a white solid (86 mg, 77%), mp 89-90 oc; 
1H NMR (400 MHz, acetone-d6) 8 9.12 (lH, d, J =2.0 Hz), 8.48 (1H, d, J = 2.0 Hz), 
8.26 (1H, dd, J = 2.0 Hz, J = 2.0 Hz), 8.09-8.07 (1H, m), 8.02-7.99 (1H, m), 7.95 (1H, 
dd, J= 2.0 Hz, J= 2.0 Hz), 7.80-7.76 (1H, m), 7.66-7.61 (1H, m), 7.18-7.14 (1H, m), 
3.98 (3H, OCH3, s); 13C NMR (100 MHz, acetone-d6) 8 161.21, 151.35 147.52, 147.03, 
139.33, 135.42, 130.25, 129.64, 129.33, 128.44, 128.06, 127.00, 121.40, 117.77, 53.21; 
MS (El) m/z 236 (M+, 100%). HRMS(EI) calcd for C 15H12N20 (M+) 236.0950, found 
236.0950. 
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3-( 6-Ethoxy-pyridin-3-yl)-quinoline (150) 
EtO 
Conditions A: 124 (73 mg, 0.4 mmol), 3-bromoquinoline 
(153 mg, 0.7 mmol), tetrakis(triphenylphosphino)palladium 
(35 mg) and Na2C03 (IM, 1.3 mL); reaction time 63 h; 
eluent, DCM:EtOAc (9:1 v/v) gave 150 as a. white solid (54 
mg, 49%). Conditions B: 124 (12 mg, 0.07 mmol), 3-bromoquinoline (21 mg, 0.1 
mmol), Pd(PPh3) 2Ch (3 mg) and Cs2C03 (1M, 0.25 mL); reaction time 63 h; eluent 
DCM:EtOAc (9:1 v/v) gave 150 as a white solid (10 mg, 59%), mp 104-105°C; 1H 
NMR (250 MHz, acetone-d6) 8 9.21 (IH, d, J =2.5 Hz), 8.63 (1H, d, J = 2.0 Hz), 8.54 
(1H, d, J= 2.0 Hz), 8.16 (IH, dd, J= 2.7 Hz, J= 2.7 Hz), 8.10-8.00 (2H, m);7.80-7.73 
(1H, m), 7.67-7.60 (1H, m), 6.93 (IH, d, J = 8.0 Hz), 4.43 (2H, q, J = 7.0 Hz), 1.39 (3H, 
t, J= 7.0 Hz); 13C NMR (63 MHz, acetone-d6) 8 164.95, 150.34 148.58, 146.66, 138.81, 
133.38, 131.82(2C), 130.36(2C), 129.30, 128.11, 127.87, 112.31, 62.62, 15.18; MS (El) 
mlz 250 (M+, 55%). HRMS(EI) calcd for C16H14N20 (M+) 250.1106, found 250.1106. 
2-( 6-Methoxy-pyridin-3-yl)-pyrimidine (151) 
Conditions A: 123 (100 mg, 0.7 mmol), 2-bromopyrimidine 
(105 mg, 0.7 mmol), tetrakis(triphenylphosphino) palladium 
(56 mg), DMF and Na2C03 (1 M, 2.0 mL); reaction time 70 h; 
eluent petroleum ether (bp 40-60 °C):Et0Ac (3:2 v/v) gave 151 as a white solid (34 mg, 
28%), mp 70-71 °C; 1H NMR (400 MHz, acetone-d6) 8 9.09 (1H, d, J = 2.4 Hz), 8.72 
(2H, d, J= 4.8 Hz), 8.51 (1H, dd, J= 2.2 Hz, J= 2.2 Hz), 7.25 (lH, t, J= 5.2 Hz), 6.77-
6.75 (1H, m), 3.85 (3H, OMe, s); 13C NMR (100 MHz, acetone-d6) 8 166.22, 163.20, 
158.02(2C), 148.12, 138.58, 127.55, 119.96, 110.91, 53.56; MS (El) mlz 186 (M+, 
100%). Anal. Calcd for C 10H9N30: C, 64.16%; H, 4.85%; N, 22.45%. Found: C, 
63.79%; H, 4.89%; N, 22.19%. 
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5-( 6-Methoxy-pyridin-3-yD)-pyrimidline (152) 
Conditions A: 123 (50 mg, 0.3 mmol), 5-bromopyrimidine (60 
Meo---<J---(~) mg, 0.4 mmol), tetrakis(triphenylphosphine) palladium (26 
N N 
mg), DMF and Na2C03 (1 M, 1.0 mL); reaction time 70 h; 
eluent petroleum ether (bp 40-60 °C):Et0Ac (1 :9 v/v) gave 152 as a white solid (20 mg, 
35%), mp 162-164 oc; 1H NMR (300 MHz, acetone-d6) 8 9.14 (1H, s), 9.07 (lH, s), 
8.57 (lH, d, J = 1.8 Hz), 8.10 (1H, dd, J = 2.7 Hz, J = 2.7 Hz), 6.95 (lH, dd, J = 0.6 Hz, 
J = 0.6 Hz), 3.96 (3H, OMe, s); 13C NMR (75 MHz, acetone-d6) 8 164.66, 157.53, 
154.58(2C), 145.61, 137.66, 131.42, 123.77, 111.41, 53.22; MS (El) mlz 187 (M+, 
100%). HRMS(El) calcd for C10H9N30 (M+) 187.0746, found 187.0746. 
5-(6-Methoxy-pyridin-3-yl)-pyrazine-2-ylamine (153) 
Conditions A: 123 (100 mg, 0.7 mmol), 2-bromo-5-
Me0~-=t-NH2 aminopyrazine (63 mg, 0.5 mmol), 
N N 
tetrakis(triphenylphosphino)palladium (38 mg), DMF and 
Na2C03 (1 M, 2.0 mL); reaction time 70 h; eluent EtOAc gave 153 as an off-white solid 
(33 mg, 26%), mp 164-165 °C (from toluene); 1H NMR (300 MHz, acetone-d6) 8 8.70 
(1H, d, J = 2.4 Hz), 8.46 (1H, s), 8.20 (1H, dd, J = 2.7 Hz, J = 2.7 Hz), 8.05 (1H, s), 
6.82 (1H, d, J = 8.4 Hz), 5.92 (2H, NH2, br s), 3.92 (3H, OMe, s); 13C NMR (125 MHz, 
D20) 8 166.58, 163.20, 157.76, 146.52, 141.49, 141.17, 138.64, 134.48, 129.83, 113.32, 
55.60; MS (El) m/z 202 (M+, 100%). HRMS(El) calcd for C10H10N40 (M+) 202.0855, 
found 202.0857. 
2-Methoxy-5-thiazol-2-yl-pyridine (154) 
Conditions A: 123 (100 mg, 0.7 mmol), 2-bromothiazole (184 
~NJ mg, 0.6 mmol), tetrakis(triphenylphosphino)palladium (38 mg), MeO\~,___y-< I 
N S DMF and Na2C03 (1 M, 2.0 mL); reaction time 70 h; eluent 
petroleum ether (bp 40-60 °C):Et0Ac (7:3 v/v) gave 154 as an off-white solid (107 mg, 
85%), mp 76-79 oc; 1H NMR (300 MHz, acetone-d6) 8 8.75 (1H, d, J= 2.1 Hz), 8.23 
(1H, dd, J= 2.7 Hz, J= 2.7 Hz), 7.87 (1H, d, J= 3.0 Hz), 7.61 (1H, d, J= 3.0 Hz), 6.89 
(lH, d, J= 8.7 Hz), 3.95 (3H, OMe, s); 13C NMR (63 MHz, acetone-~) 8 166.21, 
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146.20, 144.88, 137.87, 124.95, 122.77, 120.14, 112.20, 54.26; MS (El) mlz 192 (M+, 
100%). Anal. Calcd for C9H8N20S: C, 56.23%; H, 4.19%; N, 14.57%. Found: C, 
56.10%; H, 4.31%; N, 14.23%. 
2-Metboxy-5-thien-2-yl-pyridine (155) 
Conditions A: 123 (229 mg, 1.5 mmol), 2-bromothiophene (170 
MeO ~ /11.. mg, 1.0 mmol), tetrakis(triphenylphosphino)palladium (30 mg), 
\N=.f"s/ 
DMF and Na2C03 (1 M, 4.5 mL); reaction time 65 h; eluent 
petroleum ether (bp 40-60 °C):Et0Ac (9:1 v/v) gave 155 as a yellow oil (174 mg, 87%). 
1H NMR (300 MHz, CDCh) o 8.41 (1H, d, J = 2.1 Hz), 7.73 (1H, dd, J = 2.6 Hz, J = 
2.6 Hz), 7.24 (lH, dd, J= 0.7 Hz, J= 0.7 Hz), 7.18 (1H, dd, J= 0.6 Hz, J= 0.6 Hz), 
7.05-7.03 (lH, m), 6.74 (lH, dd, J= 0.5 Hz, J= 0.5 Hz), 3.95 (3H, OMe, s); 13C NMR 
(75 MHz, CDCh) 8 163.75, 144.15, 140.97, 136.70, 128.30, 124.88, 124.31, 123.14, 
111.17, 53.82; MS (El) m/z 191 (~, 100%). Anal. Calcd for C10H9NOS: C, 62.80%; 
H, 4.74%; N, 7.32%. Found: C, 62.54%; H, 4.77%; N, 7.33%. 
2-Methoxy-5-thien-3-yl-pyridine (156) 
Conditions A: 123 (229 mg, 1.5 mmol), 2-bromothiophene (172 
MeO ~ C's mg, 1.1 mmol), tetrakis(triphenylphosphino)palladium (30 mg), \N~' 
DMF and Na2C03 (1 M, 4.5 mL); reaction time 65 h; eluent 
petroleum ether (bp 40-60 °C):Et0Ac (9:1 v/v) gave 156 as a yellow solid (163 mg, 
77%), mp 31-31 °C. 1H NMR (300 MHz, CDCh) 8 8.41 (1H, d, J= 2.7 Hz), 7.75 (1H, 
dd, J= 2.7 Hz, J= 2.7 Hz), 7.39-7.31 (3H, m), 6.77 (1H, d, J= 8.4 Hz), 3.97 (3H, OMe, 
s); 13C NMR (75 MHz, CDCh) 8 163.51, 144.60, 139.08, 137.06, 126.90, 126.08, 
125.47, 119.95, 111.10, 53.77; MS (El) mlz 191 (M+, 100%). Anal. Calcd for 
C10H9NOS: C, 62.80%; H, 4.74%; N, 7.32%. Found: C, 62.75%; H, 4.77%; N, 7.34%. 
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2-Methoxy-5-(5-nitrothien-2-yl)-pyridine (157) 
Conditions A: 123 (50 mg, 0.3 mmol), 2-bromo-5-
MeO~N02 nitrothiophene (115 mg, 0. 7 mmol), 
N- S tetrakis(triphenylphosphino)palladium (37 mg), DMF and 
Na2C03 (1 M, 2.0 mL); reaction time 63 h; eluent DCM:MeOH (99: 1 v/v) gave 157 as a 
yellow solid (109 mg, 94%), mp 186-187 oc. 1H NMR (300 MHz, CDCh) o 8.48 (1H, 
d, J= 2.1 Hz), 7.91 (1H, dd, J= 0.6 Hz, J= 0.6 Hz), 7.79 (1H, dd, J= 2.3 Hz, J= 2.3 
Hz), 7.16 (1H, d, J = 4.2 Hz), 6.84 (1H, d, J = 8.7 Hz), 4.00 (3H, OMe, s); 13C NMR 
(125 MHz, CDCh) o 165.34, 148.94, 145.12, 136.64, 130.01, 122.12, 111.98, 111.94, 
54.21; MS (El) m/z 236 (M+, 100%). Anal. Calcd for C10H8N20 3S: C, 50.84%; H, 
3.41%; N, 11.86%. Found: C, 50.61%; H, 3.41%; N, 11.90%. 
5-Furan-2-yl-methoxy-pyridine (158) 
Conditions A: 123 (100 mg, 0.7 mmol), 2-bromofuran (83 mg, 
MeO---o-o 0.6 mmol), tetrakis(triphenylphosphino)palladium (41 mg), 
DMF and Na2C03 (2 M, 1.0 mL) reaction time 110 h; eluent, 
DCM gave 158 as a yellow oil (65 mg, 67%). Conditions B 123 (2.0 g, 13.1 mmol), 2-
bromofuran (1.7 g, 11.2 mmol), Pd(PPh3)2Ch (472 mg) and Cs2C03 (1 M, 39 mL); 
reaction time 69 h; eluent, DCM gave 158 as a yellow oil (1.8 g, 91 %); 1H NMR (500 
MHz, acetone-d6) o 8.53 (1H, d, J= 2.0 Hz), 7.99 (1H, dd, J= 2.5 Hz, J= 2.5 Hz), 7.64 
(1H, m), 6.84 (1H, dd, J = 1.0 Hz, J = 1.0 Hz), 6.81 (lH, dd, J = 0.5 Hz, J = 0.5 Hz), 
6.56-6.55 (lH, m), 3.92 (3H, OCH3, s); 13C NMR (125 MHz, acetone-d6) o 163.59, 
151.63, 142.63, 142.52, 134.66, 121.13, 111.94, 111.02, 104.94, 53.05; MS (El) m/z 
175 (M+, 1 00%). HRMS(El) calcd for C10H90 2N (M+) 175.0633, found 175.0634. 
5-Furan-3-yl-methoxy-pyridine (159) 
Conditions A: 123 (122 mg, 0.8 mmol), 3-bromofuran (82 mg, 
MeO ~ ~0 0.6 mmol), tetrakis(triphenylphosphino)palladium (46 mg), 1,4-~~\ 
dioxane and Na2C03 (2 M, 1.3 mL) reaction time 88 h; eluent, 
DCM gave 159 as a clear liquid (53 mg, 54%) which rapidly darkened in colour on 
storage; 1H NMR (400 MHz, acetone-d6) o 8.01 (1H, d, J = 0.4 Hz), 7.89 (1H, dd, J = 
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2.4 Hz, J = 2.4 Hz), 7.67-7.65 (lH, m), 6.89-6.88 (1H, m), 6.79 (1H, dd, J = 0.4 Hz, J = 
0.4 Hz), 3.90 (3H, OCH3, s); 13C NMR (500 MHz, acetone-d6) 8 163.43, 144.50, 
144.01, 138.73, 136.56, 126.70, 110.90, 108.59, 52.89; MS (El) m/z 175 (M+, 100%). 
2,5-Bis(2-methoxy-4-pyridyl)thiophene (160) 
M eO 
Conditions A: 123 (324 mg, 2.1 mmol), 2,5-
0Me dibromothiophene (215 mg, 0.5 mmol), 
tetrakis(triphenylphosphino) palladium (244 mg), 
DMF and NazC03 (1 M, 7.0 mL); reaction time 70 h; eluent DCM:EtOAc (9:1 v/v) gave 
160 as a yellow solid (53 mg, 34%), mp 126-127 °C (from cyclohexane). 1H NMR (200 
MHz, acetone-d6) 8 8.36 (2H, d, J = 2.3 Hz), 7.85 (2H, dd, J = 3.3 Hz, J = 3.3 Hz), 7.29 
(2H, s), 6.72 (2H, d, J = 10.8 Hz), 3.80 (6H, OMe, s); 13C NMR (100 MHz, CDCh) 8 
163.83(2C), 143 .96(2C), 140.13(2C), 136.45(2C), 124.1 0(2C), 111.29(2C), 53 .90(2C); 
MS (El) m/z 298 (M+, 100%). Anal. Calcd for C16H14N20 2S: C, 64.41 %; H, 4.73%; N, 
9.39%. Found: C, 64.50%; H, 4.84%; N, 9.20%. 
3-(5-Bromo-2-methoxy-pyridin-4-yl)-quinoline (161) 
M eO ~ /; Br 
Conditions A: 134 (100 mg, 0.4 mmol), 3-bromoquinoline (123 
mg, 0.6 mmol), tetrakis(triphenylphosphine)palladium (25 mg), 
DMF and Na2C03 (1 M, 1.5 mL); reaction time 46 h; eluent 
DCM:EtOAc (8:2 v/v) gave 161 as a white solid (68 mg, 50%), 
N Conditions B: 134 (100 mg, 0.4 mmol), 3-bromoquinoline (123 
mg, 0.6 mmol) Pd(PPh3)2Ch (16 mg) and Cs2C03 (1 M, 1.2 mL); reaction time 98 h; 
eluent, DCM:EtOAc (9:1 v/v) gave 161 as a white solid (68 mg, 50%), mp 120-123 oc; 
1H NMR (400 MHz, acetone-d6) 8 9.14 (lH, d, J =2.0 Hz), 8.54 (1H, d, J = 2.4 Hz), 
8.33 (1H, d, J= 2.8 Hz), 8.12 (1H, d, J = 2.4 Hz), 8.10-8.08 (1H, m), 8.04-8.01 (1H, m), 
7.83-7.79 (1H, m), 7.67-7.63 (1H, m), 3.99 (3H, OCH3, s); 13C NMR (125 MHz, 
acetone-d6) 8 160.32, 151.04 147.73, 147.17, 141.32, 135.92, 130.01, 129.35, 128.81, 
128.57, 127.94, 127.15, 123.56, 112.09, 53.78; MS (El) mlz 316 ([M+2t, 98%), 314 
(M+, 100%). HRMS(EI) calcd for C15H 11BrN20 (M+) 314.0055, found 314.0054. 
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5'-Chloro-2'-methoxy-[2,4']bipyridinyl (162) 
Conditions A: 137 (100 mg, 0.5 mmol), 2-bromopyridine (163 mg, 
0.6 mmol), tetrakis(triphenylphosphine )palladium (31 m g), DMF 
and Na2C03 (1 M, 1.5 mL); reaction time 65 h; eluent 
DCM:EtOAc (9:1 v/v) gave 162 as a white solid (41 mg, 35%), 
mp 76.5-78 oc; 1H NMR (400 MHz, acetone-d6) 8 8.58-8.56 (1H, m), 8.26 (1H, d, J= 
2.4 Hz), 8.08 (lH, d, J = 2.4 Hz), 8.03-8.01 (1H, m), 7.76-7.71 (lH, m), 7.26-7.22 (lH, 
m), 3.90 (3H, OMe, s); 13C NMR (100 MHz, acetone-d6) 8 159.90, 152.21, 149.90, 
145.05, 138.70, 136.56, 124.63, 124.50, 123.97, 123.22, 53.72; MS (El) m/z 222 
([M+2t, 10%), 220 (M+, 30%). Anal. Calcd for C11 H9ClN20: C, 59.88%; H, 4.11%; N, 
12.70%. Found: C, 60.12%; H, 4.32%; N, 12.53%. 
5-Chloro-2-methoxy-4-(5-nitrothien-2-yl)-pyridine (163) 
MeOQ-o- Conditions A: 137 (100 mg, 0.5 mmol), 2-bromo-5-
nitrothiophene (129 mg, 0.6 mmol), 
N N02 
tetrakis(triphenylphosphino )palladium (31 m g), DMF and 
Cl Na2C03 (1 M, 1.5 mL); reaction time 65 h· eluent 
' 
DCM:petroleum ether (bp 40-60 °C) (9:1 v/v) gave 163 as a yellow solid (40 mg, 
28%), mp 177-200 oc; 1H NMR (400 MHz, acetone-~) 8 8.32 (1H, d, J = 2.4 Hz), 
8.13 (1H, d, J = 2.4 Hz), 7.95 (1H, d, J = 4.4 Hz), 7.80 (lH, d, J = 4.4 Hz), 4.04 (3H, 
OMe, s); 13C NMR (125 MHz, acetone-d6) 8 174.68, 158.08, 146.02, 142.76, 135.92, 
128.85, 125.79, 124.83, 116.78, 54.30; MS (El) m/z 272 ([M+2t, 18%), 270 (M+, 
40%). Anal. Calcd for C10H7ClN203S: C, 44.37%; H, 2.61 %; N, 10.35%. Found: C, 
43.88%; H, 2.63%; N, 9.91 %. 
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3-(5-Chloro-2-methoxy-pyridin-4-yl)-quinoline (164) 
M eO 
Conditions B: 137 (100 mg, 0.5 mmol), 3-bromoquinoline (123 
mg, 0.6 mmol), Pd(PPh3)zCh (20 mg) and Cs2C03 (1 M, 1.6 
mL); reaction time 98 h; eluent, DCM : EtOAc (9: 1 v/v) gave 
164 as a white solid (86 mg, 60%), mp 130-132 oc; 1H NMR 
(400 MHz, acetone-d6) 8 9.02 (lH, d, J=2.0 Hz), 8.50 (1H, d, J 
= 2.0 Hz), 8.34 (1H, s), 8.10 (2H, dd, J= 8.2 Hz, J= 8.2 Hz), 7.88-7.84 (1H, m), 7.72-
7.68 (lH, m), 7.05 (lH, s), 3.97 (3H, OCH3, s); 13C NMR (100 MHz, acetone-d6) 8 
163.58, 150.17 148.09, 147.41, 146.81, 136.25, 130.56, 130.09, 129.44, 128.72, 127.54, 
127.48, 122.71, 112.90, 53.58; MS (El) m/z 270 (M+, 100%). HRMS(EI) calcd for 
CtsHttClN20 (M+) 270.0560, found 270.0559. 
5-Bromo-2-ethoxy-4-(5-nitro-thiophen-2-yl)-pyridine (165) 
EtO NQ--o-N02 
Br 
Conditions B: 138 (20mg, 0.08 mmol), 2-bromo-5-
nitrothiophene (20 mg, 0.1 mmol), Pd(PPh3)zCh (3 mg) and 
Cs2C03 (1 M, 0.25 mL); reaction time 59 h; eluent CH2Ch 
gave 165 as a yellow solid (11 mg, 45%), mp 84-86 °C; 1H 
NMR (500 MHz, acetone-d6) 8 8.32 (1H, s), 7.99 (1H, d, J = 4.0 Hz), 7.51 (1H, d, J = 
4.5 Hz), 6.96 (lH, s), 4.25 (2H, q, J = 4.5 Hz), 1.24 (3H, t, J = 7.0 Hz); 13C NMR (125 
MHz, acetone-d6) 8 163.80, 152.95, 150.44, 145.21, 142.44, 129.32, 129.00, 112.96, 
110.31, 62.57, 14.10; MS (El) m/z 330 (M+, 50%). HRMS (El) calcd for 
CttH9BrN203S (M+) 327.9517, found 327.9517. 
5-Chloro-4-furan-2-yl-2-methoxy-pyridine (166) 
0~ ;::~~o~:~::e~:,,~~~:::i~~:~~~~:~::~~~:::::~: 
M eo-G-el 
N (14 mg, 30%), mp 56-58 oc; 1H NMR (400 MHz, acetone-d6) 8 8.09 
(1H, d, J= 0.4 Hz), 7.69 (1H, dd, J= 0.8 Hz, J= 0.8 Hz), 7.31 (1H, dd, J= 0.4 Hz, J= 
0.4 Hz), 7.04 (1H, d, J= 0.4 Hz), 6.58-6.56 (1H, m), 3.78 (3H, OCH3, s); 13C NMR 
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(100 MHz, acetone-d6) o 163.68, 147.96, 147.72, 144.73, 137.74, 119.14, 114.37, 
112.54, 106.96, 53.48; MS (El) m/z 207 (M+, 100%). 
3-(6-Chloro-pyridin-3-yl)-quinoline (167) 8 
Cl 
Phosphoryl chloride (345 mg, 2.3 mmol) was added 
dropwise to stirred solution of 142 (1 06 mg, 0.5 mmol) in 
dry DMF at 0 °C. The stirring was continued for 1 h then 
the mixture was heated at 110 oc for 19 h. It was cooled 
to 0 oc and was quenched with saturated sodium acetate solution (25 mL). The mixture 
was extracted with EtOAc (4x50 mL). The organic layer was then washed with water 
(3x100 mL) and was dried over MgS04. The residue was chromatographed through a 
silica gel column; eluent EtOAc:Petroleum Ether(40-60°C) (7:3 v/v) to give 167 as a 
white solid (49 mg, 44%), mp 180-181 °C (from MeOH); 1H NMR (300 MHz, acetone-
d6) o 9.13 (IH, d, J = 2.4 Hz), 8. 77 (1H, d, J = 2.1 Hz), 8.55 (lH, d, J = 1.8 Hz), 8.20 
(1H, dd, J = 2.7 Hz, J = 2.7 Hz), 7.99-7.92 (2H, m), 7.72-7.66 (1H, m), 7.60-7.50 (2H, 
m); 13C NMR (125 MHz, CDCb) o 151.29, 148.88, 148.17, 147.48, 137.34, 
133.71(2C), 132.60, 130.22, 129.38, 128.05, 127.68, 127.51, 124.59; MS (El) m/z, 240 
(M+, 100%). Anal. Calcd for C14H9ClN2: C, 69.86%; H, 3.77%; N, 11.64%. Found: C, 
69.40%; H, 3.80%; N, 11.53%. 
5.5 Experimental Procedures of Chapter 4 
General procedure for the synthesis of 183-185 (Procedure A) 
A solution of 182 in CH3CN (5 mL) was added, while stirring, to a solution of the 
aldehyde in CH3CN (5 mL). The reaction mixture was refluxed for 18 h. After the 
completion of the reaction (TLC), solvent was removed in vacuo and the crude product 
was purified by silica gel column chromatography to afford the desired product. 
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2-Diethoxymethylfuran (169i 
A mixture of 168 (18.6 g, 193.2 mmol), triethy1orthoformate (35.6 g, 
(EtOhHC---eJ 240.5 mmol) and a warm solution of ammonium nitrate in MeOH 
0 (1.0 gin 10 mL) was heated at 130 oc for 4 h. The crude mixture 
was filtered and sodium carbonate (1.0 g) was added to the filtrate. The filtrate was 
then fractionally distilled under reduced pressure to give 169 as a clear liquid (23.0 g, 
70%). 1H NMR (300 MHz, acetone-d6) 8 7.53-7.51 (lH, m), 6.42-6.40 (2H, m), 5.52-
5.41 (1H, m), 3.62-3.51 (4H, m), 1.21-1.13 (6H, m). 
5-Formylfuran-2-boronic Acid (170) 
To a solution of 169 (1.0 g, 5.9 mmol) in anhydrous THF (20 
OHC-o-B(OHh mL) at -78 oc was added nBuLi (1.6 M in hexane, 2.2 mL, 3.5 
~ h mmol), dropwise. The reaction mixture was stirred for 5 h at -
78 oc then TMB (8.15 mg, 9.6 mmol) was added dropwise and the reaction mixture was 
allowed to warm to 25 °C and stir overnight. Workup as described for 92, with the 
addition of washing the precipitated product with ether (1 0 mL), gave 170 as a brown 
solid (428 mg, 52%), mp 150-151 oc; 1H NMR (250 MHz, acetone-d6) 8 9.70 (lH, s, 
CHO), 7.92 (2H, s, OH), 7.40 (1H, d, J = 3.5 Hz), 7.19 (1H, d, J = 3.5 Hz); 13C NMR 
(100 MHz, acetone-d6) 8 178.44, 155.97, 122.79, 121.63. Anal. Calcd for C5H5B02: C, 
42.93%; H, 3.60%. Found: C, 42.72%; H, 3.70%. 
[2,2 ']Bifuranyl-5-carbaldehyde (171) 
Conditions A: 170 (100 mg, 0.7 mmol), 2-bromofuran (99 mg, 
OHc--()---0 0. 7 mmol), tetrakis(triphenylphosphino )palladium ( 41 mg), DMF 
and Na2C03 (1 M, 1.1 mL); reaction time 109 h; eluent, DCM 
gave 171 as a yellow oil (37 mg, 34%). Conditions B: 170 (200 mg, 1.4 mmol), 2-
bromofuran (165 mg, 1.4 mmol), Pd(PPh3) 2Ch (52 mg) and Cs2C03 (1 M, 5.0 mL); 
reaction time 90 h; eluent, DCM gave 171 as a yellow oil (139 mg, 64%); 1H NMR (500 
MHz, acetone-d6) 8 9.66 (lH, CHO, s), 7.78 (lH, dd, J= 0.5 Hz, J= 1.0 Hz), 7.54 (lH, 
d, J = 3.5 Hz), 7.00 (1H, d, J = 3.5 Hz), 6.91 (lH, d, J = 3.5 Hz), 6.69-6.68 (lH, d, J = 
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3.5 Hz); 13C NMR (125 MHz, acetone-d6) 8 177.02, 152.23, 150.89, 145.11, 144.82, 
124.03, 112.42, 109.63, 107.73; MS (El) m/z 162 (M+, 100%). HRMS(EI) calcd for 
C9H603 (M+) 162.0317, found 162.0319. 
5-Thiophen-2-yl-furan-2-carbaldehyde (1 72) 
Conditions A: 170 (100 mg, 0.7 mmol), 2-bromothiophene (102 OHc-Q--0 mg, 0.6 mmol), tetrakis(triphenylphosphino)palladium (41 mg), 
0 \ ~ DMF and Na2C03 (1 M, 1.1 mL); reaction time 126 h; eluent, 
DCM gave 172 as a yellow oil (34 mg, 30%). Conditions B: 170 (200 mg, 1.4 mmol), 
2-bromothiophene (170 mg, 1.3 rnmol), Pd(PPh3)2C}z (52 mg) and Cs2C03 (1 M, 5.0 
mL); reaction time 91 h; eluent, DCM gave 172 as a yellow oil (136mg, 61 %); 1H NMR 
(500 MHz, acetone-d6) 8 9.64 (1H, CHO, s), 7.68 (1H, dd, J= 1.5 Hz, J= 1.5 Hz), 7.66 
(lH, dd, J= 1.3 Hz, J= 1.3 Hz), 7.53 (1H, d, J= 3.5 Hz), 7.23-7.21 (1H, m), 6.99 (1H, d, 
J= 3.5 Hz); 13C NMR (125 MHz, acetone-d6) 8 176.84, 154.57, 152.06, 131.83, 128.63, 
128.14, 126.62, 124.46, 107.85; MS (El) m/z 178 (M+, 100%). HRMS(El) calcd for 
C9H602S (M+) 178.0089, found 178.0089. 
5-( 6-Methoxy-pyridin-3-yl)-furan-2-carbaldehyde (173) 
Conditions A: 170 (1 00 mg, 0. 7 rnmol), 5-bromo-2-
0Hc--Q---Q--oMe methoxypyridine (116 mg, 0.6 rnmo1), 
tetrakis(triphenylphosphino )palladium ( 41 mg), DMF and 
Na2C03 (2 M, 1.5 mL); reaction time 112 h; eluent, DCM:EtOAc (9:1 v/v) gave 173 as 
an orange needles (20 mg, 16%). Conditions B: 170 (200 mg, 1.4 rnmol), 5-bromo-2-
methoxypyridine (247 mg, 1.3 mmol), Pd(PPh3)2C}z (52 mg) and CszC03 (1 M, 5.0 
mL); reaction time 134 h; eluent, DCM:EtOAc (9: 1 v/v) gave 173 as orange needles 
(137 mg, 52%), mp 121-123 oc (from cyclohexane); 1H NMR (400 MHz, acetone-d6) 8 
9.66 (lH, CHO, s), 8.71 (1H, dd, J= 0.8 Hz, J= 0.8 Hz), 8.14 (1H, dd, J= 2.4 Hz, J= 
2.4 Hz), 7.54 (1H, d, J= 3.6 Hz), 7.13 (lH, d, J= 3.6 Hz), 6.92 (1H, dd, J= 0.8 Hz, J= 
0.8 Hz), 3.96 (3H, OCH3, s); 13C NMR (100 MHz, acetone-d6) 8 177.03, 164.88, 
156.89, 152.59, 144.54, 135.74, 124.30, 119.51, 111.44, 107.68, 53.36; MS (El) m/z 
203 (M+, 100%). Anal. Calcd for C11H9N03: C, 65.02%; H, 4.46%; N, 6.89%. Found: 
C, 65.07%; H, 4.63%; N, 6.93%. 
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5-(5-Trifluoromethyl-pyridin-2-yl)-furan-2-carbaldehyde (174) 
Conditions A: 170 (100 mg, 0.7 mmol), 2-bromo-5-
0HC~CF3 (trifluoromethyl)pyridine (110 mg, 0.6 mmol), 
tetrakis(triphenylphosphino)palladium (41 mg), DMF and 
NazC03 (2 M, 1.5 mL); reaction time 134 h; eluent, DCM:EtOAc (9:1 v/v) gave 174 as 
an orange needles (37 mg, 24%). Conditions B: 170 (239 mg, 1.7 mmol), 2-bromo-5-
(trifluoromethyl)pyridine (354 mg, 2.0mmol), Pd(PPh3)2Ch (62mg) and Cs2C03 (lM, 
5.0mL); reaction time 111 h; eluent, DCM:EtOAc (9: 1 v/v) gave 174 as orange needles 
(126 mg, 31 %), mp 93-94 oc (from cyclohexane); 1H NMR (300 MHz, acetone-~) 8 
9.66 (lH, CHO, s), 8.87 (lH, s), 8.20 (1H, dd, J = 2.4 Hz, J = 2.4 Hz), 8.02 (1H, d, J = 
8.4 Hz), 7.49 (1H, d, J = 3.9 Hz), 7.36 (1H, d, J = 3.6 Hz); 13C NMR (125 MHz, 
acetone-d6) 8 178.11, 156.56, 153.82, 151.30, 147.14, 135.06, 125.68 (J = 32.9 Hz), 
123.29, 122.92, 119.76, 112.96; MS (El) m/z 241 (M+, 100%). Anal. Calcd for 
C11H6F3NOz: C, 54.78%; H, 2.51%; N, 5.81%. Found: C, 54.67%; H, 2.48%; N, 5.81 
%. 
5-Pyridin-2-yl-furan-2-carbaldehyde (175) 
Conditions B: 170 (200 mg, 1.4 mmol), 2-bromopyridine (163 
oHc---()---QN /; mg, 1.2 mmol), Pd(PPhJ)zCh (52 mg) and Cs2C03 (1 M, 5.0 
mL); reaction time 110 h; eluent, DCM:EtOAc (9: 1 v/v) gave 
175 as a yellow solid (121 mg, 57%), mp 88-90 oc; 1H NMR (400 MHz, acetone-d6) 8 
9.73 (1H, CHO, s), 8.68-8.66 (1H, m), 7.98-7.92 (2H, m), 7.57 (1H, d, J = 3.6 Hz), 
7.44-7.40 (1H, m), 7.32 (lH, d, J = 3.6 Hz); 13C NMR (100 MHz, acetone-d6) 8 177.79, 
158.30, 153.16, 150.40, 148.08, 137.42, 124.21, 123.65, 119.86, 110.83; MS (El) m/z 
173 (M+, 100%). Anal. Calcd for C10H7N02: C, 69.36%; H, 4.07%; N, 8.09%. Found: 
C, 69.17%; H, 4.08%; N, 8.14%. 
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5-(5-Formyl-furan-2-yl)-nicotinonitrile (176) 
CN 
OH C--u----d 
Conditions B: 170 (200 mg, 1.4 mmol), 3-bromo-5-
cyanopyridine (238mg, 1.3 mmol), Pd(PPh3) 2Clz (52 mg) and 
Cs2C03 (1 M, 5.0 mL); reaction time 110 h; eluent, 
DCM:EtOAc (7:3 v/v) gave 176 as an orange solid (39 mg, 
15%), mp 219-220 oc (from CH3CN); 1H NMR (400 MHz, DMSO) 8 9.67 (1H, CHO, 
s), 9.04 (1H, d, J= 2.0 Hz), 9.31 (1H, d, J= 2.0 Hz), 8.78 (lH, t, J= 2.0 Hz), 7.71 (1H, 
d, J = 3.6 Hz), 7.56 (1H, d, J = 3.6 Hz); 13C NMR (100 MHz, acetone-d6) 8 177.33, 
152.25, 151.48, 151.13, 147.89, 134.67, 123.82, 123.52, 115.31, 110.65, 108.52; MS 
(El) rn/z 198 (M+, 100%). Anal. Calcd for C11 H6N20 2: C, 66.67%; H, 3.05%; N, 
14.14%. Found: C, 66.40%; H, 3.08%; N, 14.19 %. 
5-(6-Nitro-pyridin-3-yl)-furan-2-carbaldehyde (177) 
Conditions B: 170 (50 mg, 0.4 mmol), 5-bromo-2-
0HC--fr-Q-No2 nitropyridine (81 mg, 0.4 mmol), Pd(PPh3)2Ch (13 mg) 
and Cs2C03 (1 M, 1.0 mL); reaction time 48 h; eluent, 
DCM:EtOAc (9:1 v/v) gave 177 as an orange solid (35 mg, 44%), mp 162-164 °C; 1H 
NMR (500 MHz, acetone-d6) 8 9.83 (1H, CHO, s), 9.46 (1H, d, J = 3.0 Hz), 8.77 (lH, 
dd, J = 2.7 Hz, J = 2.7 Hz), 8.21 (lH, d, J = 8.5 Hz), 7.66 (1H, d, J = 4.0 Hz), 7.58 (1H, 
d, J = 4.0Hz); 13C NMR (125 MHz, acetone-d6) 8 178.38, 156.01, 154.22, 152.28, 
145.76, 143.97, 133.08, 123.25, 120.04, 114.30; MS (ED m/z 218 (M+, 100%). Anal. 
Calcd for C10H6N20 4: C, 55.05%; H, 2.77%; N, 12.84%. Found: C, 55.05%; H, 2.89%; 
N, 12.55%. 
5-(5-Nitro-thiophen-2-yl)-furan-2-carbaldehyde (178) 
Conditions B: 170 (50 mg, 0.4 mmol), 5-bromo-2-
0HC~No2 nitrothiophene (90 mg, 0.4 mmol), Pd(PPh3)2Ch (13 mg) 
and Cs2C03 (1 M, 1.0 mL); reaction time 41 h; eluent, 
DCM:Hexane (9:1 v/v) gave 178 as a yellow solid (43 mg, 54%), mp 150-152 oc; 1H 
NMR (400 MHz, acetone-d6) 8 9.73 (1H, CHO, s), 8.09 (lH, d, J= 4.4 Hz), 7.69 (1H, 
d, J= 4.4 Hz), 7.60 (1H, d, J= 4.0 Hz), 7.37 (1H, d, J= 3.6 Hz); 13C NMR (400 MHz, 
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acetone-d6) o 177.71, 153.17, 151.46, 138.14(2C), 130.42, 125.45, 123.68, 111.98; MS 
(El) rn/z 223 (M+, 100%). Anal. Calcd for C9H5N04S: C, 48.43%; H, 2.26%; N, 6.28%. 
Found: C, 48.42%; H, 2.36%; N, 6.24 %. 
5-Bromonicotinamide (180) 
,)--NH2 Ethyl-5-bromonicotinate (5.5 g, 24.0 mmol) was added to a concentrated ammonia solution (100 mL) and was stirred at 25 oc 
Br--cJ 
N 
for 24 h. The solution was then evaporated to dryness and the crude 
product was recrystallised from EtOH to give 180 as a tan solid (4.1 
g, 85%), mp 222-223 °C (lit mpa = 224 °C); 1H NMR (200 MHz, DMSO-d6) o 8.97 
(1H, d, J = 1.6 Hz), 8.83 (1H, d, J = 2.2 Hz), 8.41 (1H, t, J = 2.0 Hz), 8.22 (1H, br s), 
7.73 (1H, br s); 13C NMR (100 MHz, DMSO-d6) o 165.63, 153.25, 147.96, 138.22, 
131.98, 120.76. Anal. Calcd for C6H5BrN20: C, 35.85%; H, 2.51%; N, 13.94%. 
Found: C, 35.70%; H, 2.35%; N, 13.64%. 
3-Bromo-5-cyanopyridine (181) 
CN Br-Q 
5-Bromonicotinamide (3.9 g, 19.3 mmol) and phosphorus pentoxide (7.7 
g, 54.2 mmol) were added together and underwent a solid distillation. 
N 
The distillate was then recrystallised from petroleum ether ( 40-60) to 
give 181 as white needles (883 mg, 25%), mp 104-106 °C (lit mpb = 
105-106 °C); 1H NMR (200 MHz, CDCh) o 8.83 (1H, d, J = 1.8 Hz), 8.75 (1H, d, J = 
1.2 Hz), 8.05 (1H, t, J = 1.6 Hz); 13C NMR (100 MHz, CDCh) o 154.75, 150.59, 
141.60, 120.94, 115.31, 111.46; MS (El) mlz 183 (M+, 100%). Anal. Calcd for 
C6H3BrN2: C, 39.38%; H, 1.65%; N, 15.31%. Found: C, 39.37%; H, 1.62%; N, 
15.25%. 
• Czuba. Recuei/1963, 82, 988. 
b Zwart; Wilbaut. Recuei/1955, 74, 1063. 
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3-[5-(6-Methoxy-pyridin-3-yl)-furan-2-yl]-acrylic acid ethyl ester (183) 
M eO 0 
Synthesised according to procedure A: 173 (50 mg, 
0.3 mmol) and 182 (91 mg, 0.3 mmol). Eluent used, 
OEt DCM:EtOAc (9: 1 v/v) gave 183 as a yellow powder 
(56 mg, 82%), mp 88-89 oc; 1H NMR (200 MHz, acetone-d6) 8 8.68 (1H, d, J = 2.0 
Hz), 8.13 (lH, dd, J=2.4 Hz, J= 2.4 Hz), 7.48 (1H, d, J= 15.6 Hz), 7.00-6.95 (2H, m), 
6.87 (1H, dd, J = 0.6 Hz, J = 0.6 Hz), 6.41 (1H, d, J = 15.8 Hz), 4.21 (2H, q, J = 7.2 
Hz), 3.94 (3H, OCH3, s), 1.29 (3H, t, J = 7.0 Hz); 13C NMR (100 MHz, acetone-d6) 8 
166.41, 164.21, 153.98, 150.58, 143.54, 135.14, 130.60, 120.19, 117.90, 115.30, 
111.21, 107.76, 60.12, 53.21, 13.97; MS (El) rnlz 273 (M+, 100%). Anal. Calcd for 
C 15H 15N04: C, 65.92 %; H, 5.53%; N, 5.13%. Found: C, 65.83%; H, 5.59%; N, 5.11%. 
3-[5-(5-Trifluoromethyl-pyridin-2-yl)-furan-2-yl]-acrylic acid ethyl ester (184) 
Synthesised according to procedure A: 174 (50 mg, 
0 0.2 mmol) and 182 (77 mg, 0.2 mmol). Eluent used, 
DCM:EtOAc (9:1 v/v) gave 184 as a yellow powder 
OEt 
(60 mg, 92%), mp 96-98 oc; 1H NMR (400 MHz, 
acetone-d6) 8 8.21 (lH, s), 7.53-7.44 (2H, m), 6.81 (lH, d, J= 16.0 Hz), 6.65 (1H, d, J 
= 3.6 Hz), 6.35 (1H, d, J = 3.6 Hz), 5.82 (1H, d, J = 15.6Hz), 3.50 (2H, q, J = 7.2 Hz), 
0.57 (3H, t, J= 6.8 Hz); 13C NMR (100 MHz, acetone-d6) 8 166.10, 154.34, 152.72, 
151.72, 146.96(2C), 134.73, 130.45, 122.80 (J = 33.0 Hz), 118.94, 117.66, 113.58, 
110.00, 60.35, 13.93; MS (El) rnlz 311 (M+, 40%). Anal. Calcd for C 15H,2F3N04: C, 
57.88 %; H, 3.89%; N, 4.50%. Found: C, 57.76%; H, 3.99%; N, 4.45%. 
3-(5-Pyridin-2-yl)-furan-2-yl)-acrylic acid ethyl ester (185) 
~air-----.\ < Synthesised according to the procedure A: 175 (50 mg, 0.3 CJ U 'c_it rnrnol) and 182 (101 rng, 0.3 rnrnol). Eluent used, 
OEt DCM:EtOAc (7:3 v/v) gave 185 as a yellow powder (53 
mg, 75%), mp 121-122 oc; 1H NMR (400 MHz, acetone-d6) 8 8.49-8.47 (1H, s), 7.84-
7.73 (2H, m), 7.38 (1H, d, J= 16.0 Hz), 7.21-7.18 (1H, m), 7.08 (lH, d, J= 3.6 Hz), 
6.90-6.88 (1H, m), 6.35 (lH, d, J = 15.2 Hz), 4.09 (2H, q, J = 7.2 Hz), 1.17 (3H, t, J = 
137 
Experimental Procedures 
7.2 Hz); 13C NMR (100 MHz, acetone-d6) 8 166.25, 155.92, 151.53, 150.16, 148.62, 
137.16, 130.69, 123.22, 119.14, 117.72, 116.39, 111.19, 60.22, 13.95; MS (El) m/z 243 
(M+, 52%). Anal. Calcd for C14H13N03: C, 69.12 %; H, 5.39%; N, 5.76%. Found: C, 
68.89%; H, 5.51%; N, 5.71%. 
2-[5-(5-'frifluoromethylpyridin-2-yB)-fuuran-2-yl methylene]-[1, 3]-dithiol-4, 5-
dicarboxylic acid dimethyl ester 0 87) 
To a solution of (4,5-Bis-methoxycarbonyl-
[1 ,3]dithiol-2-yl) tributylphosphonium 
tetrafluoroborate (127 mg, 0.3 mmol) in THF (5 
mL) at -78 °C, nBuLi (1.6 M in hexane, 0.2 
mL, 0.3 mmol) was added dropwise. The mixture was stirred for ~ 1 Omins. A solution 
of 174 (60 mg, 0.3 mmol) in THF (5 mL) was added to the mixture at -78 °C. The 
mixture was allowed to warm to 25 °C, and then the mixture was refluxed for 24 h. The 
THF was removed in vacuo. The remaining residue was dissolved in DCM (20 mL), 
which was washed with water (20 mL) and dry with MgS04. The crude product was 
purified by silica gel column chromatography, eluent DCM:EtOAc (19:1 v/v) gave 187 
as a red solid (56 mg, 51%), mp 135-138 °C; 1H NMR (400 MHz, CDCh) 8 8.80-8.79 
(lH, m), 7.97 (1H, dd, J= 2.4 Hz, J= 2.4 Hz), 7.78 (lH, d, J= 8.4 Hz), 7.27 (lH, d, J= 
3.6 Hz), 6.42 (lH, s), 6.33 (lH, d, J = 4.0 Hz), 3.91 (3H, s, OCH3), 3.88 (3H, s, OCH3); 
13C NMR (100 MHz, CDCb) 8 158.98, 158.77, 151.71, 150.65, 150.46, 145.68, 133.05, 
130.74, 129.67, 122.78 (J = 33.0 Hz), 116.43, 112.42, 108.61(3C), 101.56, 52.48(2C); 
MS (El) 443 (M+, 100%). HRMS(EI) calcd for C1sH12F3NOsS2 (M+) 444.2175, found 
443.4218. 
2-[5-(4,5-Dimethyl-[1,3]-dithiol-2-ylidenemethyl-furan-2yl]-5-
trifluoromethylpyridine (189) 
To a solution of (4,5-dimethyl-[1,3]dithiol-2-yl)-
phosphonic acid dimethyl ester (1 00 mg, 0.3 mmol) 
in THF (5 mL) at -78 °C, nBuLi (1.6 M in hexane, 
0.2 mL, 0.3 mmol) was added dropwise. The mixture was stirred for ~ 1 Omins. A 
solution of 174 (60 mg, 0.3 mmol) in THF (5 mL) was added to the mixture at -78 °C. 
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The mixture was allowed to warm to 25 °C, and then the mixture was refluxed for 24 h. 
The THF was removed in vacuo. The remaining residue was dissolved in DCM (20 
mL), which was washed with water (20 mL) and dry with MgS04. The crude product 
was purified by silica gel column chromatography, eluent DCM:EtOAc (19: 1 v/v) gave 
189 as a yellow oil (12 mg, 11 %). 1H NMR (400 MHz, CDCh) 8 8.75 (lH, s), 7.86 
(1H, d, J= 8.4 Hz), 7.70 (1H, d, J= 8.4 Hz), 7.07 (lH, d, J= 3.6 Hz), 6.36 (lH, d, J= 
3.2 Hz), 4.72 (1H, t, J= 5.6 Hz), 1.86 (3H, s, CH3), 1.32 (3H, s, CH3); 13C NMR (125 
MHz, CDCh) 8 154.82, 152.19, 150.88, 146.85, 137.24, 134.49, 134.46, 123.09 (J = 
33.0 Hz), 123.01, 122.01, 117.26, 114.08, 108.07, 99.23, 12.84, 12.24; MS (El) 355 
(M+, 2%), 242 (M+, 100%). HRMS(EI) calcd for C16HuF3N02S2 (M+) 355.4024, found 
355.4023. 
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